FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Vianna, EQ
   Piergiorge, RM
   Goncalves, AP
   dos Santos, JM
   Calassara, V
   Rosenberg, C
   Krepischi, ACV
   da Silva, RTB
   dos Santos, SR
   Ribeiro, MG
   Machado, FB
   Medina-Acosta, E
   Pimentel, MMG
   Santos-Reboucas, CB
AF Vianna, Evelyn Quintanilha
   Piergiorge, Rafael Mina
   Goncalves, Andressa Pereira
   dos Santos, Jussara Mendonca
   Calassara, Veluma
   Rosenberg, Carla
   Krepischi, Ana Cristina Victorino
   Boy da Silva, Raquel Tavares
   dos Santos, Suely Rodrigues
   Ribeiro, Marcia Goncalves
   Machado, Filipe Brum
   Medina-Acosta, Enrique
   Pimentel, Marcia Mattos Goncalves
   Santos-Reboucas, Cintia Barros
TI Understanding the Landscape of X-linked Variants Causing Intellectual
   Disability in Females Through Extreme X Chromosome Inactivation Skewing
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE X-linked intellectual disability; X chromosome inactivation; Array-CGH;
   Whole-exome sequencing; Escape genes
ID DEVELOPMENTAL DELAY; HDAC8 MUTATIONS; GENE-EXPRESSION; RETT-SYNDROME;
   TBL1XR1; CORNELIA; SPECTRUM; FEATURES; REVEALS; MOSAICISM
AB Intellectual disability (ID) affects 30% more males than females. This sex bias can be attributed to the enrichment of genes on the X chromosome playing essential roles in the central nervous system and their hemizygous state on males. Moreover, as a result of X chromosome inactivation (XCI), most genes on one of the X chromosomes in female somatic cells are epigenetically silenced, so that females carrying X-linked variants are not expected to be so severely affected as males. Consequently, the knowledge about X-linked ID (XLID) in females is still scarce. Herein, we used extreme XCI skewing (>= 90%) to predict X-linked variants in females with idiopathic ID. XCI profiles from 53 probands were estimated from blood and buccal mucosa through a methylation-sensitiveAR/RP2assay. DNA samples with extreme XCI skewing were then submitted to array-comparative genomic hybridization and whole-exome sequencing. Seven females (13.2%) exhibited extreme XCI skewing, a percentage significantly higher than expected for healthy females in our population. XLID-potentially related variants were identified in five patients with extreme XCI skewing, including one pathogenic rstructural rearrangement [der(X) chromosome from a t(X;2)] and four single nucleotide variants inNLGN4X,HDAC8,TAF1, andUSP9Xgenes, two of which affecting XCI escape genes. XCI skewing showed to be an outstanding approach for the characterization of molecular mechanisms underlying XLID in females. Beyond expanding the spectrum of variants/phenotypes associated with ID, our results pointed to compensatory biological pathways underlying XCI and uncover new insights into the involvement of escape genes on XLID, impacting genetic counseling.
C1 [Vianna, Evelyn Quintanilha; Piergiorge, Rafael Mina; Goncalves, Andressa Pereira; dos Santos, Jussara Mendonca; Calassara, Veluma; Pimentel, Marcia Mattos Goncalves; Santos-Reboucas, Cintia Barros] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Genet, Rua Sao Francisco Xavier 524,PHLC Sala 501F, BR-20550013 Rio De Janeiro, RJ, Brazil.
   [Rosenberg, Carla; Krepischi, Ana Cristina Victorino] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary, Sao Paulo, Brazil.
   [Boy da Silva, Raquel Tavares] Univ Estado Rio De Janeiro, Pedro Ernesto Univ Hosp, Rio De Janeiro, Brazil.
   [dos Santos, Suely Rodrigues] Univ Fed Estado Rio de Janeiro, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [Ribeiro, Marcia Goncalves] Univ Fed Rio de Janeiro, IPPMG, Clin Genet Serv, Rio De Janeiro, Brazil.
   [Machado, Filipe Brum] Minas Gerais State Univ, Dept Biol Sci, Belo Horizonte, MG, Brazil.
   [Medina-Acosta, Enrique] State Univ Northern Rio De Janeiro Darcy Ribeiro, Lab Biotechnol, Rio De Janeiro, Brazil.
RP Santos-Reboucas, CB (corresponding author), Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Genet, Rua Sao Francisco Xavier 524,PHLC Sala 501F, BR-20550013 Rio De Janeiro, RJ, Brazil.
EM cbs@uerj.br
RI Piergiorge, R M/N-7940-2016; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Santos-Reboucas,
   Cintia/0000-0003-4729-2373; Piergiorge, Rafael Mina/0000-0002-0744-4355
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (CEPID -FAPESP); Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior -Brasil (CAPES)CAPES [001]; Centro de Producao da
   Universidade do Estado do Rio de Janeiro (CEPUERJ)
FX This work was supported by funds from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (CEPID -FAPESP), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) -Finance
   Code 001, and Centro de Producao da Universidade do Estado do Rio de
   Janeiro (CEPUERJ).
CR Armour CM, 2016, AM J MED GENET A, V170, P1820, DOI 10.1002/ajmg.a.37684
   Balaton BP, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0053-7
   Banerjee S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00058
   Bittel DC, 2008, J MED GENET, V45, P309, DOI 10.1136/jmg.2007.055244
   Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004
   Borges BPCN, 2018, INVESTIGACAO PADROES
   Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301
   Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677
   Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479
   Carrel L, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0355
   Carrette LLG, 2018, P NATL ACAD SCI USA, V115, pE668, DOI 10.1073/pnas.1715124115
   Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8
   Cukier HN, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-1
   Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316
   Domingo A, 2016, CELL MOL LIFE SCI, V73, P3205, DOI 10.1007/s00018-016-2159-4
   Dowsett L, 2019, AM J MED GENET A, V179, P150, DOI 10.1002/ajmg.a.61033
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Feng L, 2014, J HUM GENET, V59, P536, DOI 10.1038/jhg.2014.60
   Fieremans N, 2016, HUM MUTAT, V37, P804, DOI 10.1002/humu.23012
   Fieremans N, 2014, HUM GENET, V133, P1359, DOI 10.1007/s00439-014-1469-6
   Goncalves TF, 2016, EXPERT REV MOL DIAGN, V16, P501, DOI 10.1586/14737159.2016.1135739
   Greenwood Genetic Center, 2020, X LINK INT DIS
   Gudmundsson S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46632-8
   Gupta Neerja, 2006, Indian Journal of Pediatrics, V73, P840, DOI 10.1007/BF02790399
   Harakalova M, 2012, J MED GENET, V49, P539, DOI 10.1136/jmedgenet-2012-100921
   Helgeson M, 2018, J HUM GENET, V63, P349, DOI 10.1038/s10038-017-0387-6
   Hurst Sarah E, 2018, Neuronal Signal, V2, pNS20180141, DOI 10.1042/NS20180141
   Janakiraman U, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104539
   Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394
   Johnson BV, 2020, BIOL PSYCHIAT, V87, P100, DOI 10.1016/j.biopsych.2019.05.028
   Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002
   Kopanos C, 2019, BIOINFORMATICS, V35, P1978, DOI 10.1093/bioinformatics/bty897
   Kou Y, 2012, AM J MED GENET C, V160C, P130, DOI 10.1002/ajmg.c.31330
   Krawczynska N, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00203
   Kruusvee V, 2017, P NATL ACAD SCI USA, V114, pE3243, DOI 10.1073/pnas.1700731114
   Landini M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101765
   Li JY, 2015, AM J CLIN EXP UROL, V3, P13
   Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004
   Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362
   Long JM, 2004, GENES BRAIN BEHAV, V3, P51, DOI 10.1046/j.1601-183x.2003.00045.x
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714
   MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078
   Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0
   Neri G, 2018, AM J MED GENET A, V176, P1375, DOI 10.1002/ajmg.a.38710
   O'Rawe JA, 2015, AM J HUM GENET, V97, P922, DOI 10.1016/j.ajhg.2015.11.005
   O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764
   O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989
   Orstavik KH, 2009, HUM GENET, V126, P363, DOI 10.1007/s00439-009-0670-5
   Peeters SB, 2014, BIOESSAYS, V36, P746, DOI 10.1002/bies.201400032
   Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709
   Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123
   Pons L, 2015, AM J MED GENET A, V167, P164, DOI 10.1002/ajmg.a.36759
   Reijnders MRF, 2016, AM J HUM GENET, V98, P373, DOI 10.1016/j.ajhg.2015.12.015
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Riehmer V, 2017, AM J MED GENET A, V173, P2132, DOI 10.1002/ajmg.a.38285
   Rosenberg C, 2016, CLIN GENET, V89, P473, DOI 10.1111/cge.12683
   Saitsu H, 2014, J HUM GENET, V59, P581, DOI 10.1038/jhg.2014.71
   Sans N, 2016, NEURONAL AND SYNAPTIC DYSFUNCTION IN AUTISM SPECTRUM DISORDER AND INTELLECTUAL DISABILITY, P189, DOI 10.1016/B978-0-12-800109-7.00013-3
   Santos-Reboucas CB, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00101
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382
   Tabet AC, 2014, AM J MED GENET A, V164, P2335, DOI 10.1002/ajmg.a.36619
   Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016
   Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265
   Vaqueiro AC, 2018, EUR J MED GENET, V61, P29, DOI 10.1016/j.ejmg.2017.10.008
   Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999
   White J, 2015, AM J HUM GENET, V96, P612, DOI 10.1016/j.ajhg.2015.02.015
   Yang C, 2011, HUM GENET, V130, P175, DOI 10.1007/s00439-011-0994-9
   Zaghlula M, 2018, AM J MED GENET A, V176, P1683, DOI 10.1002/ajmg.a.38689
   Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9
   Ziats CA, 2020, CLIN GENET, V97, P418, DOI 10.1111/cge.13667
   Zweier C, 2013, J MED GENET, V50, P838, DOI 10.1136/jmedgenet-2013-101918
   Zylicz JJ, 2019, CELL, V176, P182, DOI 10.1016/j.cell.2018.11.041
NR 74
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD SEP
PY 2020
VL 57
IS 9
BP 3671
EP 3684
DI 10.1007/s12035-020-01981-8
EA JUN 2020
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA MV1EN
UT WOS:000541406000003
PM 32564284
DA 2020-12-16
ER

PT J
AU Santos-Reboucas, CB
   Boy, R
   Vianna, EQ
   Goncalves, AP
   Piergiorge, RM
   Abdala, BB
   dos Santos, JM
   Calassara, V
   Machado, FB
   Medina-Acosta, E
   Pimentel, MMG
AF Santos-Reboucas, Cintia B.
   Boy, Raquel
   Vianna, Evelyn Q.
   Goncalves, Andressa P.
   Piergiorge, Rafael M.
   Abdala, Bianca B.
   dos Santos, Jussara M.
   Calassara, Veluma
   Machado, Filipe B.
   Medina-Acosta, Enrique
   Pimentel, Marcia M. G.
TI Skewed X-Chromosome Inactivation and Compensatory Upregulation of Escape
   Genes Precludes Major Clinical Symptoms in a Female With a Large Xq
   Deletion
SO FRONTIERS IN GENETICS
LA English
DT Article
DE AR; escape genes; transcriptome-wide analysis; X-chromosome deletion;
   X-chromosome inactivation; RP2; transcriptome-wide analysis
ID DOSAGE COMPENSATION; INTELLECTUAL DISABILITY; DNA METHYLATION; LINKED
   GENES; MAMMALIAN X; EXPRESSION; MUTATIONS; TISSUES; VARIABILITY;
   LANDSCAPE
AB In mammalian females, X-chromosome inactivation (XCI) acts as a dosage compensation mechanism that equalizes X-linked genes expression between homo- and heterogametic sexes. However, approximately 12-23% of X-linked genes escape from XCI, being bi-allelic expressed. Herein, we report on genetic and functional data from an asymptomatic female of a Fragile X syndrome family, who harbors a large deletion on the X-chromosome. Array-CGH uncovered that the de novo, terminal, paternally originated 32 Mb deletion on Xq25-q28 spans 598 RefSeq genes, including escape and variable escape genes. Androgen receptor (AR) and retinitis pigmentosa 2 (RP2) methylation assays showed extreme skewed XCI ratios from both peripheral blood and buccal mucosa, silencing the abnormal X-chromosome. Surprisingly, transcriptome-wide analysis revealed that escape and variable escape genes spanning the deletion are mostly upregulated on the active X-chromosome, precluding major clinical/cognitive phenotypes in the female. Metaphase high count, hemizygosity concordance for microsatellite markers, and monoallelic expression of genes within the deletion suggest the absence of mosaicism in both blood and buccal mucosa. Taken together, our data suggest that an additional protective gene-by-gene mechanism occurs at the transcriptional level in the active X-chromosome to counterbalance detrimental phenotype effects of large Xq deletions.
C1 [Santos-Reboucas, Cintia B.; Vianna, Evelyn Q.; Goncalves, Andressa P.; Piergiorge, Rafael M.; Abdala, Bianca B.; dos Santos, Jussara M.; Calassara, Veluma; Pimentel, Marcia M. G.] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Genet, Rio De Janeiro, Brazil.
   [Boy, Raquel] Univ Estado Rio De Janeiro, Pedro Ernesto Univ Hosp, Rio De Janeiro, Brazil.
   [Machado, Filipe B.] Minas Gerais State Univ, Dept Biol Sci, Uba, Brazil.
   [Medina-Acosta, Enrique] State Univ Northern Rio de Janeiro Darcy Ribeiro, Lab Biotechnol, Rio De Janeiro, Brazil.
RP Santos-Reboucas, CB (corresponding author), Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Genet, Rio De Janeiro, Brazil.
EM cbs@uerj.br
RI Piergiorge, R M/N-7940-2016; Medina-Acosta, Enrique/G-3041-2010
OI Santos-Reboucas, Cintia/0000-0003-4729-2373; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Piergiorge, Rafael Mina/0000-0002-0744-4355
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES)CAPES
FX The authors thank the studied family for their kind cooperation,
   Caroline Alves Maia for technical support in expanding karyotype
   analysis, and Professor Ana Tereza Ribeiro de Vasconcelos for providing
   access to the server. This work was supported by the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), the Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES), and
   the Centro de Producao da Universidade do Estado do Rio de Janeiro
   (CEPUERJ).
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Andrews S., 2010, FASTQC QUALITY CONTR
   [Anonymous], 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Arnold AP, 2018, CANCER RES, V78, P5504, DOI 10.1158/0008-5472.CAN-18-2219
   Balaton BP, 2016, TRENDS GENET, V32, P348, DOI 10.1016/j.tig.2016.03.007
   Balaton BP, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0053-7
   Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206
   Bittel DC, 2008, J MED GENET, V45, P309, DOI 10.1136/jmg.2007.055244
   Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004
   Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677
   Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen XS, 2015, MOL BIOL EVOL, V32, P1456, DOI 10.1093/molbev/msv036
   Chen ZX, 2015, G3-GENES GENOM GENET, V5, P1057, DOI 10.1534/g3.115.017632
   Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564
   Cotton AM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r122
   de Araujo LS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01586
   Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687
   Deng XX, 2013, DEV CELL, V25, P55, DOI 10.1016/j.devcel.2013.01.028
   Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948
   Disteche CM, 2016, SEMIN CELL DEV BIOL, V56, P9, DOI 10.1016/j.semcdb.2016.04.013
   Disteche CM, 1999, P NATL ACAD SCI USA, V96, P14180, DOI 10.1073/pnas.96.25.14180
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Fezai M, 2014, KIDNEY BLOOD PRESS R, V39, P546, DOI 10.1159/000368465
   Fieremans N, 2016, HUM MUTAT, V37, P804, DOI 10.1002/humu.23012
   Fieremans N, 2015, EUR J MED GENET, V58, P324, DOI 10.1016/j.ejmg.2015.03.003
   Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010
   Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29
   Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645
   Goncalves TF, 2016, EXPERT REV MOL DIAGN, V16, P501, DOI 10.1586/14737159.2016.1135739
   Gupta Angela S, 2019, Case Rep Genet, V2019, P8492965, DOI 10.1155/2019/8492965
   Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hurst LD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002315
   Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522
   Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Kumar R, 2018, HUM MUTAT, V39, P1126, DOI 10.1002/humu.23557
   Kumar R, 2015, AM J HUM GENET, V97, P302, DOI 10.1016/j.ajhg.2015.05.021
   Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406
   Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905
   Ma Q, 2019, CELL DEATH DIFFER, V26, P321, DOI 10.1038/s41418-018-0121-8
   Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078
   Morey C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002212
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705
   Ogilvie CM, 2005, J HISTOCHEM CYTOCHEM, V53, P285, DOI 10.1369/jhc.4B6409.2005
   Reijnders MRF, 2016, AM J HUM GENET, V98, P373, DOI 10.1016/j.ajhg.2015.12.015
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rooman RPA, 2002, J PEDIATR ENDOCR MET, V15, P1051
   Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440
   Rossetti F, 2004, EUR J HUM GENET, V12, P829, DOI 10.1038/sj.ejhg.5201186
   Santos-Reboucas CB, 2015, J HUM GENET, V60, P207, DOI 10.1038/jhg.2015.1
   SCHMIDT M, 1991, AM J MED GENET, V38, P411, DOI 10.1002/ajmg.1320380252
   Schriml LM, 2019, NUCLEIC ACIDS RES, V47, pD955, DOI 10.1093/nar/gky1032
   Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111
   Szelinger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113036
   Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016
   Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015
   Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904
   Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265
   Wainer-Katsir K, 2016, BIORXIV, DOI [10.1101/079830, DOI 10.1101/079830]
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711
   Yachelevich N, 2011, AM J MED GENET A, V155A, P870, DOI 10.1002/ajmg.a.33936
   Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000
   Yasukochi Y, 2010, P NATL ACAD SCI USA, V107, P3704, DOI 10.1073/pnas.0914812107
   Yin SY, 2009, BIOCHEM BIOPH RES CO, V383, P378, DOI 10.1016/j.bbrc.2009.04.021
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zaitoun I, 2010, EPIGENETICS-US, V5, P149, DOI 10.4161/epi.5.2.11081
   Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5
   Zhang Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000430
   Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148
NR 76
TC 2
Z9 2
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAR 4
PY 2020
VL 11
AR 101
DI 10.3389/fgene.2020.00101
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA LC3SM
UT WOS:000525245100001
PM 32194616
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Francisco, RD
   Ferreira, CD
   Silva, JCSE
   Machado, DT
   Martins, YC
   Ramos, V
   Carnivali, GS
   Garcia, AB
   Medina-Acosta, E
AF Francisco Junior, Ronaldo da Silva
   Ferreira, Cristina dos Santos
   Santos e Silva, Juan Carlo
   Machado, Douglas Terra
   Martins, Yasmmin Cortes
   Ramos, Victor
   Carnivali, Gustavo Simoes
   Garcia, Ana Beatriz
   Medina-Acosta, Enrique
TI Pervasive Inter-Individual Variation in Allele-Specific Expression in
   Monozygotic Twins
SO FRONTIERS IN GENETICS
LA English
DT Article
DE allele-specific expression; allele imbalance; Down syndrome; genomic
   imprinting; heterokaryotypic monozygotic co-twins; mitochondrial
   heteroplasmy; random monoallelic expression; trisomy 21
ID RANDOM MONOALLELIC EXPRESSION; X-CHROMOSOME INACTIVATION;
   GENE-EXPRESSION; DISCORDANT; RNA; GENOME; DNA; LANDSCAPE; DATABASE; RISK
AB Despite being developed from one zygote, heterokaryotypic monozygotic (MZ) co-twins exhibit discordant karyotypes. Epigenomic studies in biological samples from heterokaryotypic MZ co-twins are of the most significant value for assessing the effects on gene- and allele-specific expression of an extranumerary chromosomal copy or structural chromosomal disparities in otherwise nearly identical germline genetic contributions. Here, we use RNA-Seq data from existing repositories to establish withinpair correlations for the breadth and magnitude of allele-specific expression (ASE) in heterokaryotypic MZ co-twins discordant for trisomy 21 and maternal 21q inheritance, as well as homokaryotypic co-twins. We show that there is a genome-wide disparity at ASE sites between the heterokaryotypic MZ co-twins. Although most of the disparity corresponds to changes in the magnitude of biallelic imbalance, ASE sites switching from either strictly monoallelic to biallelic imbalance or the reverse occur in few genes that are known or predicted to be imprinted, subject to X-chromosome inactivation or A-to-I(G) RNA edited. We also uncovered comparable ASE differences between homokaryotypic MZ twins. The extent of ASE discordance in MZ twins (2.7%) was about 10-fold lower than the expected between pairs of unrelated, non-twin males or females. The results indicate that the observed within-pair dissimilarities in breadth and magnitude of ASE sites in the heterokaryotypic MZ co-twins could not solely be attributable to the aneuploidy and the missing allelic heritability at 21q.
C1 [Francisco Junior, Ronaldo da Silva; Martins, Yasmmin Cortes] Lab Nacl Comp Cient, Lab Bioinformat, Petropolis, RJ, Brazil.
   [Ferreira, Cristina dos Santos; Santos e Silva, Juan Carlo; Machado, Douglas Terra; Garcia, Ana Beatriz; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Lab Biotecnol, Nucleo Diagnost & Invest Mol, Campos Dos Goytacazes, Brazil.
   [Ramos, Victor] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil.
   [Carnivali, Gustavo Simoes] Univ Fed Minas Gerais, Dept Computat Sci, Belo Horizonte, MG, Brazil.
   [Francisco Junior, Ronaldo da Silva] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.
RP Francisco, RD (corresponding author), Lab Nacl Comp Cient, Lab Bioinformat, Petropolis, RJ, Brazil.; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Lab Biotecnol, Nucleo Diagnost & Invest Mol, Campos Dos Goytacazes, Brazil.; Francisco, RD (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.
EM ronaldoj@lncc.br; quique@uenf.br
RI ; Medina-Acosta, Enrique/G-3041-2010
OI Carnivali, Gustavo/0000-0002-1722-5359; da Silva Francisco Junior,
   Ronaldo/0000-0001-7419-3907; Carnivali, Gustavo/0000-0002-2924-1452; S
   Silva, Juan Carlo/0000-0002-7327-4294; Ramos,
   Victor/0000-0001-7353-3420; Ferreira, Cristina/0000-0002-9961-8788;
   Medina-Acosta, Enrique/0000-0002-2529-0548
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro -FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E26/010.001036/2015]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico -CNPqNational Council for
   Scientific and Technological Development (CNPq) [308780/2015-9];
   PIBIC/CNPq from the Universidade Estadual do Norte Fluminense Darcy
   Ribeiro UENF (BR); Fundacao Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior -CAPESCAPES
FX This study was supported by grants from the Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro -FAPERJ (BR)
   (http://www.faperj.br/) [grant number E26/010.001036/2015 to EM-A] and
   from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   -CNPq (BR) (http://cnpq.br/) [grant number 308780/2015-9 to EM-A]. JS
   and DM received undergraduate PIBIC/CNPq fellowships from the
   Universidade Estadual do Norte Fluminense Darcy Ribeiro UENF (BR)
   (http://www.uenf.br/).CF is a recipient of a graduate fellowship from
   the Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   -CAPES (http://www.capes.gov.br/).The agencies had no role in the study
   design, data collection, and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdellaoui A, 2015, TWIN RES HUM GENET, V18, P1, DOI 10.1017/thg.2014.86
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Albert JR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4835-2
   da Silva AFA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154108
   Antonarakis M. G., 2018, EXTENSIVE CELLULAR H, DOI [10.1073/pnas.1806811115, DOI 10.1073/PNAS.1806811115]
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274
   Balaton BP, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0053-7
   Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115
   Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990
   Begemann M, 2018, J MED GENET, V55, P497, DOI 10.1136/jmedgenet-2017-105190
   Bennett CM, 2008, AM J HEMATOL, V83, P778, DOI 10.1002/ajh.21219
   Blay N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz776
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown AA, 2014, ELIFE, V3, DOI 10.7554/eLife.01381
   Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162
   Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479
   Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6
   Chaiyasap P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100191
   Chakravarti A, 2011, CIRC RES, V109, P1202, DOI 10.1161/RES.0b013e31823c4992
   Chamberlain S., 2018, RSNPS GET SNP
   Chess A, 2013, NEUROPSYCHOPHARMACOL, V38, P55, DOI 10.1038/npp.2012.85
   Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003
   Core Team R, 2019, R LANG ENV STAT COMP
   Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564
   Cotton AM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r122
   Dahoun S, 2008, AM J MED GENET A, V146A, P2086, DOI 10.1002/ajmg.a.32431
   Deng XX, 2019, NAT STRUCT MOL BIOL, V26, P851, DOI 10.1038/s41594-019-0314-y
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600
   Ding N, 2017, GENOM PROTEOM BIOINF, V15, P37, DOI 10.1016/j.gpb.2016.12.002
   Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Eckersiey-Maslin MA, 2014, TRENDS GENET, V30, P237, DOI 10.1016/j.tig.2014.03.003
   Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017
   Essaoui M, 2013, EUR J MED GENET, V56, P502, DOI 10.1016/j.ejmg.2013.06.007
   Furukawa H, 2013, HUM IMMUNOL, V74, P170, DOI 10.1016/j.humimm.2012.11.007
   Garg P, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007707
   Garieri M, 2018, P NATL ACAD SCI USA, V115, P13015, DOI 10.1073/pnas.1806811115
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Gilbert B, 2002, PRENATAL DIAG, V22, P697, DOI 10.1002/pd.383
   Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910
   Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616
   Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473
   Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848
   Hu YJ, 2015, J AM STAT ASSOC, V110, P962, DOI 10.1080/01621459.2015.1038449
   Huang Y, 2019, MOL THER-NUCL ACIDS, V14, P204, DOI 10.1016/j.omtn.2018.11.015
   Jirtle J., 2012, GENEIMPRINT DATABASE
   Katsir KW, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5507-6
   Knopman JM, 2014, FERTIL STERIL, V102, P82, DOI 10.1016/j.fertnstert.2014.03.039
   Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222
   Larsson AJM, 2019, NAT STRUCT MOL BIOL, V26, P963, DOI 10.1038/s41594-019-0306-y
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328
   Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200
   Leung WC, 2009, FETAL DIAGN THER, V25, P397, DOI 10.1159/000236153
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   LI JY, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PGEN.1002629
   Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018
   Lin CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22753-4
   Lin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044017
   Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624
   Liu SQ, 2018, TWIN RES HUM GENET, V21, P361, DOI 10.1017/thg.2018.41
   Liu Z, 2014, GENET EPIDEMIOL, V38, P591, DOI 10.1002/gepi.21846
   Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603
   LUBINSKY MS, 1991, LANCET, V337, P1288, DOI 10.1016/0140-6736(91)92956-3
   Araujo GDM, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00036
   Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S
   Metsalu T, 2014, EPIGENETICS-US, V9, P1397, DOI 10.4161/15592294.2014.970052
   Morgan M., 2017, ANNOTATIONHUB CLIENT
   Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797
   Mott R, 2014, CELL, V156, P332, DOI 10.1016/j.cell.2013.11.043
   Moyerbrailean GA, 2016, GENOME RES, V26, P1627, DOI 10.1101/gr.209759.116
   Nieuwint A, 1999, PRENATAL DIAG, V19, P72, DOI 10.1002/(SICI)1097-0223(199901)19:1<72::AID-PD465>3.0.CO;2-V
   ORSTAVIK RE, 1995, AM J MED GENET, V56, P210
   Pettigrew KA, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9157-6
   Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484
   Pirinen M, 2015, BIOINFORMATICS, V31, P2497, DOI 10.1093/bioinformatics/btv074
   Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472
   Raghupathy N, 2018, BIOINFORMATICS, V34, P2177, DOI 10.1093/bioinformatics/bty078
   Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996
   Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]
   Santoni FA, 2017, AM J HUM GENET, V100, P444, DOI 10.1016/j.ajhg.2017.01.028
   Savova V, 2017, MOL PSYCHIATR, V22, P1785, DOI 10.1038/mp.2017.13
   Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493
   Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106
   SCOTT JM, 1973, J OBSTET GYN BR COMM, V80, P52
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shvetsova E, 2019, EUR J HUM GENET, V27, P455, DOI 10.1038/s41431-018-0291-3
   Skipper M, 2008, NAT REV GENET, V9, P4, DOI 10.1038/nrg2287
   Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172
   Soderlund CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115740
   Souren NYP, 2016, HUM MUTAT, V37, P765, DOI 10.1002/humu.23003
   Sun C, 2013, PEDIATR RES, V73, P523, DOI 10.1038/pr.2013.6
   Symmons O, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007874
   Tachon G, 2014, HUM REPROD, V29, P2814, DOI 10.1093/humrep/deu275
   Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041
   Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123
   Vigneau S, 2018, NAT GENET, V50, P1198, DOI 10.1038/s41588-018-0188-7
   von Hippel PT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0024-z
   Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18
   Wang X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r79
   Wei YJ, 2014, DEVELOPMENT, V141, P2516, DOI 10.1242/dev.105320
   Weissbein U, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12144
   Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135
   Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317
   Wood DLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126911
   Yamada L, 2017, J DEV ORIG HLTH DIS, V8, P30, DOI 10.1017/S2040174416000507
   Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545
   Young PE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182638
   Zhou ZY, 2018, NUCLEIC ACIDS RES, V46, P8888, DOI 10.1093/nar/gky613
NR 115
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD NOV 26
PY 2019
VL 10
AR 1178
DI 10.3389/fgene.2019.01178
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA MY0NI
UT WOS:000558115100001
PM 31850058
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Neri, V
   Louvain, T
   Medina-Acosta, E
   Vandesteen, L
   Pessoa, A
   Nascimento, AL
   Siquara, A
   Vianna, D
   de Carvalho, JF
   de Sa, JD
   Pereira, B
   dos Santos, VM
   Costa, A
   Renon, T
   Maia, S
   Lopes, ACS
   Motte, M
   Santana, M
   Lima, AL
   Neto, PG
AF Neri, V.
   Louvain, T.
   Medina-Acosta, E.
   Vandesteen, L.
   Pessoa, A.
   Nascimento, A. L.
   Siquara, A.
   Vianna, D.
   Fazoli de Carvalho, J.
   Damasceno de Sa, J.
   Pereira, B.
   Moreira dos Santos, V.
   Costa, A.
   Renon, T.
   Maia, S.
   Souza Lopes, A. C.
   Motte, M.
   Santana, M.
   Lima, A. L.
   Gloria Neto, P.
TI Genetic study, histochemical analysis and neuroimaging profile in
   Brazilian patients with cadasil
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Meeting Abstract
CT World Congress of Neurology (WCN)
CY OCT 27-31, 2019
CL Emirates Neurol Soc, Dubai, U ARAB EMIRATES
SP World Federat Neurol
HO Emirates Neurol Soc
C1 [Neri, V.] Univ Fed Estado Rio Janeiro, Neurol, Rio De Janeiro, Brazil.
   [Neri, V.; Vianna, D.] Ctr Doenca Alzheimer & Parkinson, Neurol, Campos Dos Goytacazes, Brazil.
   [Neri, V.; Fazoli de Carvalho, J.; Damasceno de Sa, J.; Pereira, B.; Moreira dos Santos, V.; Costa, A.; Renon, T.; Maia, S.; Souza Lopes, A. C.; Motte, M.; Santana, M.; Lima, A. L.; Gloria Neto, P.] Fac Med Campos, Neurol, Campos Dos Goytacazes, Brazil.
   [Louvain, T.] Fac Med Campos, Genet, Campos Dos Goytacazes, Brazil.
   [Louvain, T.; Medina-Acosta, E.] Univ Estadual Norte Fluminense, Genet, Campos Dos Goytacazes, Brazil.
   [Vandesteen, L.] Fac Med Campos, Neuroradiol, Campos Dos Goytacazes, Brazil.
   [Pessoa, A.] Univ Estado Rio De Janeiro, Dermatol, Rio De Janeiro, Brazil.
   [Nascimento, A. L.] Univ Estado Rio De Janeiro, Histol, Rio De Janeiro, Brazil.
   [Siquara, A.] Univ Fed Fluminense, Pathol, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2019
VL 405
SU S
MA WCN19-1268
AR 104273
DI 10.1016/j.jns.2019.10.611
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KQ2PN
UT WOS:000516770702036
OA Bronze
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   de Souza, TL
   Barcellos, TD
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   de Souza, Thais Louvain
   Barcellos, Thiago da Silva
   Medina-Acosta, Enrique
TI An Exclusively Skewed Distribution of Pediatric Immune Reconstitution
   Inflammatory Syndrome Toward the Female Sex Is Associated With Advanced
   Acquired Immune Deficiency Syndrome
SO FRONTIERS IN PEDIATRICS
LA English
DT Article
DE acquired immune deficiency syndrome (IRIS); antiretroviral therapy
   (ART); human immunodeficiency virus (HIV); immune reconstitution
   inflammatory syndrome (IRIS); skewed female sex ratio; X-chromosome
   inactivation (XCI)
ID ACTIVE ANTIRETROVIRAL THERAPY; BACILLUS-CALMETTE-GUERIN; RESTORATION
   DISEASE; INFECTED CHILDREN; RISK-FACTORS; X-CHROMOSOME; TUBERCULOSIS;
   INITIATION; MANIFESTATION; INFANTS
AB In human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients with very low CD4 cell counts, there is a temporal relationship between administration of antiretroviral therapy (ART) and an increased inflammatory response state known as the immune reconstitution inflammatory syndrome (IRIS). The predominant clinical presentation of IRIS is an infectious disease that can be life-threatening. IRIS-related infectious events are distributed similarly between adult males and females, albeit a few studies have shown a skewing toward the male sex in pediatric IRIS. Here, we assessed sex-specific differences in the causes and extent of IRIS infectious events in HIV-infected pediatric patients on ART. We carried out a prospective clinical analysis (from 2000 to 2018) of IRIS-related infectious events after ART in a cohort of 82 Brazilian children and adolescents infected with HIV-1 through mother-to-child transmission as well as a comprehensive cross-referencing with public records on IRIS-related infectious causes in pediatric HIV/AIDS. Twelve events fulfilling the criteria of IRIS occurred exclusively in 11 females in our cohort. The median age at IRIS events was 3.6 years. The infectious causes included Mycobacterium bovis, varicella-zoster virus, molluscum contagiosum virus, human papillomavirus, cytomegalovirus, and Mycobacterium tuberculosis. In one female, there was regional bacillus Calmette-Guerin dissemination and cytomegalovirus esophagitis. There was complete health recovery after 10 IRIS events without the use of corticosteroids or ART interruption. One case of IRIS-associated miliary tuberculosis was fatal. The biological female sex was a significant risk factor for IRIS events (odds ratio: 23.67; 95% confidence interval 95%: 1.341-417.7; P = 0.0016 and P < 0.01 by the multivariable analysis). We observed an effect of the advanced HIV/AIDS variable in IRIS females as compared with non-IRIS females (mean CD4(+) T cell percentage 13.36 vs. 18.63%; P = 0.0489 and P < 0.05 by the multivariable analysis), underpinning the exclusively skewed distribution toward the female sex of this cohort. Moreover, the IRIS females in our cohort had higher mean CD4(+) T cell percentages before (13.36%) and after IRIS (26.56%) than those of the IRIS females (before IRIS, 4.978%; after IRIS, 13.81%) in previous studies conducted worldwide. The exclusively skewed distribution of pediatric IRIS toward the female sex in the cohort was not linked to preferential X-chromosome inactivation rates. We concluded that the exclusively skewed distribution of pediatric IRIS toward females is associated with more advanced AIDS.
C1 [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Barcellos, Thiago da Silva] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, Lab Biotechnol, Ctr Biosci & Biotechnol, Campos Dos Goytacazes, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, Lab Biotechnol, Ctr Biosci & Biotechnol, Campos Dos Goytacazes, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq,
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [301034/2012-5, 308780/2015-9]
FX The study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico-CNPq, Brazil (http://cnpq.br/) [grant number
   301034/2012-5 and 308780/2015-9 to EM-A].
CR Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565
   Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012
   Brazil, 2009, POCKET MANUAL SERIES, V85, P213
   Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742
   Chamekh M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01806
   Christiansen T, 2010, EPIDATA COMPREHENSIV
   Cox CM, 2013, PEDIATR BLOOD CANCER, V60, P1274, DOI 10.1002/pbc.24516
   Davies MA, 2009, CLIN INFECT DIS, V49, P973, DOI 10.1086/605501
   de Carvalho VO, 2010, PEDIATR DERMATOL, V27, P631, DOI 10.1111/j.1525-1470.2010.01322.x
   Fernandes RCDC, 2010, INT J INFECT DIS, V14, pE361, DOI 10.1016/j.ijid.2009.11.017
   Fernandes RCDC, 2009, EUR J PEDIATR, V168, P691, DOI 10.1007/s00431-008-0822-y
   French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06
   French MA, 2009, CLIN INFECT DIS, V48, P101, DOI 10.1086/595006
   French MAH, 2012, MED J AUSTRALIA, V196, P318, DOI 10.5694/mja12.10089
   Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290
   Gkentzi D, 2014, PEDIATR INFECT DIS J, V33, P953, DOI 10.1097/INF.0000000000000331
   Gribnau J, 2017, BIORXIV, DOI [10. 1101/076950, DOI 10.1101/076950]
   Hatherill S, 2009, J CHILD NEUROL, V24, P879, DOI 10.1177/0883073809332399
   He B, 2013, BRAZ J INFECT DIS, V17, P170, DOI 10.1016/j.bjid.2012.10.014
   Innes S, 2009, S AFR J HIV MED, P44
   Kalk E, 2013, PEDIATR INFECT DIS J, V32, P157, DOI 10.1097/INF.0b013e31827031aa
   Krauss MR, 2015, BRAZ J INFECT DIS, V19, P23, DOI 10.1016/j.bjid.2014.08.007
   Kumar SR, 2012, INT J STD AIDS, V23, P419, DOI 10.1258/ijsa.2009.009439
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.7326/0003-4819-151-4-200908180-00136, 10.1371/journal.pmed.1000100]
   Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714
   Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607
   Narendran G., 2006, Indian Journal of Pediatrics, V73, P627, DOI 10.1007/BF02759931
   Nesheim SR, 2013, PEDIATR INFECT DIS J, V32, P1089, DOI 10.1097/INF.0b013e31829ee893
   Orikiiriza J, 2010, AIDS, V24, P2009, DOI 10.1097/QAD.0b013e32833b260a
   Perez N, 2009, AIDS, V23, P645, DOI 10.1097/QAD.0b013e32832407e2
   Pessach IM, 2009, J AUTOIMMUN, V33, P17, DOI 10.1016/j.jaut.2009.03.003
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P53, DOI 10.1097/01.inf.0000195618.55453.9a
   Puthanakit T, 2005, CLIN INFECT DIS, V41, P1049, DOI 10.1086/433177
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P645, DOI 10.1097/01.inf.0000225786.00940.37
   R Core Team, 2018, R LANG ENV STAT COMP
   Rabie H, 2011, INT J TUBERC LUNG D, V15, P1194, DOI 10.5588/ijtld.10.0721
   Rabie H, 2010, J TROP PEDIATRICS, V56, P355, DOI 10.1093/tropej/fmp141
   Rasul S, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/743597
   Safdar A, 2002, CLIN INFECT DIS, V35, P1250, DOI 10.1086/344056
   Schurz H, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-018-0185-z
   Shah I, 2011, INDIAN J PEDIATR, V78, P540, DOI 10.1007/s12098-010-0330-8
   Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a
   Shvetsova E, 2019, EUR J HUM GENET, V27, P455, DOI 10.1038/s41431-018-0291-3
   Smith K, 2009, AIDS, V23, P1097, DOI 10.1097/QAD.0b013e32832afefc
   Stival A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105277
   Stoll M, 2004, AUTOIMMUN REV, V3, P243, DOI 10.1016/j.autrev.2003.09.005
   Tangsinmankong N, 2004, J ALLERGY CLIN IMMUN, V113, P742, DOI 10.1016/j.jaci.2004.01.768
   Vignesh R, 2013, JAIDS-J ACQ IMM DEF, V64, P241, DOI 10.1097/QAI.0b013e31829f6df2
   Walters E, 2014, ARCH DIS CHILD, V99, P998, DOI 10.1136/archdischild-2013-305509
   Wang ME, 2009, PEDIATR INFECT DIS J, V28, P900, DOI 10.1097/INF.0b013e3181a4b7fa
   Wilcox CM, 1999, AM J GASTROENTEROL, V94, P339, DOI 10.1111/j.1572-0241.1999.00853.x
NR 51
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2360
J9 FRONT PEDIATR
JI Front. Pediatr.
PD JUL 10
PY 2019
VL 7
AR 293
DI 10.3389/fped.2019.00293
PG 8
WC Pediatrics
SC Pediatrics
GA IH8XP
UT WOS:000474790700001
PM 31355171
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Abelleyro, MM
   Marchione, VD
   Palmitellil, M
   Radic, CP
   Neme, D
   Larripa, IB
   Medina-Acosta, E
   De Brasi, CD
   Rossetti, LC
AF Abelleyro, Miguel Martin
   Marchione, Vanina Daniela
   Palmitellil, Micaela
   Radic, Claudia Pamela
   Neme, Daniela
   Larripa, Irene Beatriz
   Medina-Acosta, Enrique
   De Brasi, Carlos Daniel
   Rossetti, Liliana Carmen
TI Inverse PCR to perform long-distance haplotyping: main applications to
   improve preimplantation genetic diagnosis in hemophilia
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID ALLELE; DNA; RECOMBINATION; FREQUENCY; HOTSPOT; COMMON; LOCI; MAP; F8
AB Among other applications of long-distance haplotype phasing in clinical genetics, determination of linked DNA markers as surrogate for problematic structural variants (e.g., repeat-mediated rearrangements) is essential to perform diagnosis from low-quality DNA samples. We describe a next-of-kin-independent (physical) phasing approach based on inverse-PCR (iPCR) paired-end amplification (PI). This method enables typing the multialleles of the short tandem repeat (STR) F8Int21 [CA]n at the F8-intron 21, as a surrogate DNA marker for the F8-intron 22 inversion (Inv22), the hemophilia A-causative hotspot, within the transmitted haplotype in informative carriers. We provide proof-of-concept by blindly validating the PI approach in 15 carrier mother/affected-son duos. Every F8Int21[CA]n STR allele determined in phase with the Inv22 allele in the female carriers from the informative duos was confirmed in the hemizygous proband (P = 0 .00003) . A second surrogate STR locus at the F8-IVS22 was obtained by the PI approach improving severe-HA preimplantation genetic diagnosis by augmenting heterozygosity in Inv22 carriers bypassing the requirement for family linkage analysis. The ability of the PI-assay to combine other marker pairs was demonstrated by haplotyping a SNV (F8:c.6118T > C) with a >28kb-distant F8-IVS22 STR. The PI approach has proven flexibility to target different marker pairs and has potential for multiplex characterization of iPCR products by massively parallel sequencing.
C1 [Abelleyro, Miguel Martin; Marchione, Vanina Daniela; Palmitellil, Micaela; Radic, Claudia Pamela; Larripa, Irene Beatriz; De Brasi, Carlos Daniel; Rossetti, Liliana Carmen] Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, Inst Med Expt IMEX, Buenos Aires, DF, Argentina.
   [Neme, Daniela] Fdn Hemofilia Alfredo Pavlovsky, Buenos Aires, DF, Argentina.
   [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol Nucleo Diagnost & Invest Mol, Campos Dos Goytacazes, RJ, Brazil.
   [De Brasi, Carlos Daniel] Acad Nacl Med Buenos Aires, Inst Invest Hematol Mariano R Castex, Buenos Aires, DF, Argentina.
RP Rossetti, LC (corresponding author), Consejo Nacl Invest Cient & Tecn, Acad Nacl Med, Inst Med Expt IMEX, Buenos Aires, DF, Argentina.
EM rossetti@hematologia.anm.edu.ar
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; De Brasi, Carlos
   Daniel/0000-0003-2379-4379
FU National Research Council (CONICET)Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); National Agency for Scientific and
   Technological Promotion (ANPCyT)ANPCyT; World Federation of Hemophilia
FX This study was supported by grants from the National Research Council
   (CONICET), National Agency for Scientific and Technological Promotion
   (ANPCyT) and the World Federation of Hemophilia. The authors thank
   Miguel de Tezanos Pinto (National Academy of Medicine and National
   Hemophilia Foundation) and Judith Mincman and Roberto Cocco (Fecunditas
   Clinic) for their help in different phases of the work.
CR Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298
   Apellaniz-Ruiz M, 2015, PHARMACOGENOMICS J, V15, P288, DOI 10.1038/tpj.2014.67
   Citterio CE, 2013, MOL CELL ENDOCRINOL, V381, P220, DOI 10.1016/j.mce.2013.07.034
   De Rycke M, 2015, HUM REPROD, V30, P1763, DOI 10.1093/humrep/dev122
   Do C, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1250-y
   Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
   Hosomichi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-355
   Hui WWI, 2017, CLIN CHEM, V63, P513, DOI 10.1373/clinchem.2016.268375
   Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232
   Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217
   Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110
   Kolovos P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-1
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236
   Liang Y, 2009, PRENATAL DIAG, V29, P664, DOI 10.1002/pd.2271
   Liu Q, 1998, BLOOD, V92, P1458, DOI 10.1182/blood.V92.4.1458.splL4_1458_1459
   Machado FB, 2011, HAEMOPHILIA, V17, P257, DOI 10.1111/j.1365-2516.2010.02404.x
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   Mora A, 2016, BRIEF BIOINFORM, V17, P980, DOI 10.1093/bib/bbv097
   Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200
   NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773
   Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270
   Rossetti LC, 2008, J THROMB HAEMOST, V6, P830, DOI 10.1111/j.1538-7836.2008.02926.x
   Rossetti LC, 2005, CLIN CHEM, V51, P1154, DOI 10.1373/clinchem.2004.046490
   Sambrook J., 1989, MOL CLONING LAB MANU
   Scott SA, 2013, J MOL DIAGN, V15, P783, DOI 10.1016/j.jmoldx.2013.06.004
   Shastry BS, 2014, METHODS MOL BIOL, V1175, P671, DOI 10.1007/978-1-4939-0956-8_18
   Sim Sarah C., 2010, Human Genomics, V4, P278
   Snyder MW, 2015, NAT REV GENET, V16, P344, DOI 10.1038/nrg3903
   Traeger-Synodinos J, 2017, BEST PRACT RES CL OB, V39, P74, DOI 10.1016/j.bpobgyn.2016.10.010
   Turner DJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn373
   Zanger Ulrich M., 2013, Frontiers in Genetics, V4, P24, DOI 10.3389/fgene.2013.00024
   Zhang K, 2006, NAT GENET, V38, P382, DOI 10.1038/ng1741
   Zhao M, 2017, J THROMB HAEMOST, V15, P1473, DOI 10.1111/jth.13685
   Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432
NR 36
TC 1
Z9 1
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD APR
PY 2019
VL 27
IS 4
BP 603
EP 611
DI 10.1038/s41431-018-0334-9
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HO7YY
UT WOS:000461167300013
PM 30626931
OA Green Published, Bronze
DA 2020-12-16
ER

PT J
AU Araujo, GDM
   Francisco, RD
   Ferreira, CD
   Rodrigues, PTM
   Machado, DT
   de Souza, TL
   de Souza, JT
   da Silva, CFO
   da Silva, AFA
   Andrade, CCF
   da Silva, AT
   Ramos, V
   Garcia, AB
   Machado, FB
   Medina-Acosta, E
AF Machado Araujo, Graziela de Sa
   da Silva Francisco Junior, Ronaldo
   Ferreira, Cristina dos Santos
   Mozer Rodrigues, Pedro Thyago
   Machado, Douglas Terra
   de Souza, Thais Louvain
   de Souza, Jozimara Teixeira
   Osorio da Silva, Cleiton Figueiredo
   Alves da Silva, Antonio Francisco
   Franco Andrade, Claudia Caixeta
   da Silva, Alan Tardin
   Ramos, Victor
   Garcia, Ana Beatriz
   Machado, Filipe Brum
   Medina-Acosta, Enrique
TI Maternal 5(m)CpG Imprints at the PARD6G-AS1 and GCSAML Differentially
   Methylated Regions Are Decoupled From Parent-of-Origin Expression
   Effects in Multiple Human Tissues
SO FRONTIERS IN GENETICS
LA English
DT Article
DE PARD6G-AS1; GCSAML; GRB10; ZNF124; OR2L13; LOC284240; genomic
   imprinting; imprinting disease
ID HUMAN GRB10; ANALYSIS REVEALS; ABERRANT METHYLATION; WIDE ASSOCIATION;
   CELL-TYPES; GENES; ALLELE; ANNOTATION; LANDSCAPE; DATABASE
AB A hallmark of imprinted genes in mammals is the occurrence of parent-of-origin-dependent asymmetry of DNA cytosine methylation (5(m)C) of alleles at CpG islands (CGIs) in their promoter regions. This 5(m)CpG asymmetry between the parental alleles creates allele-specific imprinted differentially methylated regions (iDMRs). iDMRs are often coupled to the transcriptional repression of the methylated allele and the activation of the unmethylated allele in a tissue-specific, developmental-stage-specific and/or isoform-specific fashion. iDMRs function as regulatory platforms, built through the recruitment of chemical modifications to histones to achieve differential, parent-of-origin-dependent chromatin segmentation states. Here, we used a comparative computational data mining approach to identify 125 novel constitutive candidate iDMRs that integrate the maximal number of allele-specific methylation region records overlapping CGIs in human methylomes. Twenty-nine candidate iDMRs display gametic 5(m)CpG asymmetry, and another 96 are candidate secondary iDMRs. We established the maternal origin of the 5(m)CpG imprints of one gametic (PARD6G-AS1) and one secondary (GCSAML) iDMRs. We also found a constitutively hemimethylated, nonimprinted domain at the PWWP2AP1 promoter CGI with oocyte-derived methylation asymmetry. Given that the 5(m)CpG level at the iDMRs is not a sufficient criterion to predict active or silent locus states and that iDMRs can regulate genes from a distance of more than 1Mb, we used RNA-Seq experiments from the Genotype-Tissue Expression project and public archives to assess the transcriptional expression profiles of SNPs across 4.6Mb spans around the novel maternal iDMRs. We showed that PARD6G-AS1 and GCSAML are expressed biallelically in multiple tissues. We found evidence of tissue-specific monoallelic expression of ZNF124 and OR2L13, located 363 kb upstream and 419 kb downstream, respectively, of the GCSAML iDMR. We hypothesize that the GCSAML iDMR regulates the tissue-specific, monoallelic expression of ZNF124 but not of OR2L13. We annotated the non-coding epigenomic marks in the two maternal iDMRs using data from the Roadmap Epigenomics project and showed that the PARD6G-AS1 and GCSAML iDMRs achieve contrasting activation and repression chromatin segmentations. Lastly, we found that the maternal 5(m)CpG imprints are perturbed in several hematopoietic cancers. We conclude that the maternal 5(m)CpG imprints at PARD6G-AS1 and GCSAML iDMRs are decoupled from parent-of-origin transcriptional expression effects in multiple tissues.
C1 [Machado Araujo, Graziela de Sa; da Silva Francisco Junior, Ronaldo; Ferreira, Cristina dos Santos; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; de Souza, Thais Louvain; de Souza, Jozimara Teixeira; Osorio da Silva, Cleiton Figueiredo; Alves da Silva, Antonio Francisco; Franco Andrade, Claudia Caixeta; da Silva, Alan Tardin; Garcia, Ana Beatriz; Machado, Filipe Brum; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Nucleo Diagnost & Invest Mol, Lab Biotecnol, Campos Dos Goytacazes, Brazil.
   [da Silva Francisco Junior, Ronaldo] Lab Nacl Comp Cient, Petropolis, Brazil.
   [de Souza, Thais Louvain] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [Franco Andrade, Claudia Caixeta] Fac Metropolitana Sao Carlos, Bom Jesus Do Itabapoana, Brazil.
   [Ramos, Victor] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   [Alves da Silva, Antonio Francisco] Secretaria Estado Saude Espirito Santo, Vitoria, Brazil.
   [Machado, Filipe Brum] Univ Estado Minas Gerais, Dept Ciencias Biol, Unidade Uba, Uba, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Nucleo Diagnost & Invest Mol, Lab Biotecnol, Campos Dos Goytacazes, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Junior, Ronaldo S F/I-4073-2014;
   Louvain de Souza, Thais/G-2646-2014
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Junior, Ronaldo S
   F/0000-0001-7419-3907; Louvain de Souza, Thais/0000-0002-0179-272X;
   Ramos, Victor/0000-0001-7353-3420; Ferreira,
   Cristina/0000-0002-9961-8788
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E26/010.001036/2015]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPqNational Council for
   Scientific and Technological Development (CNPq) [301034/2012-5,
   308780/2015-9]; PIBIC/CNPq fellowships from the Universidade Estadual do
   Norte Fluminense Darcy Ribeiro UENF; Fundacao Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-CAPESCAPES;
   FAPERJ/UENFCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CAPES/PADCT
FX This work was supported by grants from the Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro - FAPERJ (BR) (http://www.faperj.br/) [grant
   number E26/010.001036/2015 to EM-A] and from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq (BR) (http://cnpq.br/)
   [grant numbers 301034/2012-5 and 308780/2015-9 to EM-A]. RdSFJ and DTM
   received undergraduate PIBIC/CNPq fellowships from the Universidade
   Estadual do Norte Fluminense Darcy Ribeiro UENF (BR)
   (http://www.uenf.br/). CdSF and PTMR are recipients of graduate
   fellowships from the Fundacao Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior-CAPES (http://www.capes.gov.br/). ATdS received a
   graduate fellowship from FAPERJ/UENF, and FBM received a postdoctoral
   fellowship from CAPES/PADCT. The agencies had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153
   Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290, 10.1093/nar/gks1189]
   da Silva AFA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154108
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110
   Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274
   Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115
   Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382
   Barrow TM, 2015, INT J CANCER, V137, P537, DOI 10.1002/ijc.29419
   Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045
   Beygo J, 2015, EUR J HUM GENET, V23, P180, DOI 10.1038/ejhg.2014.72
   Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587
   Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6
   Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514
   Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470
   Chess A, 2016, ANNU REV GENET, V50, P317, DOI 10.1146/annurev-genet-120215-035120
   Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110
   Cooper WN, 2010, BRIEF FUNCT GENOMICS, V9, P315, DOI 10.1093/bfgp/elq018
   Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113
   Court F, 2013, HUM MUTAT, V34, P595, DOI 10.1002/humu.22276
   Crespi B, 2008, BIOL REV, V83, P441, DOI 10.1111/j.1469-185X.2008.00050.x
   Cuellar Partida G, 2017, BIORXIV, DOI [10.1101/161471, DOI 10.1101/161471]
   Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010
   da Silva-Santiago SC, 2014, INT J DATA MIN BIOIN, V10, P329, DOI 10.1504/IJDMB.2014.064547
   Do C, 2016, AM J HUM GENET, V98, P934, DOI 10.1016/j.ajhg.2016.03.027
   Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116
   Eggermann T, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0143-8
   Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157
   Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109
   Green BB, 2015, EPIGENETICS-US, V10, P834, DOI 10.1080/15592294.2015.1073880
   Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544
   Hamada H, 2016, AM J HUM GENET, V99, P1045, DOI 10.1016/j.ajhg.2016.08.021
   Hanna CW, 2016, GENOME RES, V26, P756, DOI 10.1101/gr.196139.115
   Hannula-Jouppi K, 2014, EPIGENETICS-US, V9, P351, DOI 10.4161/epi.27160
   Hatt L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160319
   Hatt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128918
   Hinrichs AS, 2016, BIOINFORMATICS, V32, P1430, DOI 10.1093/bioinformatics/btv766
   Hitchins MP, 2001, EUR J HUM GENET, V9, P82, DOI 10.1038/sj.ejhg.5200583
   Jirtle J., 2012, GENEIMPRINT DATABASE
   Kagami M, 2017, GENET MED, V19, P476, DOI 10.1038/gim.2016.123
   Karim S, 2015, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3088-1
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kobayashi H, 2013, EPIGENETICS-US, V8, P635, DOI 10.4161/epi.24887
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133
   Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995
   Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707
   Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714
   Maeda T, 2014, GENET MED, V16, P903, DOI 10.1038/gim.2014.46
   Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058
   Marzi SJ, 2016, EPIGENETICS-US, V11, P24, DOI 10.1080/15592294.2015.1127479
   McCann JA, 2001, BIOCHEM BIOPH RES CO, V286, P943, DOI 10.1006/bbrc.2001.5500
   Mergenthaler S, 2001, AM J HUM GENET, V68, P543, DOI 10.1086/318192
   Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016
   Monahan K, 2015, ANNU REV CELL DEV BI, V31, P721, DOI 10.1146/annurev-cellbio-100814-125308
   Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248
   Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008
   Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624
   NHLBI GO Exome Sequencing Project, 2012, EX VAR SERV
   Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868
   Paliwal A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003622
   Poot M, 2007, AM J MED GENET A, V143A, P1038, DOI 10.1002/ajmg.a.31690
   Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96
   Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637
   Rochtus A, 2016, CLIN EPIGENETICS, V8
   Rodrigues JA, 2015, GENE DEV, V29, P2517, DOI 10.1101/gad.269902.115
   Romanelli V, 2014, EPIGENETICS-US, V9, P783, DOI 10.4161/epi.28323
   Sanchez-Delgado M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006427
   Sanchez-Delgado M, 2016, TRENDS GENET, V32, P444, DOI 10.1016/j.tig.2016.05.001
   Savol AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182568
   Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Skaar DA, 2012, ILAR J, V53, P341, DOI 10.1093/ilar.53.3-4.341
   Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581
   Soellner L, 2017, CLIN GENET, V91, P3, DOI 10.1111/cge.12827
   Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985
   Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373
   Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394
   Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243
   van Dongen J, 2015, TWIN RES HUM GENET, V18, P686, DOI 10.1017/thg.2015.74
   van Kempen LCL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai9188
   Viana J, 2014, EPIGENETICS-US, V9, P587, DOI 10.4161/epi.27806
   Wan ES, 2015, MOL REPROD DEV, V82, P377, DOI 10.1002/mrd.22483
   Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340
   Wei YJ, 2014, DEVELOPMENT, V141, P2516, DOI 10.1242/dev.105320
   Yoshihashi H, 2000, AM J HUM GENET, V67, P476, DOI 10.1086/302997
   YUEN RKC, 2011, EPIGENET CHROMATIN, V4
   Yuen RKC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007389
   Zhang Y, 2010, RNA, V16, P1889, DOI 10.1261/rna.2226910
   Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772
NR 91
TC 5
Z9 5
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAR 1
PY 2018
VL 9
AR 36
DI 10.3389/fgene.2018.00036
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA FX9CS
UT WOS:000426393600001
PM 29545821
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Rabelo, K
   Fernandes, RCDC
   de Souza, LJ
   de Souza, TL
   dos Santos, FB
   Nunes, PCG
   de Azeredo, EL
   Salomao, NG
   Trindade, GF
   Basilio-de-Oliveira, CA
   de Carvalho, JJ
   Medina-Acosta, E
   Paes, MV
AF Rabelo, Kissila
   de Souza Campos Fernandes, Regina Celia
   de Souza, Luiz Jose
   de Souza, Thais Louvain
   dos Santos, Flavia Barreto
   Guerra Nunes, Priscila Conrado
   de Azeredo, Elzinandes Leal
   Salomao, Natalia Gedeao
   Trindade, Gisela Freitas
   Basilio-de-Oliveira, Carlos A.
   de Carvalho, Jorge Jose
   Medina-Acosta, Enrique
   Paes, Marciano Viana
TI Placental Histopathology and Clinical Presentation of Severe Congenital
   Zika Syndrome in a Human Immunodeficiency Virus-Exposed Uninfected
   Infant
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; placenta; congenital Zika syndrome; histopathology;
   microcephaly; human immunodeficiency virus
ID DENGUE VIRUS; INFECTION; PATHOLOGY; CELLS; TRANSMISSION; ANTIBODIES;
   FETUSES; REPAIR; BRAZIL; BRAIN
AB In the large Zika virus (ZIKV) epidemic that occurred in Brazil in 2015, the intrauterine fetal exposure to ZIKV was associated with a significant risk of developing microcephaly and neurological disorders in the infected infants. ZIKV-associated disease has since been reported in 24 countries in the Americas. At present, definitive evidence is lacking regarding the intrauterine co-exposure to ZIKV and other viral infections and whether the coinfection impacts the risk of acquiring either infection or disease severity. Here, we provide evidence of intrauterine exposure to both ZIKV and human immunodeficiency virus (HIV) infections, causing congenital Zika syndrome in an HIV-exposed uninfected infant. Clinical, imaging and laboratory examinations of the pregnant woman and the newborn were performed. Histopathology, ZIKV/HIV-specific immunoassays, and ultrastructural evaluation of the placenta were performed. The Zika-asymptomatic, HIV-positive pregnant woman underwent ultrasounds revealing fetal cerebral ventriculomegaly, microcephaly, and brain atrophy. Her baby girl was born small for gestational age and with the neurological sequelae of congenital Zika syndrome. The evaluation of the abnormally large term placenta revealed severe damage to the maternal decidua and chorionic villi, cells positive for ZIKV-specific antigens but not for HIV antigens, and intracellular membranous clusters of virus-like particles approximately 25 nm in diameter. The rapid progression and severity of the congenital Zika syndrome may be related to the uncontrolled HIV disease in the mother. The poor inflammatory response observed in the placenta may have reduced the inherent risk of mother-to-child transmission of HIV.
C1 [Rabelo, Kissila; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrut & Biol Tecidual, Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Luiz Jose; de Souza, Thais Louvain] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Lab Biotechnol, Campos Dos Goytacazes, Brazil.
   [dos Santos, Flavia Barreto; Guerra Nunes, Priscila Conrado; de Azeredo, Elzinandes Leal] Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Salomao, Natalia Gedeao; Paes, Marciano Viana] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Trindade, Gisela Freitas] Biomanguinhos, Lab Tecnol Virol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Carlos A.] Univ Fed Estado Rio De Janeiro, Anat Patol, Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Lab Biotechnol, Campos Dos Goytacazes, Brazil.; Paes, MV (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
EM quique@uenf.br; marciano@ioc.fiocruz.br
RI Medina-Acosta, Enrique/G-3041-2010; Trindade, Gustavo
   Ferraz/O-9107-2016; amsalu, ribka/G-8780-2019
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Trindade, Gustavo
   Ferraz/0000-0001-6998-814X; Carvalho, Jorge/0000-0002-9426-6381; Paes,
   Marciano/0000-0002-2266-2801; Santos, Flavia/0000-0002-1309-5366;
   Rabelo, Kissila/0000-0001-7579-7788; Trindade,
   Gisela/0000-0002-1630-4143
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308780/2015-9]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/110.511/2014,
   E-26/010.001.498/2016, E26/202.003/2016]
FX The authors thank the Hospital Plantadores de Cana for the care of the
   patient and the assistance with sample collection, and the Platform of
   Confocal and Electron Microscopy at the State University of Rio de
   Janeiro and the Platform of Electron Microscopy in Fiocruz. This work
   was supported by the CNPq (308780/2015-9) and the FAPERJ
   (E-26/110.511/2014, E-26/010.001.498/2016 and E26/202.003/2016).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eaton JW, 2014, AIDS, V28, pS507, DOI 10.1097/QAD.0000000000000412
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fu D, 2015, DNA REPAIR, V35, P13, DOI 10.1016/j.dnarep.2015.09.008
   Goff SP, 2001, FIELDS VIROLOGY, P1871
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Inoue A, 2014, J BIOL CHEM, V289, P7109, DOI 10.1074/jbc.M113.520429
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Johnson EL, 2016, CURR OPIN INFECT DIS, V29, P248, DOI 10.1097/QCO.0000000000000267
   Kalk E, 2017, TROP MED INT HEALTH, V22, P604, DOI 10.1111/tmi.12858
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Schonenberger F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0618-9
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Torrentes-Carvalho A, 2016, CLIN IMMUNOL, V164, P95, DOI 10.1016/j.clim.2016.01.005
NR 28
TC 11
Z9 11
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD DEC 7
PY 2017
VL 8
AR 1704
DI 10.3389/fimmu.2017.01704
PG 8
WC Immunology
SC Immunology
GA FO9XH
UT WOS:000417251200001
PM 29270171
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Lima, JY
   Machado, FB
   Farro, APC
   Barbosa, LD
   da Silveira, LS
   Medina-Acosta, E
AF Lima, Juliana Ywasaki
   Machado, Filipe Brum
   Cazerta Farro, Ana Paula
   Barbosa, Lupercio de Araujo
   da Silveira, Leonardo Serafim
   Medina-Acosta, Enrique
TI Population genetic structure of Guiana dolphin (Sotalia guianensis) from
   the southwestern Atlantic coast of Brazil
SO PLOS ONE
LA English
DT Article
ID BOTTLE-NOSED DOLPHINS; MICROSATELLITE LOCI; NORTH-ATLANTIC; FRANCISCANA
   DOLPHIN; TURSIOPS-TRUNCATUS; MOLECULAR ECOLOGY; MEDITERRANEAN SEA;
   MITOCHONDRIAL; MARINE; DIFFERENTIATION
AB Sotalia guianensis is a small dolphin that is vulnerable to anthropogenic impacts. Along the Brazilian Atlantic coast, this species is threatened with extinction. A prioritized action plan for conservation strategies relies on increased knowledge of the population. The scarcity of studies about genetic diversity and assessments of population structure for this animal have precluded effective action in the region. Here, we assessed, for the first time, the genetic differentiation at 14 microsatellite loci in 90 S. guianensis specimens stranded on the southeastern Atlantic coast of the State of Espirito Santo, Brazil. We estimated population parameters and structure, measured the significance of global gametic disequilibrium and the intensity of non-random multiallelic interallelic associations and constructed a provisional synteny map using Bos taurus, the closest terrestrial mammal with a reference genome available. All microsatellite loci were polymorphic, with at least three and a maximum of ten alleles each. Allele frequencies ranged from 0.01 to 0.97. Observed heterozygosity ranged from 0.061 to 0.701. The mean inbreeding coefficient was 0.103. Three loci were in Hardy-Weinberg disequilibrium even when missing genotypes were inferred. Although 77 of the 91 possible two-locus associations were in global gametic equilibrium, we unveiled 13 statistically significant, sign-based, non-random multiallelic interallelic associations in 10 two-locus combinations with either coupling (D' values ranging from 0.782 to 0.353) or repulsion (D' values -0.517 to -1.000) forces. Most of the interallelic associations did not involve the major alleles. Thus, for either physically or non-physically linked loci, measuring the intensity of non-random interallelic associations is important for defining the evolutionary forces at equilibrium. We uncovered a small degree of genetic differentiation (F-ST = 0.010; P-value = 0.463) with a hierarchical clustering into one segment containing members from the southern and northern coastal regions. The data thus support the scenario of little genetic structure in the population of S. guianensis in this geographic area.
C1 [Lima, Juliana Ywasaki; da Silveira, Leonardo Serafim] Univ Estadual Norte Fluminense, Lab Morphol & Anim Pathol, Campos Goytacazes, Rio De Janeiro, Brazil.
   [Lima, Juliana Ywasaki; Machado, Filipe Brum; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Campos Goytacazes, Rio De Janeiro, Brazil.
   [Cazerta Farro, Ana Paula] Univ Fed Espirito Santo, Lab Genet & Anim Conservat, Sao Mateus, ES, Brazil.
   [Barbosa, Lupercio de Araujo] Inst Org & Environm Consciousness ORCA, Vila Velha, ES, Brazil.
RP Lima, JY (corresponding author), Univ Estadual Norte Fluminense, Lab Morphol & Anim Pathol, Campos Goytacazes, Rio De Janeiro, Brazil.; Lima, JY; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Biotechnol Lab, Campos Goytacazes, Rio De Janeiro, Brazil.
EM ju.ywasaki@gmail.com; quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Lima, Juliana/U-2098-2019; Farro,
   Ana Paula/H-2009-2019
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Ywasaki Lima,
   Juliana/0000-0002-5494-6809
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR)
   [E-26/111.665/2011, E-26/112.573/ 2012, E-26/110.775/2011, E-26/111.715/
   2012, E26/010.001036/2015]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (BR) [301034/2012-5]; Universidade Estadual do
   Norte Fluminense Darcy Ribeiro (BR) [1121306322]
FX This work was supported by grants from the Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (BR) (http://www.faperj.br/) [grant numbers
   E-26/111.665/2011 and E-26/112.573/ 2012 to LSS), E-26/110.775/2011,
   E-26/111.715/ 2012 and E26/010.001036/2015 to EM-A, and from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (BR)
   (http://cnpq.br/) [grant number 301034/2012-5 to EM-A]. JYL received a
   graduate fellowship (grant number 1121306322) from Universidade Estadual
   do Norte Fluminense Darcy Ribeiro (BR) (http:/www.uenf.br/). The
   agencies had no role in the study design, data collection, and analysis,
   decision to publish, or preparation of the manuscript.
CR Acevedo-Gutierrez Alejandro, 2005, Latin American Journal of Aquatic Mammals, V4, P49
   Adams LD, 2006, MAR BIOL, V148, P671, DOI 10.1007/s00227-005-0094-2
   Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290, 10.1093/nar/gks1189]
   Allen SJ, 2016, MOL ECOL, V25, P2735, DOI 10.1111/mec.13622
   Amaral AR, 2010, CONSERV GENET, V11, P1143, DOI 10.1007/s10592-009-9903-3
   [Anonymous], 1988, OCORRENCIA POPULACAO, P57
   Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x
   Archer F, 2001, MAR MAMMAL SCI, V17, P540, DOI 10.1111/j.1748-7692.2001.tb01003.x
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x
   Bilgmann K, 2007, MAR ECOL PROG SER, V341, P265, DOI 10.3354/meps341265
   Brandstrom M, 2008, MOL BIOL EVOL, V25, P2579, DOI 10.1093/molbev/msn201
   BRASIL, 2014, BRASIL FEDERAL UNION
   Caballero S, 2013, BIOCHEM SYST ECOL, V48, P263, DOI 10.1016/j.bse.2012.12.016
   Caldwell M, 2002, MOL ECOL NOTES, V2, P393, DOI 10.1046/j.1471-8286.2002.00270.x
   Chen L, 2010, MAR BIOL, V157, P1453, DOI 10.1007/s00227-010-1420-x
   Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x
   Costa-Urrutia P, 2012, J HERED, V103, P92, DOI 10.1093/jhered/esr103
   Cunha HA, 2010, WILDL PROT DESTR EXT, P261
   Cunha HA, 2007, MOL ECOL NOTES, V7, P1229, DOI 10.1111/j.1471-8286.2007.01839.x
   da Silva VMF, 1996, BEST RC MAMMALIAN SP, P1
   Edwards HH, 2001, MAR MAMMAL SCI, V17, P445, DOI 10.1111/j.1748-7692.2001.tb00998.x
   Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588
   Eroglu HE, 2015, CARYOLOGIA, V68, P239, DOI 10.1080/00087114.2015.1032614
   Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x
   Falush D, 2003, GENETICS, V164, P1567
   Flach L, 2008, MAR MAMMAL SCI, V24, P503, DOI 10.1111/j.1748-7692.2008.00198.x
   Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30
   Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198
   Gaspari S, 2007, CONSERV GENET, V8, P727, DOI 10.1007/s10592-006-9205-y
   Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227
   Gravena W, 2009, MOL ECOL RESOUR, V9, P600, DOI 10.1111/j.1755-0998.2008.02458.x
   Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170
   Herald E. S., 1967, Pacific Discovery, V20, P2
   Hoelzel A.R., 1992, MOL GENETIC ANAL POP
   Hollatz C, 2011, MAR BIOL, V158, P927, DOI 10.1007/s00227-010-1619-x
   Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x
   HUSSON A.M., 1978, ZOOLOGISCHE MONOGRAP
   ICMBio, 2011, BRAS CHIC MEND I CON, P129
   International Union for Conservation of Nature (IUCN), IUCN RED LIST THREAT
   Perez-Alvarez MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123956
   Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95
   Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202. Article published online before March 2002
   Krause J., 2002, LIVING GROUPS
   Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x
   Krutzen M, 2004, MAR MAMMAL SCI, V20, P28, DOI 10.1111/j.1748-7692.2004.tb01139.x
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lewis PO, 2001, GENETIC DATA ANAL CO
   Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530
   Machado FB, 2012, MOL BIOL REP, V39, P1447, DOI 10.1007/s11033-011-0881-4
   Medina-Acosta E, 2010, HAEMOPHILIA, V16, P525, DOI 10.1111/j.1365-2516.2009.02161.x
   Medina-Acosta E, 2011, MOL BIOL REP, V38, P4003, DOI 10.1007/s11033-010-0518-z
   Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7
   Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x
   Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y
   Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218
   Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076
   Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x
   Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y
   NEI M, 1981, GENETICS, V97, P145
   Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1
   Pritchard JK, 2000, GENETICS, V155, P945
   Quintela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108640
   RICHARD KR, 1994, CAN J ZOOL, V72, P873, DOI 10.1139/z94-118
   Richards VP, 2013, J HERED, V104, P765, DOI 10.1093/jhered/est070
   Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x
   Rosel PE, 2005, MOL ECOL NOTES, V5, P830, DOI 10.1111/j.1471-8286.2005.01078.x
   Segura I, 2006, BIOL CONSERV, V133, P336, DOI 10.1016/j.biocon.2006.06.017
   Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301
   Sussan-Duque S, 2006, DISTRIBUCIO USO HABI
   Szpiech ZA, 2011, THEOR POPUL BIOL, V80, P100, DOI 10.1016/j.tpb.2011.03.006
   Tereba A., 1999, DNA TECH TIPS, V3, P14, DOI DOI 10.1016/J.FSIGEN.2012.11.011
   van Bree P.J.H., 1975, Uitgaven Natuurw Studkring Suriname, VNo. 84, P79
   Van Waerebeek K., 1990, PRELIMINARY NOTES EX, P71
   Viricel A, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2999-3
   Viricel A, 2014, MOL ECOL, V23, P5018, DOI 10.1111/mec.12923
   WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
   Zapata C, 2001, GENETICS, V158, P1235
NR 83
TC 4
Z9 5
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 24
PY 2017
VL 12
IS 8
AR e0183645
DI 10.1371/journal.pone.0183645
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FE7CK
UT WOS:000408365000094
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU de Souza, TL
   Fernandes, RCDC
   da Silva, JA
   Alves, VG
   Coelho, AG
   Faria, ACS
   Simao, NMMS
   Souto, JT
   Deswarte, C
   Boisson-Dupuis, S
   Torgerson, D
   Casanova, JL
   Bustamante, J
   Medina-Acosta, E
AF de Souza, Thais Louvain
   de Souza Campos Fernandes, Regina C.
   da Silva, Juliana Azevedo
   Alves Junior, Vladimir Gomes
   Coelho, Adelia Gomes
   Souza Faria, Afonso C.
   Moreira Salomao Simao, Nabia M.
   Souto Filho, Joao T.
   Deswarte, Caroline
   Boisson-Dupuis, Stephanie
   Torgerson, Dara
   Casanova, Jean-Laurent
   Bustamante, Jacinta
   Medina-Acosta, Enrique
TI Microbial Disease Spectrum Linked to a Novel IL-12R beta 1 N-Terminal
   Signal Peptide Stop-Gain Homozygous Mutation with Paradoxical Receptor
   Cell-Surface Expression
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE IL-12R beta 1 deficiency; Mendelian susceptibility to mycobacterial
   diseases; impaired receptor; IFN-gamma; signal peptide; founder
   stop-gain mutation
ID BETA-1 DEFICIENCY; PRIMARY IMMUNODEFICIENCY; SALMONELLA INFECTIONS;
   MYCOBACTERIAL DISEASE; CLINICAL-PRACTICE; WARNING SIGNS; IL12RB1 GENE;
   CHILD; IMMUNITY; HISTOPLASMOSIS
AB Patients with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) exhibit variable vulnerability to infections by mycobacteria and other intramacrophagic bacteria (e.g., Salmonella and Klebsiella) and fungi (e.g., Histoplasma, Candida, Paracoccidioides, Coccidioides, and Cryptococcus). The hallmark of MSMD is the inherited impaired production of interferon gamma (IFN-gamma) or the lack of response to it. Mutations in the interleukin (IL)-12 receptor subunit beta 1 (IL12RB1) gene accounts for 38% of cases of MSMD. Most IL12RB1 pathogenic allele mutations, including ten known stop-gain variants, cause IL-12R beta 1 complete deficiency (immunodeficiency-30, IMD30) by knocking out receptor cell-surface expression. IL12RB1 loss-of-function genotypes impair both IL-12 and IL-23 responses. Here, we assess the health effects of a rare, novel IL12RB1 stop-gain homozygous genotype with paradoxical IL-12R beta 1 cell-surface expression. We appraise four MSMD children from three unrelated Brazilian kindreds by clinical consultation, medical records, and genetic and immunologic studies. The clinical spectrum narrowed down to Bacillus Calmette-Guerin (BCG) vaccine-related suppurative adenitis in all patients with one death, and recrudescence in two, histoplasmosis, and recurrence in one patient, extraintestinal salmonellosis in one child, and cutaneous vasculitis in another. In three patients, we established the homozygous Trp7Ter predicted loss-of-function inherited genotype and inferred it from the heterozygote parents of the fourth case. The Trp7Ter mutation maps to the predicted IL-12R beta 1 N-terminal signal peptide sequence. BCG- or phytohemagglutinin-blasts from the three patients have reduced cell-surface expression of IL-12R beta 1 with impaired production of IFN-gamma and IL-17A. Screening of 227 unrelated healthy subjects from the same geographic region revealed one heterozygous genotype (allele frequency 0.0022) vs. one in over 841,883 public genome/exomes. We also show that the carriers bear European ancestry-informative alleles and share the extended CACCAGTCCGG IL12RB1 haplotype that occurs worldwide with a frequency of 8.4%. We conclude that the novel IL12RB1 N-terminal signal peptide stop-gain loss-of-function homozygous genotype confers IL-12R beta 1 deficiency with varying severity and early-onset age through diminished cell-surface expression of an impaired IL-12R beta 1 polypeptide. We firmly recommend attending to warning signs of IMD30 in children who are HIV-1 negative with a history of adverse effects to the BCG vaccine and presenting with recurrent Histoplasma spp. and extraintestinal Salmonella spp. infections.
C1 [de Souza, Thais Louvain; de Souza Campos Fernandes, Regina C.; Alves Junior, Vladimir Gomes; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Lab Biotecnol, Nucleo Diagnost & Invest Mol, Campos Dos Goytacazes, Brazil.
   [de Souza, Thais Louvain; de Souza Campos Fernandes, Regina C.; Alves Junior, Vladimir Gomes; Souto Filho, Joao T.] Fac Med Campos, Campos Dos Goytacazes, Brazil.
   [da Silva, Juliana Azevedo] Univ Estadual Norte Fluminense, Lab Biol Reconhecer, Campos Dos Goytacazes, Brazil.
   [Coelho, Adelia Gomes] Hosp Municipal Ferreira Machado, Campos Dos Goytacazes, Brazil.
   [Souza Faria, Afonso C.] Pronto Atendimento UNIMED, Campos Dos Goytacazes, Brazil.
   [Moreira Salomao Simao, Nabia M.] Hosp Escola Alvaro Alvim, Campos Dos Goytacazes, Brazil.
   [Deswarte, Caroline; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Bustamante, Jacinta] INSERM, Lab Human Genet Infect Dis, Paris, France.
   [Deswarte, Caroline; Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Bustamante, Jacinta] Paris Descartes Univ, Imagine Inst, Lab Human Genet Infect Dis Mendelian Predisposit, Paris, France.
   [Boisson-Dupuis, Stephanie; Casanova, Jean-Laurent; Bustamante, Jacinta] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Torgerson, Dara] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Casanova, Jean-Laurent] Necker Hosp Sick Children, AP HP, Pediat Hematol Immunol Unit, Paris, France.
   [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
   [Bustamante, Jacinta] Necker Hosp Sick Children, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Lab Biotecnol, Nucleo Diagnost & Invest Mol, Campos Dos Goytacazes, Brazil.
EM quique@uenf.br
RI Deswarte, Caroline/H-8018-2017; Filho, Joao Tadeu Damian
   Souto/E-7323-2013; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis,
   Stephanie/I-2040-2017; Louvain de Souza, Thais/G-2646-2014; Bustamante,
   Jacinta/H-7877-2017; Medina-Acosta, Enrique/G-3041-2010
OI Deswarte, Caroline/0000-0002-8775-3368; Filho, Joao Tadeu Damian
   Souto/0000-0003-2641-1425; Boisson-Dupuis,
   Stephanie/0000-0002-7115-116X; Louvain de Souza,
   Thais/0000-0002-0179-272X; Bustamante, Jacinta/0000-0002-3439-2482;
   Medina-Acosta, Enrique/0000-0002-2529-0548; Casanova,
   Jean-Laurent/0000-0002-7782-4169
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR)
   [E-26/110.775/2011, E-26/111.715/2012, E26/010.001036/2015,
   E-26/202.426/2015]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (BR) [301034/2012-5]; Universidade Estadual do Norte
   Fluminense Darcy Ribeiro (BR) [1121200877]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R37AI095983,
   R37AI095983, R37AI095983, R37AI095983, R37AI095983, R37AI095983,
   R37AI095983, R37AI095983, R37AI095983, R37AI095983] Funding Source: NIH
   RePORTER
FX This work was supported by grants from the Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro (BR) (http://www.faperj.br/) [grant numbers
   E-26/110.775/2011, E-26/111.715/2012 and E26/010.001036/2015 to EM and
   E26/010.000892/2015 to RF], and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (BR) (http://cnpq. br/) [grant
   number 301034/2012-5 to EM]. TL received a graduate fellowship (grant
   number 1121200877) from Universidade Estadual do Norte Fluminense Darcy
   Ribeiro (BR) (http://www.uenf.br/). VG received an undergraduate
   fellowship (grant number E-26/202.426/2015) from Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (BR). The agencies had no role in
   the study design, data collection, and analysis, decision to publish, or
   preparation of the manuscript.
CR Abolhassani H, 2015, EXPERT REV CLIN IMMU, V11, P289, DOI 10.1586/1744666X.2015.990440
   Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432
   Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298
   Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524
   Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008
   Caragol I, 2003, CLIN INFECT DIS, V37, P302, DOI 10.1086/375587
   Carneiro-Sampaio M, 2011, PEDIAT ALLERG IMM-UK, V22, P345, DOI 10.1111/j.1399-3038.2010.01084.x
   Carvalho Beatriz Tavares Costa, 2003, J. Pediatr. (Rio J.), V79, P273, DOI 10.1590/S0021-75572003000300015
   Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514
   Clemons KV, 2000, MICROBES INFECT, V2, P997, DOI 10.1016/S1286-4579(00)01253-3
   Costa-Carvalho BT, 2014, J CLIN IMMUNOL, V34, P10, DOI 10.1007/s10875-013-9954-6
   de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832
   de Jong R, 1998, SCIENCE, V280, P1435
   de Moraes-Vasconcelos D, 2005, CLIN INFECT DIS, V41, pE31, DOI 10.1086/432119
   Doffinger R, 1999, ALLERGY, V54, P409, DOI 10.1034/j.1398-9995.1999.00088.x
   Fieschi C, 2004, BLOOD, V104, P2095, DOI 10.1182/blood-2004-02-0584
   Filiz S, 2014, PEDIATR DERMATOL, V31, P236, DOI 10.1111/j.1525-1470.2012.01856.x
   Jirapongsananuruk O, 2012, ASIAN PAC J ALLERGY, V30, P79
   Kutukculer N, 2006, J PEDIATR-US, V148, P407, DOI 10.1016/j.jpeds.2005.10.003
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lichtenauer-Kaligis EGR, 2003, EUR J IMMUNOL, V33, P59, DOI 10.1002/immu.200390008
   Faiolla RCL, 2013, REV SOC BRAS MED TRO, V46, P461, DOI 10.1590/0037-8682-0124-2013
   Luangwedchakarn V, 2009, ASIAN PAC J ALLERGY, V27, P161
   MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021
   Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639
   Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624
   NHLBI GO Exome Sequencing Project, 2012, EX VAR SERV
   Patiroglu T, 2013, ACTA MICROBIOL IMM H, V60, P155, DOI 10.1556/AMicr.60.2013.2.6
   Ramirez-Alejo N, 2014, CLIN GENET, V86, P161, DOI 10.1111/cge.12253
   Sanal O, 2006, J CLIN IMMUNOL, V26, P1, DOI 10.1007/s10875-006-7830-3
   Schepers K, 2013, J CLIN IMMUNOL, V33, P1285, DOI 10.1007/s10875-013-9941-y
   Scheuerman O, 2007, ISRAEL MED ASSOC J, V9, P560
   Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394
   Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243
   Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P622, DOI 10.1016/j.jaci.2012.03.045
   van de Vosse E, 2013, HUM MUTAT, V34, P1329, DOI 10.1002/humu.22380
   Vinh DC, 2011, CLIN INFECT DIS, V52, pE99, DOI 10.1093/cid/ciq215
   Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259
   Woodfolk JA, 2015, ALLERGOL INT, V64, P295, DOI 10.1016/j.alit.2015.06.001
   Zahid MF, 2014, J IMMUNODEFIC DISORD, V3, DOI [10.4172/2324-853X.1000109, DOI 10.4172/2324-853X.1000109]
   Zerbe CS, 2005, CLIN INFECT DIS, V41, pE38, DOI 10.1086/432120
NR 41
TC 9
Z9 9
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 13
PY 2017
VL 8
AR 616
DI 10.3389/fmicb.2017.00616
PG 10
WC Microbiology
SC Microbiology
GA ER9YI
UT WOS:000399182700001
PM 28450854
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Grzesiuk, JD
   Pereira, CS
   Grangeiro, CHP
   Picanco-Albuquerque, CG
   Oliveira-Gennaro, FG
   Machado, FB
   Medina-Acosta, E
   Ramos, ES
   Yoshimoto, M
   Martelli, L
AF Grzesiuk, Juliana Dourado
   Pereira, Ciro Silveira
   Paiva Grangeiro, Carlos Henrique
   Picanco-Albuquerque, Clarissa Gondim
   Oliveira-Gennaro, Flavia Gaona
   Machado, Filipe Brum
   Medina-Acosta, Enrique
   Ramos, Ester Silveira
   Yoshimoto, Maisa
   Martelli, Lucia
TI Familial chromosomal translocation X; 22 associated with infertility and
   recurrent X mosaicism (vol 9, 45, 2016)
SO MOLECULAR CYTOGENETICS
LA English
DT Correction
C1 [Grzesiuk, Juliana Dourado; Paiva Grangeiro, Carlos Henrique; Picanco-Albuquerque, Clarissa Gondim; Oliveira-Gennaro, Flavia Gaona; Ramos, Ester Silveira; Martelli, Lucia] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049900 Ribeirao Preto, Brazil.
   [Pereira, Ciro Silveira] San Raphael Hosp, Ctr Biotecnol & Cellular Therapy, BR-41253190 Salvador, BA, Brazil.
   [Machado, Filipe Brum; Medina-Acosta, Enrique] Darcy Ribeiro State Univ Northern Rio de Janeiro, Ctr Biosci & Biotechnol, BR-28013600 Campos Dos Goytacazes, Brazil.
   [Yoshimoto, Maisa] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.
RP Grzesiuk, JD (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049900 Ribeirao Preto, Brazil.
EM juli_dourado@hotmail.com
RI Medina-Acosta, Enrique/G-3041-2010; Ramos, Ester/E-3200-2019
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Ramos,
   Ester/0000-0001-7253-2143
CR Grzesiuk JD, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0249-5
NR 1
TC 0
Z9 0
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1755-8166
J9 MOL CYTOGENET
JI Mol. Cytogenet.
PD JUL 5
PY 2016
VL 9
AR 53
DI 10.1186/s13039-016-0262-8
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA DR9VY
UT WOS:000380245400001
PM 27382416
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   de Souza, TL
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   de Souza, Thais Louvain
   Medina-Acosta, Enrique
TI Congenital Zika syndrome in Brazil
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, BR-28035581 Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, BR-28010140 Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia; de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, BR-28035200 Rio De Janeiro, Brazil.
RP Fernandes, RCDC (corresponding author), Fac Med Campos, BR-28035581 Rio De Janeiro, Brazil.; Fernandes, RCDC (corresponding author), Municipal Program Surveillance Sexually Transmitt, BR-28010140 Rio De Janeiro, Brazil.; Fernandes, RCDC (corresponding author), Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, BR-28035200 Rio De Janeiro, Brazil.
EM reg.fernandes@bol.com.br
RI Louvain de Souza, Thais/G-2646-2014; Medina-Acosta, Enrique/G-3041-2010
OI Louvain de Souza, Thais/0000-0002-0179-272X; Medina-Acosta,
   Enrique/0000-0002-2529-0548
CR [Anonymous], 2016, LANCET INFECT DIS, V16, P265
   [Anonymous], 2016, PROT VIG RESP OC MIC
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brazilian Ministry of Health, 2016, MICR 4 268 CAS SUSPE
   Brazilian Ministry of Health, 2016, SINASC SIST INF NASC
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281
NR 9
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 772
EP 772
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600021
PM 27352749
DA 2020-12-16
ER

PT J
AU Grzesiuk, JD
   Pereira, CS
   Grangeiro, CHP
   Picanco-Albuquerque, CG
   Oliveira-Gennaro, FG
   Machado, FB
   Medina-Acosta, E
   Ramos, ES
   Yoshimoto, M
   Martelli, L
AF Grzesiuk, Juliana Dourado
   Pereira, Ciro Silveira
   Paiva Grangeiro, Carlos Henrique
   Picanco-Albuquerque, Clarissa Gondim
   Oliveira-Gennaro, Flavia Gaona
   Machado, Filipe Brum
   Medina-Acosta, Enrique
   Ramos, Ester Silveira
   Yoshimoto, Maisa
   Martelli, Lucia
TI Familial chromosomal translocation X; 22 associated with infertility and
   recurrent X mosaicism
SO MOLECULAR CYTOGENETICS
LA English
DT Article
DE Infertility; X; autosome translocation; recurrent mosaicism; X
   inactivation; array-CGH
ID INACTIVATION; OOCYTES; WOMEN
AB Background: Individuals with apparently balanced translocations, often, show no clinical findings. However, in meiosis, translocations tend to cause errors on chromosome disjunction and the ones involving sex chromosomes have particular implications for the phenotype. Male carriers of balanced X-autosome translocations are almost invariably infertile due to interruption of the spermatogenesis, but the mechanism is not fully understood.
   Case presentation: In this case report, we performed a combination of classical cytogenetics (G-banding), molecular cytogenetics (fluorescence in situ hybridization and X-chromosome inactivation study), and cytogenomics (microarray-based comparative genomic hybridization) techniques for characterization of an inherited (X; 22) translocation in a family originally referred for infertility investigation. Both proband and his sister are infertile and present the maternally inherited translocation. Interestingly, the maternal grandmother was mosaic for X chromosome monosomy suggesting that the t(X; 22) in the proband's mother arose by errors at oogenesis. The presence of the same mosaicism of the X chromosome in the proband's aunt is consistent with this consideration. Array-CGH analysis showed no constitutional pathogenic gains or losses in the translocation carriers. The X-chromosome inactivation studies revealed that the translocated X; 22 was active in 99.3% of cells in the mother and in 88% of cells in the daughter. We suggest that incomplete skewing of X inactivation (> 97 %) of the daughter could justify the infertility. This study is the first description of recurrent mosaicism of the X chromosome associated with a familial X-autosome translocation.
   Conclusions: The phenotype of infertility was probably caused by disruption of spermatogenesis due to gametogenesis specific errors resulted from meiotic pairing and segregation anomalies on the translocated chromosomes.
C1 [Grzesiuk, Juliana Dourado; Paiva Grangeiro, Carlos Henrique; Picanco-Albuquerque, Clarissa Gondim; Oliveira-Gennaro, Flavia Gaona; Ramos, Ester Silveira; Martelli, Lucia] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049900 Ribeirao Preto, Brazil.
   [Pereira, Ciro Silveira] San Raphael Hosp, Ctr Biotecnol & Cellular Therapy, BR-41253190 Salvador, BA, Brazil.
   [Machado, Filipe Brum; Medina-Acosta, Enrique] Darcy Ribeiro State Univ Northern Rio de Janeiro, Ctr Biosci & Biotechnol, BR-28013600 Campos Dos Goytacazes, Brazil.
   [Yoshimoto, Maisa] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.
RP Grzesiuk, JD (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049900 Ribeirao Preto, Brazil.
EM juli_dourado@hotmail.com
RI Ramos, Ester/E-3200-2019; Medina-Acosta, Enrique/G-3041-2010;
   Oliveira-Gennaro, Flavia/L-5430-2016
OI Ramos, Ester/0000-0001-7253-2143; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Oliveira-Gennaro,
   Flavia/0000-0002-5310-5514; Grzesiuk, Juliana D/0000-0001-5730-5639
FU Coordination for the Improvement of Higher Education Personnel (CAPES,
   Brazil)CAPES; Foundation of Support to Teaching, Research and Assistance
   of Clinics Hospital, Ribeirao Preto Medical School, University of Sao
   Paulo (FAEPA-HCFMRP)
FX We acknowledge Professor Jeremy Squire and Dr. Juliana Meola Lovato for
   their thoughtful suggestions. The authors gratefully acknowledge the
   participation of the family members and the colleagues from the Medical
   Genetics Division of Ribeirao Preto Medical School, University of Sao
   Paulo. This work has been supported by the Coordination for the
   Improvement of Higher Education Personnel (CAPES, Brazil) and the
   Foundation of Support to Teaching, Research and Assistance of Clinics
   Hospital, Ribeirao Preto Medical School, University of Sao Paulo
   (FAEPA-HCFMRP).
CR Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677
   DEBRAEKELEER M, 1991, HUM REPROD, V6, P245, DOI 10.1093/oxfordjournals.humrep.a137315
   Delhanty JDA, 2013, HUM FERTIL, V16, P241, DOI 10.3109/14647273.2013.843792
   Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454
   Dong Y, 2012, J INT MED RES, V40, P2274, DOI 10.1177/030006051204000625
   Egozcue S, 2000, HUM REPROD UPDATE, V6, P93, DOI 10.1093/humupd/6.1.93
   Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108
   Gardner R J, 2011, CHROMOSOME ABNORMALI
   Hall HE, 2007, AM J MED GENET A, V143A, P2249, DOI 10.1002/ajmg.a.31918
   Hulten MA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-21
   Kagami M, 2012, EUR J HUM GENET, V20, P928, DOI 10.1038/ejhg.2012.26
   Kotzot D, 2001, J MED GENET, V38, P497, DOI 10.1136/jmg.38.8.497
   Ma S, 2003, HUM REPROD, V18, P1377, DOI 10.1093/humrep/deg247
   Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714
   Mantzouratou A, 2011, CYTOGENET GENOME RES, V133, P141, DOI 10.1159/000323794
   Martin RH, 2008, HUM REPROD UPDATE, V14, P379, DOI 10.1093/humupd/dmn017
   MATTEI MG, 1982, HUM GENET, V61, P295
   Oliver-Bonet M, 2005, CYTOGENET GENOME RES, V111, P343, DOI 10.1159/000086908
   Robberecht C, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-19
   Robles P, 2007, REPRODUCTION, V133, P899, DOI 10.1530/REP-06-0243
   Shaffer Lisa G., 2001, Genetics in Medicine, V3, P206, DOI 10.1097/00125817-200105000-00011
   Sharp AJ, 2002, HUM MOL GENET, V11, P3145, DOI 10.1093/hmg/11.25.3145
   Suzuki T, 2014, J HUM GENET, V59, P649, DOI 10.1038/jhg.2014.88
   Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018
   VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1
   Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924
   Vetro A, 2012, EUR J MED GENET, V55, P185, DOI 10.1016/j.ejmg.2012.01.010
   Voet T, 2011, HUM MUTAT, V32, P783, DOI 10.1002/humu.21502
   Wolff DJ, 2000, GENET MED, V2, P136, DOI 10.1097/00125817-200003000-00004
   Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871
NR 30
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1755-8166
J9 MOL CYTOGENET
JI Mol. Cytogenet.
PD JUN 15
PY 2016
VL 9
AR 45
DI 10.1186/s13039-016-0249-5
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA DP6MW
UT WOS:000378612200001
PM 27313662
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU da Silva, AFA
   Machado, FB
   Pavarino, EC
   Biselli-Perico, JM
   Zampieri, BL
   Francisco, RD
   Rodrigues, PTM
   Machado, DT
   Santos-Reboucas, CB
   Fernandes, MG
   Lopes, SMCD
   Rios, AFL
   Medina-Acosta, E
AF Alves da Silva, Antonio Francisco
   Machado, Filipe Brum
   Pavarino, Erika Cristina
   Biselli-Perico, Joice Matos
   Zampieri, Bruna Lancia
   Francisco Junior, Ronaldo da Silva
   Mozer Rodrigues, Pedro Thyago
   Machado, Douglas Terra
   Santos-Reboucas, Cintia Barros
   Fernandes, Maria Gomes
   Chuva de Sousa Lopes, Susana Marina
   Lopes Rios, Alvaro Fabricio
   Medina-Acosta, Enrique
TI Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and
   -Independent Manners
SO PLOS ONE
LA English
DT Article
ID MATERNAL UNIPARENTAL DISOMY; DOWN-SYNDROME; GENE-EXPRESSION; HUMAN
   GENOME; PATERNAL AGE; TRANSCRIPTION FACTORS; IMPRINTED GENES; SEQUENCING
   DATA; STEM-CELLS; CHROMOSOME-21
AB The supernumerary chromosome 21 in Down syndrome differentially affects the methylation statuses at CpG dinucleotide sites and creates genome-wide transcriptional dysregulation of parental alleles, ultimately causing diverse pathologies. At present, it is unknown whether those effects are dependent or independent of the parental origin of the nondis-joined chromosome 21. Linkage analysis is a standard method for the determination of the parental origin of this aneuploidy, although it is inadequate in cases with deficiency of samples from the progenitors. Here, we assessed the reliability of the epigenetic 5(m)CpG imprints resulting in the maternally (oocyte)-derived allele methylation at a differentially methylated region (DMR) of the candidate imprinted WRB gene for asserting the parental origin of chromosome 21. We developed a methylation-sensitive restriction enzyme-specific PCR assay, based on the WRB DMR, across single nucleotide polymorphisms (SNPs) to examine the methylation statuses in the parental alleles. In genomic DNA from blood cells of either disomic or trisomic subjects, the maternal alleles were consistently methylated, while the paternal alleles were unmethylated. However, the supernumerary chromosome 21 did alter the methylation patterns at the RUNX1 (chromosome 21) and TMEM131 (chromosome 2) CpG sites in a parent-of-origin-independent manner. To evaluate the 5(m)CpG imprints, we conducted a computational comparative epigenomic analysis of transcriptome RNA sequencing (RNA-Seq) and histone modification expression patterns. We found allele fractions consistent with the transcriptional biallelic expression of WRB and ten neighboring genes, despite the similarities in the confluence of both a 17-histone modification activation backbone module and a 5-histone modification repressive module between the WRB DMR and the DMRs of six imprinted genes. We concluded that the maternally inherited 5(m)CpG imprints at the WRB DMR are uncoupled from the parental allele expression of WRB and ten neighboring genes in several tissues and that trisomy 21 alters DNA methylation in parent-of-origin-dependent and -independent manners.
C1 [Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil.
   [Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil.
   [Alves da Silva, Antonio Francisco; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Grad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.
   [Machado, Filipe Brum] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Postgrad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.
   [Pavarino, Erika Cristina; Biselli-Perico, Joice Matos; Zampieri, Bruna Lancia] Fac Med Sao Jose Rio Preto, Sao Paulo, Brazil.
   [Santos-Reboucas, Cintia Barros] Univ Estado Rio de Janeiro, Dept Genet, BR-20550011 Rio De Janeiro, Brazil.
   [Fernandes, Maria Gomes; Chuva de Sousa Lopes, Susana Marina] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.
RP da Silva, AFA; Machado, FB; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil.; da Silva, AFA; Machado, FB; Medina-Acosta, E (corresponding author), Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil.; da Silva, AFA; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Grad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.; Machado, FB (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Postgrad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.
EM filipebma@yahoo.com.br; anttonio.allves@gmail.com; quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Biselli, Joice Matos/B-6913-2014;
   Pavarino, Erika C/L-5899-2016; Zampieri, Bruna/F-7120-2012; Junior,
   Ronaldo S F/I-4073-2014
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Pavarino, Erika
   C/0000-0003-0959-0695; Zampieri, Bruna/0000-0003-0091-1894; Junior,
   Ronaldo S F/0000-0001-7419-3907; Santos-Reboucas,
   Cintia/0000-0003-4729-2373; Matos Biselli, Joice/0000-0001-5105-9537
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/110.775/2011, E-26/111.715/2012, E26/010.001036/2015];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [301034/2012-5]; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Universidade Estadual do Norte Fluminense
FX Research supported by grants #E-26/110.775/2011 and #E-26/111.715/2012
   and #E26/010.001036/2015 to EM-A from Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (http://www.faperj.br/) and #301034/2012-5 to
   EM-A from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (http://cnpq.br/). AFAS receive a graduate fellowship from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico. FBM received a
   postgraduate fellowship form the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior. RSFJ received an undergraduate fellowship
   from Universidade Estadual do Norte Fluminense (http://www.uenf.br/).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302
   Bacalini MG, 2015, AGING-US, V7, P82
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115
   Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587
   Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281
   BLOUIN JL, 1993, AM J HUM GENET, V53, P1074
   Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268
   Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113
   Court F, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-5
   CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452
   Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010
   De Souza E, 2010, ARCH DIS CHILD, V95, P893, DOI 10.1136/adc.2009.176438
   Deelen P, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0152-4
   Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116
   ERICKSON JD, 1981, J MED GENET, V18, P22, DOI 10.1136/jmg.18.1.22
   Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196
   GAULDEN ME, 1992, MUTAT RES, V296, P69, DOI 10.1016/0165-1110(92)90033-6
   Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064
   Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24
   HATCH M, 1990, HUM GENET, V85, P355
   HENDERSON DJ, 1994, HUM MOL GENET, V3, P1373, DOI 10.1093/hmg/3.8.1373
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026
   Joergensen MW, 2013, PRENATAL DIAG, V33, P1131, DOI 10.1002/pd.4206
   Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009
   Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58
   Kazaura MR, 2002, PAEDIATR PERINAT EP, V16, P314, DOI 10.1046/j.1365-3016.2002.00446.x
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212
   Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200
   Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533
   Liehr T, 2014, UNIPARENTAL DISOMY U
   Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905
   Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798
   Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714
   Mansuet-Lupo A, 2009, FORENSIC SCI INT-GEN, V3, P141, DOI 10.1016/j.fsigen.2008.09.010
   Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058
   Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c
   Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/88209
   Muranjan M, 2010, INDIAN PEDIATR, V47, P429, DOI 10.1007/s13312-010-0078-2
   Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868
   Oliver TR, 2009, AM J MED GENET A, V149A, P1685, DOI 10.1002/ajmg.a.32942
   Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033
   Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040
   Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270
   Proudhon C, 2010, BRIEF FUNCT GENOMICS, V9, P374, DOI 10.1093/bfgp/elq020
   RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U
   Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637
   ROBINSON WP, 1994, AM J HUM GENET, V54, P290
   Rogan PK, 1999, AM J MED GENET, V83, P69, DOI 10.1002/(SICI)1096-8628(19990305)83:1<69::AID-AJMG14>3.0.CO;2-Q
   Sambrook J.F., 2001, MOLECULAR CLONING A
   Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663
   Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408
   Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571
   Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148
   Steyaert S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku847
   Stoll C., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P265
   SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303
   Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277
   Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18
   Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154
   Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]
   Wood DLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126911
   Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022
   Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024
   Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128
   Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433
NR 75
TC 10
Z9 10
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2016
VL 11
IS 4
AR e0154108
DI 10.1371/journal.pone.0154108
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK4OR
UT WOS:000374898500146
PM 27100087
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Santos, S
   Middleton, S
   da Silva, AFA
   Machado, F
   Santos-Reboucas, C
   Medina-Acosta, E
AF Santos, Suely
   Middleton, Sonia
   Alves da Silva, Antonio Francisco
   Machado, Fabio
   Santos-Reboucas, Cintia
   Medina-Acosta, Enrique
TI 48,XXYY syndrome: case report
SO CHROMOSOME RESEARCH
LA English
DT Meeting Abstract
C1 [Santos, Suely; Middleton, Sonia] Univ Fed Estado Rio de Janeiro, Genet & Mol Biol Dept, Rio de Janeiro, Brazil.
   [Alves da Silva, Antonio Francisco; Machado, Fabio; Medina-Acosta, Enrique] Univ Estadual N Fluminen, Mol Identificat & Diagnost Unit, Campos dos Goytacazes, Brazil.
   [Santos-Reboucas, Cintia] Univ Estado Rio De Janeiro, Dept Genet, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0967-3849
EI 1573-6849
J9 CHROMOSOME RES
JI Chromosome Res.
PD JUN
PY 2015
VL 23
SU 1
MA 1.P77
BP S73
EP S73
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA VB0IV
UT WOS:000411861000123
DA 2020-12-16
ER

PT J
AU Santos-Reboucas, CB
   de Almeida, LG
   Belet, S
   dos Santos, SR
   Ribeiro, MG
   da Silva, AFA
   Medina-Acosta, E
   dos Santos, JM
   Goncalves, AP
   Bahia, PRV
   Pimentel, MMG
   Froyen, G
AF Santos-Reboucas, Cintia Barros
   de Almeida, Luciana Guedes
   Belet, Stefanie
   dos Santos, Suely Rodrigues
   Ribeiro, Marcia Goncalves
   Alves da Silva, Antonio Francisco
   Medina-Acosta, Enrique
   dos Santos, Jussara Mendonca
   Goncalves, Andressa Pereira
   Valle Bahia, Paulo Roberto
   Goncalves Pimentel, Marcia Mattos
   Froyen, Guy
TI Novel microduplications at Xp11.22 including HUWE1: clinical and
   molecular insights into these genomic rearrangements associated with
   intellectual disability
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID MENTAL-RETARDATION; MALES; KDM5C
AB Recently, we defined a minimal overlapping region for causal Xp11.22 copy number gains in males with intellectual disability (ID), and identified HECT, UBA and WWE domain-containing protein-1 (HUWE1) as the primary dosage-sensitive gene, whose overexpression leads to ID. In the present study, we used this minimal interval to search for HUWE1 copy number variations by quantitative polymerase chain reaction in a large cohort of Brazilian males with idiopathic ID. We detected two unrelated sporadic individuals with syndromic ID carrying unique overlapping duplications encompassing HUWE1. Breakpoint junction analysis showed a simple tandem duplication in the first patient, which has probably arisen by microhomology-mediated break-induced repair mechanism. In the second patient, the rearrangement is complex having an insertion of an intrachromosomal sequence at its junction. This kind of rearrangement has not been reported in Xp11.22 duplications and might have emerged by a replication-or recombination-based mechanism. Furthermore, the presence of infantile seizures in the second family suggests a potential role of increased KDM5C expression on epilepsy. Our findings highlight the importance of microduplications at Xp11.22 to ID, even in sporadic cases, and reveal new clinical and molecular insight into HUWE1 copy number gains.
C1 [Santos-Reboucas, Cintia Barros; de Almeida, Luciana Guedes; dos Santos, Jussara Mendonca; Goncalves, Andressa Pereira; Goncalves Pimentel, Marcia Mattos] Univ Estado Rio De Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Belet, Stefanie; Froyen, Guy] Katholieke Univ Leuven, Human Genome Lab, VIB Ctr Biol Dis, Leuven, Belgium.
   [Belet, Stefanie; Froyen, Guy] Katholieke Univ Leuven, Human Genome Lab, Dept Human Genet, Leuven, Belgium.
   [dos Santos, Suely Rodrigues] Univ Fed Rio de Janeiro, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [Ribeiro, Marcia Goncalves] Univ Fed Rio de Janeiro, Clin Genet Serv, IPPMG, Rio De Janeiro, Brazil.
   [Alves da Silva, Antonio Francisco; Medina-Acosta, Enrique] State Univ North Fluminense Darcy Ribeiro, Biotechnol Lab, Ctr Biosci & Biotechnol, Rio De Janeiro, Brazil.
   [Valle Bahia, Paulo Roberto] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil.
RP Santos-Reboucas, CB (corresponding author), Univ Estado Rio de Janeiro, Dept Genet, Serv Genet Humana, Inst Biol Roberto Alcantara Gomes, Rua Sao Francisco Xavier 524,PHLC Sala 501 F, BR-20550013 Rio De Janeiro, RJ, Brazil.
EM cbs@uerj.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Santos-Reboucas,
   Cintia/0000-0003-4729-2373; Ribeiro, Marcia/0000-0001-8906-0189;
   Pimentel, Marcia/0000-0002-8872-7073
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ/Brazil)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)National Council
   for Scientific and Technological Development (CNPq); CEPUERJ;
   Geconcerteerde Onderzoeks Acties of the University of Leuven, Belgium
   [GOA/12/015]
FX We thank the families for their kind cooperation and Centro Estadual de
   Diagnostico por Imagem (SES, Rio de Janeiro, Brazil) for conducting the
   neuroimaging tests. This work was supported by funds from Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/Brazil), Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil),
   CEPUERJ and the Geconcerteerde Onderzoeks Acties of the University of
   Leuven, Belgium (GOA/12/015).
CR Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768
   Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002
   Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010
   Goncalves TF, 2014, EUR J MED GENET, V57, P138, DOI 10.1016/j.ejmg.2014.02.011
   Poeta L, 2013, AM J HUM GENET, V92, P114, DOI 10.1016/j.ajhg.2012.11.008
   Santos-Reboucas CB, 2014, EUR J HUM GENET, V22, P644, DOI 10.1038/ejhg.2013.216
   Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823
   Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549
   Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358
NR 9
TC 12
Z9 12
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD APR
PY 2015
VL 60
IS 4
BP 207
EP 211
DI 10.1038/jhg.2015.1
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA CG8NT
UT WOS:000353565700008
PM 25652354
DA 2020-12-16
ER

PT J
AU Radic, CP
   Rossetti, LC
   Abelleyro, MM
   Tetzlaff, T
   Candela, M
   Neme, D
   Sciuccati, G
   Bonduel, M
   Medina-Acosta, E
   Larripa, IB
   Pinto, MD
   De Brasi, CD
AF Radic, C. P.
   Rossetti, L. C.
   Abelleyro, M. M.
   Tetzlaff, T.
   Candela, M.
   Neme, D.
   Sciuccati, G.
   Bonduel, M.
   Medina-Acosta, E.
   Larripa, I. B.
   de Tezanos Pinto, M.
   De Brasi, C. D.
TI Phenotype-genotype correlations in hemophilia A carriers are consistent
   with the binary role of the phase between F8 and X-chromosome
   inactivation
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE F8 protein; human; hemophiliaA; X chromosome; X chromosome inactivation;
   X-linked genetic diseases
ID FACTOR-VIII GENE; MESSENGER-RNA; XIST GENE; FEMALE; MUTATIONS; PATTERNS;
   METHYLATION; MECHANISMS; BINDING; FAMILY
AB BackgroundThe recessive X-linked disorder hemophiliaA (HA) is rarely expressed in female carriers, most of whom express about half of normal factorVIII activity (FVIII:C).
   ObjectiveTo propose an integrative assessment model for the binary role of the phase between the mutated F8 and the active X-chromosome (Xa) in FVIII:C in HA carriers.
   MethodsWe studied 67 females at risk of severe HA, comprising five symptomatic females (FVIII:C<1.5IUdL(-1)) and 14 controls. A correlation study between FVIII:C (observed vs. expected) and X-chromosome inactivation (XCI) patterns (XIPs; androgen receptor gene [AR] system) in blood leukocyte DNA was performed in carriers, by comparison of a model correlating FVIII:C and XIP with arbitrary models devoid of biological significance, and with FVIII:C levels in non-carriers (mean model) as a proxy from background data dispersion not influenced by XIP.
   ResultsWe provide proof-of-concept example from a family presenting with extremely skewed XIPs in which the severe HA phenotype appeared in a heterozygous carrier of a crossover between AR and F8 loci that phased the mutated F8 with the maternally inherited Xa. Furthermore, four cases of severe HA affected women who had a combination of a heterozygous F8 mutation and extremely skewed XIPs in leukocytes or oral mucosa are presented. Correlation analyses between FVIII:C levels and XIPs in carriers (n=38) but not in non-carriers (n=20) showed highly significant differences between the proposed correlation model and models without biological significance. The data support a binary influence of XCI, either increasing or decreasing the FVIII:C, subject to the underlying phase set between the F8 mutation and XCI.
   ConclusionsOur evidence suggests that the phase between XCI and mutated F8 acts as a molecular switch conditioning FVIII:C levels and HA expression in carriers.
C1 [Radic, C. P.; Rossetti, L. C.; Abelleyro, M. M.; Larripa, I. B.; De Brasi, C. D.] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, RA-1425 Buenos Aires, DF, Argentina.
   [Tetzlaff, T.] UNGS, Inst Ciencias, Buenos Aires, DF, Argentina.
   [Candela, M.; de Tezanos Pinto, M.; De Brasi, C. D.] Acad Nacl Med Buenos Aires, Inst Invest Hematol IIHEMA, RA-1425 Buenos Aires, DF, Argentina.
   [Candela, M.; Neme, D.; de Tezanos Pinto, M.] Fdn Hemofilia Alfredo Pavlovsky, Buenos Aires, DF, Argentina.
   [Sciuccati, G.; Bonduel, M.] Hosp Pediat Prof Dr Juan P Garrahan, Lab Hemostasia & Trombosis, Serv Hematol & Oncol, Buenos Aires, DF, Argentina.
   [Medina-Acosta, E.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Nucleo Diagnost & Invest Mol, Lab Biotecnol, Campos Dos Goytacazes, Brazil.
RP Radic, CP (corresponding author), Acad Nacl Med Buenos Aires, Mol Genet Hemophilia Sect, Pacheco de Melo 3081, RA-1425 Buenos Aires, DF, Argentina.
EM pradic@hematologia.anm.edu.ar
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; De Brasi, Carlos
   Daniel/0000-0003-2379-4379
FU Rene Baron Foundation; Alberto J. Roemmers Foundation; Florencio Fiorini
   Foundation; National Research Council (CONICET)Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de
   Promocion de la Cientifica y Tecnologica (ANPCyT); Word Federation of
   Hemophilia
FX We would like to thank the hematologist C. Baduel and the scientists V.
   Marchione, D. Alvarez and A. Maffei for their contributions in different
   phases of the work. This study was supported by grants from the Rene
   Baron Foundation, the Alberto J. Roemmers Foundation, the Florencio
   Fiorini Foundation, the National Research Council (CONICET), and the
   Agencia Nacional de Promocion de la Cientifica y Tecnologica (ANPCyT),
   and a fellowship from the Word Federation of Hemophilia.
CR ACQUILA M, 1995, BLOOD, V85, P599
   ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   Ay C, 2010, HAEMOPHILIA, V16, P111, DOI 10.1111/j.1365-2516.2009.02108.x
   Bicocchi MP, 2005, EUR J HUM GENET, V13, P635, DOI 10.1038/sj.ejhg.5201386
   Bittel DC, 2008, J MED GENET, V45, P309, DOI 10.1136/jmg.2007.055244
   Bolduc V, 2008, J CLIN INVEST, V118, P333, DOI 10.1172/JCI33166
   de Brasi C, 2014, HAEMOPHILIA, V20, P54, DOI 10.1111/hae.12409
   El-Maarri O, 2005, J THROMB HAEMOST, V3, P332, DOI 10.1111/j.1538-7836.2005.01140.x
   Favier R, 2000, BLOOD, V96, P4373, DOI 10.1182/blood.V96.13.4373.h8004373_4373_4375
   Freson K, 1998, HUM MUTAT, V11, P470, DOI 10.1002/(SICI)1098-1004(1998)11:6<470::AID-HUMU8>3.3.CO;2-1
   Kanduri C, 2009, FEBS LETT, V583, P857, DOI 10.1016/j.febslet.2009.02.004
   Karasawa M, 2001, INT J HEMATOL, V74, P281, DOI 10.1007/BF02982062
   KITCHEN S, 2000, DIAGNOSIS HEMOPHILIA, P53
   KLING S, 1991, EUR J HAEMATOL, V47, P257
   Knobe KE, 2008, HAEMOPHILIA, V14, P846, DOI 10.1111/j.1365-2516.2008.01754.x
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0
   Martin-Salces M, 2010, THROMB HAEMOSTASIS, V104, P718, DOI 10.1160/TH10-02-0085
   MAZURIER C, 1990, BRIT J HAEMATOL, V76, P372, DOI 10.1111/j.1365-2141.1990.tb06371.x
   Naumova AK, 1996, AM J HUM GENET, V58, P1111
   NISEN PD, 1989, J CLIN INVEST, V83, P1400, DOI 10.1172/JCI114028
   Orstavik KH, 1999, J MED GENET, V36, P865
   Orstavik KH, 2000, THROMB HAEMOSTASIS, V83, P433
   PANARELLO C, 1992, CYTOGENET CELL GENET, V59, P241, DOI 10.1159/000133259
   Pavlova A, 2009, J THROMB HAEMOST, V7, P976, DOI 10.1111/j.1538-7836.2009.03346.x
   Pereira LV, 1999, AM J MED GENET, V87, P86, DOI 10.1002/(SICI)1096-8628(19991105)87:1<86::AID-AJMG19>3.3.CO;2-A
   Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353
   Plug I, 2006, BLOOD, V108, P52, DOI 10.1182/blood-2005-09-3879
   Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611
   Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089
   Renault NK, 2007, EUR J HUM GENET, V15, P628, DOI 10.1038/sj.ejhg.5201799
   Rossetti LC, 2008, J THROMB HAEMOST, V6, P830, DOI 10.1111/j.1538-7836.2008.02926.x
   Rossetti LC, 2007, HAEMATOLOGICA, V92, P842, DOI 10.3324/haematol.11112
   Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005
   Wang XF, 2009, THROMB HAEMOSTASIS, V101, P775, DOI 10.1160/TH08-12-0793
NR 35
TC 14
Z9 15
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD APR
PY 2015
VL 13
IS 4
BP 530
EP 539
DI 10.1111/jth.12854
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA CF1MK
UT WOS:000352309700007
PM 25611311
DA 2020-12-16
ER

PT J
AU Machado, FB
   Machado, FB
   Faria, MA
   Lovatel, VL
   da Silva, AFA
   Radic, CP
   De Brasi, CD
   Rios, AFL
   Lopes, SMCD
   da Silveira, LS
   Ruiz-Miranda, CR
   Ramos, ES
   Medina-Acosta, E
AF Machado, Filipe Brum
   Machado, Fabricio Brum
   Faria, Milena Amendro
   Lovatel, Viviane Lamim
   Alves da Silva, Antonio Francisco
   Pamela Radic, Claudia
   Daniel De Brasi, Carlos
   Lopes Rios, Alvaro Fabricio
   Lopes, Susana Marina Chuva de Sousa
   da Silveira, Leonardo Serafim
   Ruiz-Miranda, Carlos Ramon
   Ramos, Ester Silveira
   Medina-Acosta, Enrique
TI 5(me)CpG Epigenetic Marks Neighboring a Primate-Conserved Core Promoter
   Short Tandem Repeat Indicate X-Chromosome Inactivation
SO PLOS ONE
LA English
DT Article
ID ANDROGEN-RECEPTOR GENE; CAG REPEAT; DNA; METHYLATION; ESCAPE; LOCI;
   IDENTIFICATION; POLYMORPHISM; LIKELIHOOD; MUTATIONS
AB X-chromosome inactivation (XCI) is the epigenetic transcriptional silencing of an X-chromosome during the early stages of embryonic development in female eutherian mammals. XCI assures monoallelic expression in each cell and compensation for dosage-sensitive X-linked genes between females (XX) and males (XY). DNA methylation at the carbon-5 position of the cytosine pyrimidine ring in the context of a CpG dinucleotide sequence (5(me)CpG) in promoter regions is a key epigenetic marker for transcriptional gene silencing. Using computational analysis, we revealed an extragenic tandem GAAA repeat 230-bp from the landmark CpG island of the human X-linked retinitis pigmentosa 2 RP2 promoter whose 5(me)CpG status correlates with XCI. We used this RP2 onshore tandem GAAA repeat to develop an allele-specific 5(me)CpG-based PCR assay that is highly concordant with the human androgen receptor (AR) exonic tandem CAG repeat-based standard HUMARA assay in discriminating active (Xa) from inactive (Xi) X-chromosomes. The RP2 onshore tandem GAAA repeat contains neutral features that are lacking in the AR disease-linked tandem CAG repeat, is highly polymorphic (heterozygosity rates approximately 0.8) and shows minimal variation in the Xa/Xi ratio. The combined informativeness of RP2/AR is approximately 0.97, and this assay excels at determining the 5(me)CpG status of alleles at the Xp (RP2) and Xq (AR) chromosome arms in a single reaction. These findings are relevant and directly translatable to nonhuman primate models of XCI in which the AR CAG-repeat is monomorphic. We conducted the RP2 onshore tandem GAAA repeat assay in the naturally occurring chimeric New World monkey marmoset (Callitrichidae) and found it to be informative. The RP2 onshore tandem GAAA repeat will facilitate studies on the variable phenotypic expression of dominant and recessive X-linked diseases, epigenetic changes in twins, the physiology of aging hematopoiesis, the pathogenesis of age-related hematopoietic malignancies and the clonality of cancers in human and nonhuman primates.
C1 [Machado, Filipe Brum; Ramos, Ester Silveira] Univ Sao Paulo, Sch Med, Dept Genet, Sao Paulo, Brazil.
   [Machado, Fabricio Brum; Faria, Milena Amendro; Lovatel, Viviane Lamim; Alves da Silva, Antonio Francisco; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil.
   [Pamela Radic, Claudia; Daniel De Brasi, Carlos] Natl Acad Med, Inst Expt Med, Lab Mol Genet Hemophilia, Buenos Aires, DF, Argentina.
   [Lopes, Susana Marina Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, South Holland, Netherlands.
   [da Silveira, Leonardo Serafim] Univ Estadual Norte Fluminense, Ctr Studies & Res Wildlife, Lab Anim Morphol & Pathol, Rio De Janeiro, Brazil.
   [Ruiz-Miranda, Carlos Ramon] Univ Estadual Norte Fluminense, Lab Environm Sci, Sect Studies Ethol Reintroduct & Conservat Wild A, Rio De Janeiro, Brazil.
   [Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil.
RP Ramos, ES (corresponding author), Univ Sao Paulo, Sch Med, Dept Genet, Sao Paulo, Brazil.
EM esramos@fmrp.usp.br; quique@uenf.br
RI Ruiz-Miranda, Carlos R/H-7308-2015; Medina-Acosta, Enrique/G-3041-2010;
   Ramos, Ester/E-3200-2019; Ruiz, Carlos R/I-4446-2016
OI Ruiz-Miranda, Carlos R/0000-0001-7360-0304; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Ramos, Ester/0000-0001-7253-2143; De Brasi,
   Carlos Daniel/0000-0003-2379-4379; Lamim Lovatel,
   Viviane/0000-0001-8493-5855
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CAPES-NUFFICCAPES [302731/2009-1, E-
   26/111.450/2012, E- 111.398/2013, E-26/111.788/2013, E-26/110.035/201];
   CAPESCAPES
FX The research leading to these results has received funding from FAPERJ
   (http://www.faperj.br), CNPq (http://www.cnpq.br), FAPESP
   (http://www.fapesp.br/en/), CAPES-NUFFIC
   (http://www.capes.gov.br/cooperacao-internacional/holanda/programa-capes
   nuffic), under grant agreements 302731/2009-1, E- 26/111.450/2012, E-
   111.398/2013, E-26/111.788/2013, E-26/110.035/201, and graduate
   fellowships by FAPESP(FiBM), FAPERJ (FaBM and MAF), CAPES (VLL) and CNPq
   (AFAS). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781
   ALLEN RC, 1992, AM J HUM GENET, V51, P1229
   Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987
   Bacher J, 1998, PROFILES DNA, V2, P3
   Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132
   Beever C, 2003, AM J MED GENET A, V120A, P439, DOI 10.1002/ajmg.a.20045
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z
   Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213
   Bertelsen B, 2011, J MOL DIAGN, V13, P537, DOI 10.1016/j.jmoldx.2011.05.003
   Bird A, 2011, J MOL BIOL, V409, P47, DOI 10.1016/j.jmb.2011.01.056
   Busque L, 1996, BLOOD, V88, P59
   Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677
   Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479
   Choong CS, 1998, J MOL EVOL, V47, P334, DOI 10.1007/PL00006391
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320
   Gu ML, 2012, MOL BIOL REP, V39, P2615, DOI 10.1007/s11033-011-1014-9
   HENDRIKS RW, 1992, HUM MOL GENET, V1, P187, DOI 10.1093/hmg/1.3.187
   Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134
   Ji JP, 1996, NUCLEIC ACIDS RES, V24, P2835, DOI 10.1093/nar/24.14.2835
   Kar S, 2012, EPIGENETICS-US, V7, P994, DOI 10.4161/epi.21568
   Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112
   Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0
   LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0
   Machado FB, 2011, HAEMOPHILIA, V17, P257, DOI 10.1111/j.1365-2516.2010.02404.x
   Machado FB, 2009, HAEMOPHILIA, V15, P1135, DOI 10.1111/j.1365-2516.2009.02056.x
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   Mossner M, 2013, J MED GENET, V50, P108, DOI 10.1136/jmedgenet-2012-101093
   Mubiru JN, 2012, J MED PRIMATOL, V41, P67, DOI 10.1111/j.1600-0684.2011.00517.x
   Ohadi M, 2012, GENE, V507, P61, DOI 10.1016/j.gene.2012.07.001
   Pessia E, 2012, P NATL ACAD SCI USA, V109, P5346, DOI 10.1073/pnas.1116763109
   Radic CP, 2009, PRENATAL DIAG, V29, P1183, DOI 10.1002/pd.2393
   Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6
   Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440
   Rossetti LC, 2008, J THROMB HAEMOST, V6, P830, DOI 10.1111/j.1538-7836.2008.02926.x
   Sales ID, 2010, VET PARASITOL, V171, P123, DOI 10.1016/j.vetpar.2010.02.044
   Sambrook J F, 2001, MOL CLONING LAB MANU
   Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y
   Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172
   Schwahn U, 1998, NAT GENET, V19, P327
   Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110
   Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178
   Sin HS, 2013, EPIGENETICS-US, V8, P887, DOI 10.4161/epi.25672
   Sweeney CG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-98
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035
   Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108
NR 50
TC 11
Z9 11
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 31
PY 2014
VL 9
IS 7
AR e103714
DI 10.1371/journal.pone.0103714
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM6EF
UT WOS:000339954800068
PM 25078280
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Santos-Reboucas, CB
   Belet, S
   de Almeida, LG
   Ribeiro, MG
   Medina-Acosta, E
   Bahia, PRV
   da Silva, AFA
   dos Santos, FL
   de Lacerda, GCB
   Pimentel, MMG
   Froyen, G
AF Santos-Reboucas, Cintia Barros
   Belet, Stefanie
   de Almeida, Luciana Guedes
   Ribeiro, Marcia Goncalves
   Medina-Acosta, Enrique
   Valle Bahia, Paulo Roberto
   Alves da Silva, Antonio Francisco
   dos Santos, Flavia Lima
   Borges de Lacerda, Glenda Correa
   Goncalves Pimentel, Marcia Mattos
   Froyen, Guy
TI A novel in-frame deletion affecting the BAR domain of OPHN1 in a family
   with intellectual disability and hippocampal alterations
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE X-linked intellectual disability; Rho GTPase; Oligophrenin-1; BAR
   domain; cerebellar hypoplasia; hippocampus
ID LINKED MENTAL-RETARDATION; CEREBELLAR HYPOPLASIA; VENTRICULAR
   ENLARGEMENT; PROTEIN OLIGOPHRENIN-1; GRAF FAMILY; GENE; MUTATIONS;
   RHOGAP; REPLICATION; ENDOCYTOSIS
AB Oligophrenin-1 (OPHN1) is one of at least seven genes located on chromosome X that take part in Rho GTPase-dependent signaling pathways involved in X-linked intellectual disability (XLID). Mutations in OPHN1 were primarily described as an exclusive cause of non-syndromic XLID, but the re-evaluation of the affected individuals using brain imaging displayed fronto-temporal atrophy and cerebellar hypoplasia as neuroanatomical marks. In this study, we describe clinical, genetic and neuroimaging data of a three generation Brazilian XLID family co-segregating a novel intragenic deletion in OPHN1. This deletion results in an in-frame loss of exon 7 at transcription level (c.781_891del; r.487_597del), which is predicted to abolish 37 amino acids from the highly conserved N-terminal BAR domain of OPHN1. cDNA expression analysis demonstrated that the mutant OPHN1 transcript is stable and no abnormal splicing was observed. Features shared by the affected males of this family include neonatal hypotonia, strabismus, prominent root of the nose, deep set eyes, hyperactivity and instability/intolerance to frustration. Cranial MRI scans showed large lateral ventricles, vermis hypoplasia and cystic dilatation of the cisterna magna in all affected males. Interestingly, hippocampal alterations that have not been reported in patients with loss-of-function OPHN1 mutations were found in three affected individuals, suggesting an important function for the BAR domain in the hippocampus. This is the first description of an in-frame deletion within the BAR domain of OPHN1 and could provide new insights into the role of this domain in relation to brain and cognitive development or function. published online 9 October 2013
C1 [Santos-Reboucas, Cintia Barros; de Almeida, Luciana Guedes; dos Santos, Flavia Lima; Goncalves Pimentel, Marcia Mattos] Univ Estado Rio De Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Belet, Stefanie; Froyen, Guy] Katholieke Univ Leuven, VIB Ctr Biol Dis, Human Genome Lab, Louvain, Belgium.
   [Belet, Stefanie; Froyen, Guy] Katholieke Univ Leuven, Ctr Human, Human Genome Lab, Louvain, Belgium.
   [Ribeiro, Marcia Goncalves] Univ Fed Rio de Janeiro, IPPMG, Clin Genet Serv, Rio De Janeiro, Brazil.
   [Medina-Acosta, Enrique; Alves da Silva, Antonio Francisco] State Univ North Fluminense Darcy Ribeiro, Ctr Biosci & Biotechnol, Biotechnol Lab, Rio De Janeiro, Brazil.
   [Valle Bahia, Paulo Roberto] Univ Fed Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Borges de Lacerda, Glenda Correa] Univ Fed Fluminense, Epilepsy Outpatient Sect, Rio De Janeiro, Brazil.
   [Borges de Lacerda, Glenda Correa] Univ Estado Rio De Janeiro, Neurol & Neurophysiol Serv, Rio De Janeiro, Brazil.
RP Santos-Reboucas, CB (corresponding author), Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Genet, Serv Genet Humana, Rua Sao Francisco Xavier,524,PHLC Sala 501F, BR-20550013 Rio De Janeiro, RJ, Brazil.
EM cbs@alternex.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Pimentel,
   Marcia/0000-0002-8872-7073; Santos-Reboucas, Cintia/0000-0003-4729-2373;
   Ribeiro, Marcia/0000-0001-8906-0189; Borges de Lacerda,
   Glenda/0000-0003-0776-0769
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [473824/2011-6]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/103.215/2011];
   PPSUS-MS/CNPq/FAPERJNational Council for Scientific and Technological
   Development (CNPq)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/110.765/2010]; CEPUERJ
FX We thank the family members for their kind cooperation, 'Centro Estadual
   de Diagnostico por Imagem' (SES, Rio de Janeiro, Brazil) for conducting
   the neuroimaging tests and Professor Paulo Luciano Gomes for helping in
   the EEG procedures. This work was supported by funds from CNPq
   (473824/2011-6), FAPERJ (E-26/103.215/2011), PPSUS-MS/CNPq/FAPERJ
   (E-26/110.765/2010) and CEPUERJ.
CR Al-Owain M, 2011, CLIN GENET, V79, P363, DOI 10.1111/j.1399-0004.2010.01462.x
   Araujo A, 2008, BRAZ J MED BIOL RES, V41, P368
   Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107
   Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173
   Bienvenu T, 1997, EUR J HUM GENET, V5, P105, DOI 10.1159/000484743
   Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940
   Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677
   Chabrol B, 2005, AM J MED GENET A, V138A, P314, DOI 10.1002/ajmg.a.30882
   de Kreuk Bart-Jan, 2012, Small GTPases, V3, P45, DOI 10.4161/sgtp.18960
   Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535
   Elvers M, 2012, CARDIOVASC RES, V94, P526, DOI 10.1093/cvr/cvs079
   Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2
   Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564
   Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010
   Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210
   Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327
   Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809
   Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007
   Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189
   Larson SA, 2001, AM J MENT RETARD, V106, P231, DOI 10.1352/0895-8017(2001)106<0231:POMRAD>2.0.CO;2
   Madrigal I, 2008, J INTELL DISABIL RES, V52, P190, DOI 10.1111/j.1365-2788.2007.00997.x
   Menten B, 2007, EUR J MED GENET, V50, P446, DOI 10.1016/j.ejmg.2007.07.003
   Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022
   Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441
   Pirozzi F, 2011, HUM MUTAT, V32, pE2294, DOI 10.1002/humu.21567
   Santos CB, 2003, INT J MOL MED, V12, P385
   Stuve O, 2001, EPILEPSIA, V42, P778, DOI 10.1046/j.1528-1157.2001.40600.x
   Tentler D, 1999, EUR J HUM GENET, V7, P541, DOI 10.1038/sj.ejhg.5200320
   Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011
   Zanni G, 2005, NEUROLOGY, V65, P1364, DOI 10.1212/01.wnl.0000182813.94713.ee
   ZIVIN L, 1968, BRAIN, V91, P751, DOI 10.1093/brain/91.4.751
NR 31
TC 11
Z9 12
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAY
PY 2014
VL 22
IS 5
BP 644
EP 651
DI 10.1038/ejhg.2013.216
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AF3GS
UT WOS:000334600400014
PM 24105372
OA Bronze, Green Published
DA 2020-12-16
ER

PT J
AU Medina-Acosta, E
   Nakaya, HTI
   Pontillo, A
   Fernandes, RCDC
AF Medina-Acosta, Enrique
   Nakaya, Helder Takashi Imoto
   Pontillo, Alessandra
   de Souza Campos Fernandes, Regina Celia
TI Genetic Control of Immune Response and Susceptibility to Infectious
   Diseases
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Editorial Material
C1 [Medina-Acosta, Enrique] State Univ Norte Fluminense Darcy Ribeiro, Ctr Biosci & Biotechnol, Dept Biotechnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Nakaya, Helder Takashi Imoto] Emory Univ, Emory Vaccine Ctr, Primate Res Ctr, Atlanta, GA 30329 USA.
   [Pontillo, Alessandra] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Immunogenet Lab, BR-05508900 Sao Paulo, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Alvaro Alvim Sch Hosp, Sch Med Campos, Dept Pediat, BR-28035211 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), State Univ Norte Fluminense Darcy Ribeiro, Ctr Biosci & Biotechnol, Dept Biotechnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Pontillo, ALESSANDRA/D-4352-2012; Medina-Acosta, Enrique/G-3041-2010;
   Pontillo, Alessandra/AAD-4790-2019; Nakaya, Helder I/A-1397-2010;
   Nakaya, Helder/AAF-1738-2020; Pontillo, Alessandra/ABC-6266-2020
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Pontillo, Alessandra/0000-0002-7883-0640;
   Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Pontillo, Alessandra/0000-0002-7883-0640
NR 0
TC 0
Z9 0
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 796073
DI 10.1155/2014/796073
PG 3
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AB4GA
UT WOS:000331746400001
PM 24689057
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   Medina-Acosta, Enrique
TI Congenital neurosyphilis
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID SYPHILIS
C1 [de Souza Campos Fernandes, Regina Celia] Univ Estadual Norte Fluminense, Fac Med Campos, BR-28013602 Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Univ Estadual Norte Fluminense, Municipal Program Surveillance Sexually Transmitt, BR-28013602 Campos Dos Goytacazes, Brazil.
   [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, BR-28013602 Campos Dos Goytacazes, Brazil.
RP Fernandes, RCDC (corresponding author), Univ Estadual Norte Fluminense, Fac Med Campos, BR-28013602 Campos Dos Goytacazes, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X
   Brazilian Ministry of Health, 2012, B EP SIF 2012
   Brazilian Ministry of Health, 2005, DIR CONTR SIF CONG
   RAWSTRON SA, 1991, SEX TRANSM DIS, V18, P102, DOI 10.1097/00007435-199118020-00009
   Silva S, 2012, LANCET INFECT DIS, V12, P816, DOI 10.1016/S1473-3099(12)70059-2
   Tagarro A, 2005, J PERINAT MED, V33, P79, DOI 10.1515/JPM.2005.015
NR 6
TC 0
Z9 1
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2013
VL 13
IS 6
BP 474
EP 475
DI 10.1016/S1473-3099(13)70080-X
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA 152NZ
UT WOS:000319539700009
PM 23718917
DA 2020-12-16
ER

PT J
AU Agostinho, LD
   Rocha, CF
   Medina-Acosta, E
   Barboza, HN
   da Silva, AFA
   Pereira, SPF
   da Silva, ID
   Paradela, ER
   Figueiredo, ALD
   Nogueira, ED
   Alvarenga, RMP
   Cabello, PH
   dos Santos, SR
   Paiva, CLA
AF Agostinho, Luciana de A.
   Rocha, Catielly F.
   Medina-Acosta, Enrique
   Barboza, Hazel N.
   da Silva, Antonio F. Alves
   Pereira, Simao P. F.
   da Silva, Iane dos Santos
   Paradela, Eduardo R.
   Figueiredo, Andre L. dos S.
   Nogueira, Eduardo de M.
   Alvarenga, Regina M. P.
   Cabello, Pedro Hernan
   dos Santos, Suely R.
   Paiva, Carmen L. A.
TI Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families
   with Huntington's disease (vol 57, pg 796, 2012)
SO JOURNAL OF HUMAN GENETICS
LA English
DT Correction
RI Paiva, C. L. A./A-1503-2010; Agostinho, Luciana/H-7994-2015; PARADELA,
   EDUARDO/AAW-6807-2020
OI Paiva, C. L. A./0000-0003-2877-0296; Agostinho,
   Luciana/0000-0001-5604-8386; 
CR Agostinho LD, 2012, J HUM GENET, V57, P796, DOI 10.1038/jhg.2012.120
NR 1
TC 0
Z9 0
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
J9 J HUM GENET
JI J. Hum. Genet.
PD DEC
PY 2012
VL 57
IS 12
BP 810
EP 810
DI 10.1038/jhg.2012.125
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA 060SW
UT WOS:000312799400014
OA Bronze
DA 2020-12-16
ER

PT J
AU Agostinho, LD
   Rocha, CF
   Medina-Acosta, E
   Barboza, HN
   da Silva, AFA
   Pereira, SPF
   da Silva, ID
   Paradela, ER
   Figueiredo, ALD
   Nogueira, ED
   Alvarenga, RMP
   Cabello, PH
   dos Santos, SR
   Paiva, CLA
AF Agostinho, Luciana de A.
   Rocha, Catielly F.
   Medina-Acosta, Enrique
   Barboza, Hazel N.
   Alves da Silva, Antonio F.
   Pereira, Simao P. F.
   da Silva, Iane dos Santos
   Paradela, Eduardo R.
   Figueiredo, Andre L. dos S.
   Nogueira, Eduardo de M.
   Alvarenga, Regina M. P.
   Cabello, Pedro Hernan
   dos Santos, Suely R.
   Paiva, Carmen L. A.
TI Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families
   with Huntington's disease
SO JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE CAG repeats; CCG repeats; Huntington's disease
ID NORMAL-POPULATIONS; TRIPLET REPEATS; HD PATIENTS; GENE; ONSET;
   EXPANSION; INSTABILITY; PREVALENCE; MECHANISMS; EVOLUTION
AB We studied the allelic profile of CAG and CCG repeats in 61 Brazilian individuals in 21 independent families affected by Huntington's disease (HD). Thirteen individuals had two normal alleles for HD, two had one mutable normal allele and no HD phenotype, and forty-six patients carried at least one expanded CAG repeat allele. Forty-five of these individuals had one expanded allele and one individual had one mutable normal allele (27 CAG repeats) and one expanded allele (48 CAG repeats). Eleven of these forty-five subjects had a mutant allele with reduced penetrance, and thirty-four patients had a mutant allele with complete penetrance. Inter-and intragenerational investigations of CAG repeats were also performed. We found a negative correlation between the number of CAG repeats and the age of disease onset (r = -0.84; P<0.001) and no correlation between the number of CCG repeats and the age of disease onset (r = 0.06). We found 40 different haplotypes and the analysis showed that (CCG) 10 was linked to a CAG normal allele in 19 haplotypes and to expanded alleles in two haplotypes. We found that (CCG)(7) was linked to expanded CAG repeats in 40 haplotypes (95.24%) and (CCG) 10 was linked to expanded CAG repeats in only two haplotypes (4.76%). Therefore, (CCG)(7) was the most common allele in HD chromosomes in this Brazilian sample. It was also observed that there was a significant association of (CCG)(7) with the expanded CAG alleles (chi(2) = 6.97, P = 0.0084). Worldwide, the most common CCG alleles have 7 or 10 repeats. In Western Europe, (CCG)(7) is the most frequent allele, similarly to our findings. Journal of Human Genetics (2012) 57, 796-803; doi:10.1038/jhg.2012.120; published online 11 October 2012
C1 [da Silva, Iane dos Santos; Nogueira, Eduardo de M.; dos Santos, Suely R.; Paiva, Carmen L. A.] Univ Fed Estado Rio de Janeiro UNIRIO, Dept Genet & Mol Biol, BR-22470230 Rio De Janeiro, RJ, Brazil.
   [Agostinho, Luciana de A.; Rocha, Catielly F.; Paradela, Eduardo R.; Figueiredo, Andre L. dos S.; Alvarenga, Regina M. P.; Paiva, Carmen L. A.] Univ Fed Estado Rio de Janeiro, Programa Posgrad Neurol, Rio de Janeiro, Brazil.
   [Agostinho, Luciana de A.; Pereira, Simao P. F.] FAMINAS, Dept Biomed, Fac Med, Muriae, Brazil.
   [Medina-Acosta, Enrique; Barboza, Hazel N.; Alves da Silva, Antonio F.] Univ Estadual Norte Fluminense, Nucleo Diagnost & Invest Mol, Campos Dos Goytacazes, Brazil.
   [Cabello, Pedro Hernan] Fiocruz MS, Lab Genet Humana, BR-21045900 Rio De Janeiro, Brazil.
   [Cabello, Pedro Hernan] UNIGRANRIO, Lab Genet Humana, Duque De Caxias, Brazil.
RP Paiva, CLA (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Dept Genet & Mol Biol, Rua Custodio Serrao 14-701, BR-22470230 Rio De Janeiro, RJ, Brazil.
EM clapaiva1@gmail.com
RI PARADELA, EDUARDO/AAW-6807-2020; Agostinho, Luciana/H-7994-2015;
   Medina-Acosta, Enrique/G-3041-2010; Paiva, Carmen/A-1503-2010
OI Agostinho, Luciana/0000-0001-5604-8386; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Santos, Iane/0000-0001-5665-9611; Paiva,
   Carmen/0000-0003-2877-0296
FU CAPES/PROAP/PPGNEURO; FINEPCiencia Tecnologia e Inovacao (FINEP);
   UNIRIO; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX Many thanks are due to Professor LCS Thuler and G Tucher for helping
   with data analysis. We are grateful to CAPES/PROAP/PPGNEURO, FINEP,
   UNIRIO, CNPq and FAPERJ for the financial support, and to FAMINAS,
   Associacao Brasil Huntington (ABH) and the Department of Genetics and
   Molecular Biology for referring cases to the clinical geneticists.
CR ACMG/ASHG Statement, 1998, AM J HUM GENET, V62, P1243
   ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398
   ANDREW SE, 1995, NEURODEGENERATION, V4, P239, DOI 10.1016/1055-8330(95)90013-6
   Andrich J, 2008, MOVEMENT DISORD, V23, P879, DOI 10.1002/mds.21958
   BEIGHTON P, 1981, S AFR MED J, V59, P250
   Bonelli RM, 2007, EXPERT OPIN PHARMACO, V8, P141, DOI 10.1517/14656566.8.2.141
   Chattopadhyay B, 2003, NEUROSCI LETT, V345, P93, DOI 10.1016/S0304-3940(03)00436-1
   Costa MD, 2006, J HUM GENET, V51, P189, DOI 10.1007/s10038-005-0343-8
   DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990
   Garcia-Planells J, 2005, HUM MUTAT, V25, P453, DOI 10.1002/humu.20167
   Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x
   HALDANE JBS, 1956, BIOMETRIKA, V43, P96
   HAYDEN MR, 1987, S AFR MED J, V71, P683
   HAYDEN MR, 1981, S AFR MED J, V60, P1001
   Hecimovic S, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9055
   Kovtun Irina V., 2004, V277, P309
   Lima E, 2000, ARQ NEURO-PSIQUIAT, V58, P11
   MASUDA N, 1995, J MED GENET, V32, P701, DOI 10.1136/jmg.32.9.701
   Morovvati S, 2008, ARCH MED RES, V39, P131, DOI 10.1016/j.arcmed.2007.06.015
   Muglia M, 1996, CLIN CHEM, V42, P1601
   Nahhas FA, 2005, AM J MED GENET A, V137A, P328, DOI 10.1002/ajmg.a.30891
   Nance MA, 1999, NEUROLOGY, V52, P392, DOI 10.1212/WNL.52.2.392
   Panegyres PK, 2006, EUR NEUROL, V55, P189, DOI 10.1159/000093867
   Pramanik S, 2000, EUR J HUM GENET, V8, P678, DOI 10.1038/sj.ejhg.5200515
   Raskin S, 2000, ARQ NEURO-PSIQUIAT, V58, P977, DOI 10.1590/S0004-282X2000000600001
   RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525
   Seneca S, 2004, EUR J PEDIATR, V163, P717, DOI 10.1007/s00431-004-1537-3
   SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103
   TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409
   The Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E
   Wang CK, 2004, EUR NEUROL, V52, P96, DOI 10.1159/000079938
   Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101
   Wheeler VC, 2007, J MED GENET, V44, P695, DOI 10.1136/jmg.2007.050930
   WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x
   Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581
NR 35
TC 13
Z9 13
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD DEC
PY 2012
VL 57
IS 12
BP 796
EP 803
DI 10.1038/jhg.2012.120
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 060SW
UT WOS:000312799400010
PM 23051704
OA Bronze
DA 2020-12-16
ER

PT J
AU Agostinho, L
   Rocha, C
   Medina-Acosta, E
   Barboza, H
   da Silva, A
   Pereira, S
   Paradela, E
   Figueiredo, A
   Nogueira, E
   Alvarenga, R
   dos Santos, S
   Paiva, C
AF Agostinho, L.
   Rocha, C.
   Medina-Acosta, E.
   Barboza, H.
   da Silva, A.
   Pereira, S.
   Paradela, E.
   Figueiredo, A.
   Nogueira, E.
   Alvarenga, R.
   dos Santos, S.
   Paiva, C.
TI Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families
   with Huntington's disease
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 22nd IUBMB Congress/37th FEBS Congress
CY SEP 04-09, 2012
CL Seville, SPAIN
SP IUBMB, FEBS
C1 [Agostinho, L.] Univ Fed Estado Rio de Janeiro, FAMINAS, PPGNEURO, Rio de Janeiro, Brazil.
   [Medina-Acosta, E.; Barboza, H.; da Silva, A.] Univ Estadual N Fluminen, NUDIN, Campos dos Goytacazes, RJ, Brazil.
   [Pereira, S.] FAMINAS, Muriae, MG, Brazil.
   [Paradela, E.] DLE, PPGNEURO, Rio De Janeiro, RJ, Brazil.
   [Nogueira, E.] Univ Fed Estado Rio de Janeiro, PPGGBM, Rio de Janeiro, RJ, Brazil.
   [dos Santos, S.] Univ Fed Estado Rio de Janeiro, DGBM, Rio de Janeiro, RJ, Brazil.
RI PARADELA, EDUARDO/AAW-6807-2020; Agostinho, Luciana/H-7994-2015;
   Medina-Acosta, Enrique/G-3041-2010; Paiva, C. L. A./A-1503-2010
OI Agostinho, Luciana/0000-0001-5604-8386; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Paiva, C. L. A./0000-0003-2877-0296
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD SEP
PY 2012
VL 279
SU 1
SI SI
BP 309
EP 310
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 996XR
UT WOS:000308128602028
DA 2020-12-16
ER

PT J
AU de Souza, TL
   Fernandes, RCDC
   Medina-Acosta, E
AF de Souza, Thais Louvain
   de Souza Campos Fernandes, Regina Celia
   Medina-Acosta, Enrique
TI HIV-1 control in battlegrounds: important host genetic variations for
   HIV-1 mother-to-child transmission and progression to clinical pediatric
   AIDS
SO FUTURE VIROLOGY
LA English
DT Review
DE genetic variation; HIV-1; mother-to-child transmission; polymorphism;
   protection; susceptibility; vertical transmission
ID IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR POLYMORPHISMS;
   INFLUENCE DISEASE PROGRESSION; NERVOUS-SYSTEM IMPAIRMENT; VERTICAL
   TRANSMISSION; CLASS-I; PERINATAL TRANSMISSION; PROMOTER POLYMORPHISM;
   HIV-1-RELATED DISEASE; MOLECULAR-MECHANISMS
AB HIV-1 mother-to-child transmission (MTCT) is the passing of maternal HIV-1 to the offspring during pregnancy, labor and delivery, and/or breastfeeding. HIV-1 MTCT and the evolution to pediatric AIDS are multifactorial, dynamic and variable phenotypic conditions. Both genetic and nongenetic variables can influence susceptibility to HIV-1 MTCT or the rate of progression to clinical pediatric AIDS. In this review, we summarize the current state of knowledge about the roles of genetic variations seen in host immune response genes, and those that have been independently associated, mostly through population genetics of candidate genes, with interindividual susceptibility to HIV-1 Mid, and progression to pediatric AIDS. We examine common and rare host genetic variations at coding and noncoding polymorphisms, whether functional or not, in agonists and antagonists of the immune response, which have been implicated in HIV-1 control in battlegrounds of cell entry, replication and evolution to AIDS. Further, we point to over 380 single-nucleotide polymorphisms, mostly within the HLA super region, recently identified in unbiased genome-wide association studies of HIV replication and evolution in adults, still unexplored in the context of HIV-1 Mid, and which are likely to also influence susceptibility to pediatric HIV-1/AIDS.
C1 [de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estoduol Norte Fluminense Darcy Ribeiro, Mol Identificat & Diag Unit, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, Campos Das Goytacazes, Brazil.
   [Medina-Acosta, Enrique] Hosp Escolo Alvaro Alvim, Campos Das Goytacazes, Brazil.
   [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Lab Biotechnol, BR-28013602 Campos Das Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estoduol Norte Fluminense Darcy Ribeiro, Mol Identificat & Diag Unit, Campos Dos Goytacazes, Brazil.
EM quique@uenf.br
RI Louvain de Souza, Thais/G-2646-2014; Medina-Acosta, Enrique/G-3041-2010
OI Louvain de Souza, Thais/0000-0002-0179-272X; Medina-Acosta,
   Enrique/0000-0002-2529-0548
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro - FAPERJ, Brazil.Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Universidade
   Estadual Norte Fluminense Darcy Ribeiro
FX E Medina-Acosta is a National Research Council (CNPq) fellow, and his
   research is supported by Grants from CNPq and Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ, Brazil.
   T Louvain de Souza is sponsored by a Graduate Fellowship from
   Universidade Estadual Norte Fluminense Darcy Ribeiro. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x
   Ahmad N, 2011, LIFE SCI, V88, P980, DOI 10.1016/j.lfs.2010.09.023
   Aikhionbare Felix O, 2006, AIDS Res Ther, V3, P28
   Aikhionbare FO, 2001, AIDS, V15, P2196, DOI 10.1097/00002030-200111090-00019
   Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972
   Alfano M., 2002, Current Molecular Medicine (Hilversum), V2, P677, DOI 10.2174/1566524023361925
   Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591
   Allouch A, 2011, CELL HOST MICROBE, V9, P484, DOI 10.1016/j.chom.2011.05.004
   Amoroso A, 1999, AIDS, V13, P863, DOI 10.1097/00002030-199905070-00019
   de Angelis DSA, 2007, BRAZ J INFECT DIS, V11, P196, DOI 10.1590/S1413-86702007000200004
   Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007
   Arnaiz-Villena A, 2009, CURR HIV RES, V7, P314, DOI 10.2174/157016209788348029
   Ates O, 2009, INT J IMMUNOGENET, V36, P15, DOI 10.1111/j.1744-313X.2008.00814.x
   Barroga CF, 2000, J INFECT DIS, V182, P413, DOI 10.1086/315704
   Bellusci CP, 2010, AIDS, V24, P833, DOI 10.1097/QAD.0b013e328336abfc
   Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657
   Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017
   Bjornvold M, 2006, J AUTOIMMUN, V27, P140, DOI 10.1016/j.jaut.2006.06.007
   Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211
   Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685
   BOUR S, 1995, MICROBIOL REV, V59, P63, DOI 10.1128/MMBR.59.1.63-93.1995
   Brichacek B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012831
   Brouwer KC, 2005, AIDS RES HUM RETROV, V21, P358, DOI 10.1089/aid.2005.21.358
   Brouwer KC, 2004, AIDS, V18, P1187, DOI 10.1097/00002030-200405210-00012
   Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x
   Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x
   Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645
   Castro-Nallar E, 2012, FUTURE VIROL, V7, P239, DOI 10.2217/FVL.12.4
   Cernescu C., 1992, Revue Roumaine de Virologie, V43, P95
   Chinn LW, 2010, J INFECT DIS, V202, P1836, DOI 10.1086/657322
   Choi RY, 2010, CLIN EXP IMMUNOL, V160, P461, DOI 10.1111/j.1365-2249.2010.04096.x
   Choubey D, 2012, CLIN IMMUNOL, V142, P223, DOI 10.1016/j.clim.2011.12.007
   Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799
   Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516
   D'Alfonso S, 2002, GENES IMMUN, V3, P454, DOI 10.1038/sj.gene.6363928
   da Silva RC, 2011, HUM IMMUNOL, V72, P305, DOI 10.1016/j.humimm.2011.01.012
   Dai YY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-282
   De Maio FA, 2012, AIDS RES HUM RETROV, DOI [10.1089/aid.0291, DOI 10.1089/AID.0291]
   De Maio FA, 2011, INFECT GENET EVOL, V11, P1256, DOI 10.1016/j.meegid.2011.04.020
   de Souza PR, 2006, J REPROD IMMUNOL, V69, P77, DOI 10.1016/j.jri.2005.09.001
   Ding DL, 2011, MOL MED REP, V4, P181, DOI 10.3892/mmr.2010.400
   Dioulasso B, 2011, CONTEMP CLIN TRIALS, V32, P74, DOI 10.1016/j.cct.2010.09.008
   Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X
   Douroudis K, 2009, HUM IMMUNOL, V70, P921, DOI 10.1016/j.humimm.2009.09.349
   Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94
   Ellington SR, 2011, FUTURE VIROL, V6, P1451, DOI [10.2217/FVL.11.119, 10.2217/fvl.11.119]
   Fabris A, 2009, AIDS, V23, P177, DOI 10.1097/QAD.0b013e32832027bf
   Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616
   Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287
   Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861
   Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005
   Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160
   Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499
   Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x
   Guergnon J, 2012, J INFECT DIS, V205, P718, DOI 10.1093/infdis/jir833
   Guergnon J, 2011, CURR OPIN HIV AIDS, V6, P290, DOI 10.1097/COH.0b013e3283478449
   Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   HODGE TW, 1991, HUM IMMUNOL, V30, P99, DOI 10.1016/0198-8859(91)90077-M
   Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240
   Hughes T, 2012, ARTHRITIS RHEUM-US, V64, P485, DOI 10.1002/art.33354
   Ioannidis JPA, 2003, AIDS, V17, P1631, DOI 10.1097/00002030-200307250-00007
   Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095
   Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693
   Javanbakht H, 2006, VIROLOGY, V354, P15, DOI 10.1016/j.virol.2006.06.031
   John GC, 2000, J VIROL, V74, P5736, DOI 10.1128/JVI.74.12.5736-5739.2000
   Joubert BR, 2010, GENOME MED, V2, DOI 10.1186/gm138
   Joubert BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009212
   Kaluza W, 2001, ARTHRITIS RHEUM-US, V44, P1209, DOI 10.1002/1529-0131(200105)44:5<1209::AID-ANR205>3.3.CO;2-J
   Kantarci OH, 2005, GENES IMMUN, V6, P153, DOI 10.1038/sj.gene.6364164
   Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89
   Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999
   Kourtis AP, 2010, CLIN PERINATOL, V37, P721, DOI 10.1016/j.clp.2010.08.004
   Kourtis AP, 2010, CLIN PERINATOL, V37, pXIX, DOI 10.1016/j.clp.2010.09.001
   Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102
   Lesbats P, 2011, FUTURE VIROL, V6, P1035, DOI 10.2217/FVL.11.84
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015778
   Louvain de Souza T, 2012, RISK MODIFIERS MOTHE
   Lv CY, 2011, CLIN INVEST MED, V34, pE370
   MacDonald KS, 2001, J INFECT DIS, V183, P503, DOI 10.1086/318092
   Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528
   Mackelprang RD, 2010, J INFECT DIS, V202, P1273, DOI 10.1086/656318
   Mangano A, 2000, J ACQ IMMUN DEF SYND, V23, P52
   Marechal V, 1999, J VIROL, V73, P3608
   Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100
   Matte C, 2001, MOL MED, V7, P583, DOI 10.1007/BF03401864
   Mbemba E, 1999, VIROLOGY, V265, P354, DOI 10.1006/viro.1999.0033
   Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0
   Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318
   Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338
   Milanese M, 2006, AIDS, V20, P1673, DOI 10.1097/01.aids.0000238417.05819.40
   Misrahi M, 1998, JAMA-J AM MED ASSOC, V279, P277, DOI 10.1001/jama.279.4.277
   Modi WS, 2004, GENOMICS, V83, P735, DOI 10.1016/j.ygeno.2003.09.019
   Mofenson LM, 2010, ANTIVIR THER, V15, P537, DOI 10.3851/IMP1574
   Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x
   Murali TM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002164
   Nakayama EE, 2000, J VIROL, V74, P5452, DOI 10.1128/JVI.74.12.5452-5459.2000
   Nakayama EE, 2002, J INFECT DIS, V185, P1183, DOI 10.1086/339825
   Nogueira S A, 2001, Braz J Infect Dis, V5, P78
   Nolan D, 2005, SCIENCE, V307, P1422, DOI 10.1126/science.1110009
   Nolan D, 2006, CURR OPIN IMMUNOL, V18, P413, DOI 10.1016/j.coi.2006.05.015
   Okeoma CM, 2010, CELL HOST MICROBE, V8, P534, DOI 10.1016/j.chom.2010.11.003
   Ometto L, 2001, J INFECT DIS, V183, P814, DOI 10.1086/318828
   Padovan L, 2011, AIDS, V25, P535, DOI 10.1097/QAD.0b013e3283428b7c
   Pedersen BR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000838
   Philpott S, 1999, J ACQ IMMUN DEF SYND, V21, P189, DOI 10.1097/00126334-199907010-00002
   Pizzato N, 2004, HUM IMMUNOL, V65, P1389, DOI 10.1016/j.humimm.2004.07.239
   Platonov AE, 1998, CLIN INFECT DIS, V27, P746, DOI 10.1086/514935
   Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398
   Polycarpou A, 2002, AIDS RES HUM RETROV, V18, P741, DOI 10.1089/08892220260139477
   Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432
   Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe
   Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4
   Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0
   Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021
   Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467
   Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49
   Ricci E, 2009, JAIDS-J ACQ IMM DEF, V51, P13, DOI 10.1097/QAI.0b013e31819df249
   Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998
   Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052
   Romiti ML, 2000, MOL MED, V6, P28, DOI 10.1007/BF03401932
   Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5
   Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
   Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g
   Segat L, 2006, IMMUNOGENETICS, V58, P471, DOI 10.1007/s00251-006-0104-7
   Segat L, 2006, J MATERN-FETAL NEO M, V19, P13, DOI 10.1080/14767050500381123
   Segat L, 2009, AIDS, V23, P1916, DOI 10.1097/QAD.0b013e32832f8104
   Segat L, 2009, AIDS, V23, P649, DOI [10.1097/QAD.0b013e328327726a, 10.1097/QAD.0b013e3283277247]
   Sei S, 2001, AIDS, V15, P1343, DOI 10.1097/00002030-200107270-00003
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shin HD, 2005, EXP MOL MED, V37, P128, DOI 10.1038/emm.2005.17
   Shostakovich-Koretskaya L, 2009, AIDS, V23, P679, DOI 10.1097/QAD.0b013e3283270b3f
   Singh KK, 2005, J INFECT DIS, V191, P1971, DOI 10.1086/430091
   Singh KK, 2004, JAIDS-J ACQ IMM DEF, V35, P309, DOI 10.1097/00126334-200403010-00013
   Singh KK, 2004, J INFECT DIS, V189, P587, DOI 10.1086/381460
   Singh KK, 2003, J INFECT DIS, V188, P1461, DOI 10.1086/379038
   Singh KK, 2008, JAIDS-J ACQ IMM DEF, V49, P259, DOI 10.1097/QAI.0b013e318186eaa4
   Singh KK, 2011, JAIDS-J ACQ IMM DEF, V57, P32, DOI 10.1097/QAI.0b013e3182119244
   Singh KK, 2009, PEDIATR RES, V65, p55R, DOI 10.1203/PDR.0b013e31819dca03
   Singh KK, 2008, J ALLERGY CLIN IMMUN, V122, P173, DOI 10.1016/j.jaci.2008.05.025
   Song M, 2012, FUTURE VIROL, V7, P225, DOI 10.2217/FVL.12.6
   Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201
   Stevceva L, 2011, CURR MED CHEM, V18, P5079, DOI 10.2174/092986711797636027
   Takagi Y, 2009, HUM IMMUNOL, V70, P200, DOI 10.1016/j.humimm.2009.01.006
   Teglas JP, 1999, J ACQ IMMUN DEF SYND, V22, P267
   Telenti A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007203
   Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09
   Thorne C, 2001, AIDS, V15, P761, DOI 10.1097/00002030-200104130-00012
   Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639
   Tresoldi E, 2002, J INFECT DIS, V185, P696, DOI 10.1086/339004
   Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002
   van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333
   Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x
   Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373
   Winchester R, 1995, P NATL ACAD SCI USA, V92, P12374, DOI 10.1073/pnas.92.26.12374
   Winchester R, 2004, JAIDS-J ACQ IMM DEF, V36, P659, DOI 10.1097/00126334-200406010-00002
NR 159
TC 0
Z9 0
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUL
PY 2012
VL 7
IS 7
BP 659
EP 678
DI 10.2217/FVL.12.49
PG 20
WC Virology
SC Virology
GA 970RK
UT WOS:000306149800010
DA 2020-12-16
ER

PT J
AU Machado, FB
   Medina-Acosta, E
AF Machado, F. B.
   Medina-Acosta, E.
TI Accurate tracking genetic markers in haemophilia linkage analysis: a
   matter beyond scientific priority
SO HAEMOPHILIA
LA English
DT Letter
ID XQ28
C1 [Medina-Acosta, E.] Univ Estadual Norte Fluminense, Biotechnol Lab, Ctr Biosci & Biotechnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, E.] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Medina-Acosta, E.] Hosp Escola Alvaro Alvim, Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Biotechnol Lab, Ctr Biosci & Biotechnol, Ave Alberto Lamego 2000,Parque California, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Ding QL, 2012, HAEMOPHILIA     0126, DOI [10. 1111/j. 1365-2516. 2011. 02732. x, DOI 10.1111/J.1365-2516.2011.02732.X]
   Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963
   Machado FB, 2009, HAEMOPHILIA, V15, P1135, DOI 10.1111/j.1365-2516.2009.02056.x
   Machado FB, 2009, HAEMOPHILIA, V15, P613, DOI 10.1111/j.1365-2516.2008.01977.x
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   Medina-Acosta E, 2010, HAEMOPHILIA, V16, P525, DOI 10.1111/j.1365-2516.2009.02161.x
   Medina-Acosta E, 2008, HEMAPSTR
NR 8
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
J9 HAEMOPHILIA
JI Haemophilia
PD JUL
PY 2012
VL 18
IS 4
BP e359
EP e360
DI 10.1111/j.1365-2516.2012.02859.x
PG 2
WC Hematology
SC Hematology
GA 966FY
UT WOS:000305824400007
PM 22630826
DA 2020-12-16
ER

PT J
AU Tobias, FL
   Garcia, LNN
   Kanashiro, MM
   Medina-Acosta, E
   Brom-de-Luna, JG
   de Almeida, CMC
   Azevedo, RR
   Lemos, M
   Vieira-da-Motta, O
AF Tobias, Fernando Luiz
   Nunes Garcia, Luize Neli
   Kanashiro, Milton Masahiko
   Medina-Acosta, Enrique
   Brom-de-Luna, Joao Gato
   Costa de Almeida, Claudia Maria
   Azevedo Junior, Romildo Rocha
   Lemos, Mosar
   Vieira-da-Motta, Olney
TI GROWTH INHIBITION OF STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI STRAINS
   BY NEUTRALIZING IGY ANTIBODIES FROM OSTRICH EGG YOLK
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Ostrich IgY antibodies; inhibition; recombinant proteins; E. coli; S.
   aureus
ID IMMUNOGLOBULIN IGY; IN-VITRO; CHICKENS; BOVINE; VACCINE; STATE; MILK;
   GENE; AGR
AB Ostrich raising around the world have some key factors and farming profit depend largely on information and ability of farmers to rear these animals. Non fertilized eggs from ostriches are discharged in the reproduction season. Staphylococcus aureus and Escherichia coli are microorganisms involved in animal and human diseases. In order to optimize the use of sub products of ostrich raising, non fertilized eggs of four selected birds were utilized for development of polyclonal IgY antibodies. The birds were immunized (200ug/animal) with purified recombinant staphylococcal enterotoxin C (recSEC) and synthetic recRAP, both derived from S. aureus, and recBFPA and recEspB involved in E. coli pathogenicity, diluted in FCA injected in the braquial muscle. Two subsequent immunization steps with 21 days intervals were repeated in 0,85% saline in FIA. Blood and eggs samples were collected before and after immunization steps. Egg yolk immunoglobulins were purified by precipitation with 19% sodium sulfate and 20% ammonium sulphate methodologies. Purified IgY 50 mu L aliquots were incubated in 850 mu L BHI broth containing 50 mu L inoculums of five strains of S. aureus and five strains of E. coli during four hours at 37 degrees C. Growth inhibition was evaluated followed by photometry reading (DO550nm). Egg yolk IgY preparation from hiperimmunized birds contained antibodies that inhibited significantly (p<0,05) growth of strains tested. Potential use of ostrich IgY polyclonal antibodies as a diagnostic and therapeutic tool is proposed for diseased animals.
C1 [Tobias, Fernando Luiz; Nunes Garcia, Luize Neli; Brom-de-Luna, Joao Gato; Costa de Almeida, Claudia Maria; Vieira-da-Motta, Olney] Univ Estadual N Fluminense, Lab Sanidade Anim, Campos Dos Goytacazes, RJ, Brazil.
   [Kanashiro, Milton Masahiko] Univ Estadual N Fluminense, Lab Biol Reconhecer, Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] Univ Estadual N Fluminense, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil.
   [Tobias, Fernando Luiz; Azevedo Junior, Romildo Rocha] Univ Vila Velha, Vila Velha, ES, Brazil.
   [Lemos, Mosar] Univ Fed Fluminense, Niteroi, RJ, Brazil.
RP Tobias, FL (corresponding author), Univ Estadual N Fluminense, Lab Sanidade Anim, Campos Dos Goytacazes, RJ, Brazil.
EM tobias@uvv.br; olney@uenf.br
RI Vieira-da-Motta, Olney/U-7146-2019; Medina-Acosta, Enrique/G-3041-2010;
   de Luna, Joao Gatto Brom/S-8417-2016; Kanashiro, Milton
   Masahiko/C-1187-2013
OI Medina-Acosta, Enrique/0000-0002-2529-0548; de Luna, Joao Gatto
   Brom/0000-0002-9873-3178; Kanashiro, Milton
   Masahiko/0000-0002-5134-7341; Tobias, Fernando/0000-0003-3841-480X
FU FAPERJ Editais Jovens Cientistas do Nosso EstadoCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Desenvolvimento Tecnico Cientifico Regional; Grupos Emergentes
FX We thank to financial support to O.V. Motta by FAPERJ Editais Jovens
   Cientistas do Nosso Estado; Desenvolvimento Tecnico Cientifico Regional;
   Grupos Emergentes and to the breeder Dr. Marconi Luna for animals and
   facilities availability to realize this work.
CR Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07
   Almeida CMC, 1998, VET REC, V143, P579, DOI 10.1136/vr.143.21.579
   Amaral JA, 2008, VET RES COMMUN, V32, P281, DOI 10.1007/s11259-007-9029-3
   Aranda KRS, 2007, FEMS MICROBIOL LETT, V267, P145, DOI 10.1111/j.1574-6968.2006.00580.x
   BALABAN N, 1995, P NATL ACAD SCI USA, V92, P1619, DOI 10.1073/pnas.92.5.1619
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Guimaraes MCC, 2009, ARCH IMMUNOL THER EX, V57, P377, DOI 10.1007/s00005-009-0041-x
   de Almeida CMC, 2003, SCAND J IMMUNOL, V57, P573, DOI 10.1046/j.1365-3083.2003.01243.x
   Glatz P., 2008, RURAL IND RES DEV CO, V08, P1
   Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669
   Kiran MD, 2008, MOL PHARMACOL, V73, P1578, DOI 10.1124/mol.107.044164
   Kollberg H, 2003, PEDIATR PULM, V35, P433, DOI 10.1002/ppul.10290
   Lee EN, 2002, POULTRY SCI, V81, P632, DOI 10.1093/ps/81.5.632
   Mahdavi AH, 2010, J ANIM VET ADV, V9, P366
   Malik MW, 2006, J VET SCI, V7, P43, DOI 10.4142/jvs.2006.7.1.43
   Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3
   Melville Priscilla Anne, 2004, Cienc. Rural, V34, P1871, DOI 10.1590/S0103-84782004000600031
   Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198
   Nardi ARM, 2005, VET MICROBIOL, V105, P245, DOI 10.1016/j.vetmic.2004.11.005
   Rangel MFN, 2010, PESQUI VET BRASIL, V30, P87, DOI 10.1590/S0100-736X2010000100014
   PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988
   Ribeiro A.M.L., 2007, ACTA SCI VET, V35, P131
   ROBBINS R, 1974, APPL MICROBIOL, V28, P946, DOI 10.1128/AEM.28.6.946-950.1974
   SugitaKonishi Y, 1996, BIOSCI BIOTECH BIOCH, V60, P886, DOI 10.1271/bbb.60.886
   Sunwoo HH, 2002, J FOOD SCI, V67, P1486, DOI 10.1111/j.1365-2621.2002.tb10310.x
   Uhl MVD, 2004, VACCINE, V22, P4191, DOI 10.1016/j.vaccine.2004.05.004
   Vieira-Da-Motta O, 2008, ARQ BRAS MED VET ZOO, V60, P1014, DOI 10.1590/S0102-09352008000400034
   Vieira-da-Motta O, 2001, BRAZ J MICROBIOL, V32, P27, DOI 10.1590/S1517-83822001000100007
   Vieira-da-Motta O, 2001, PEPTIDES, V22, P1621, DOI 10.1016/S0196-9781(01)00497-1
   Vieira-da-Motta O., 2001, SCAND J IMMUNOL SB, VB 54, P117
   Zhen YH, 2008, J APPL MICROBIOL, V105, P1529, DOI 10.1111/j.1365-2672.2008.03920.x
   Zhen YH, 2008, VET MICROBIOL, V130, P126, DOI 10.1016/j.vetmic.2007.12.014
   Zhen YH, 2009, VET MICROBIOL, V133, P317, DOI 10.1016/j.vetmic.2008.07.016
NR 33
TC 4
Z9 4
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD APR-JUN
PY 2012
VL 43
IS 2
BP 544
EP 551
DI 10.1590/S1517-83822012000200015
PG 8
WC Microbiology
SC Microbiology
GA 987SN
UT WOS:000307438100015
PM 24031862
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Machado, FB
   Machado, LD
   Bydlowski, CR
   Bydlowski, SP
   Medina-Acosta, E
AF Machado, Filipe Brum
   Machado, Luana de Vasconcellos
   Bydlowski, Cynthia Rachid
   Bydlowski, Sergio Paulo
   Medina-Acosta, Enrique
TI Gametic phase disequilibrium between the syntenic multiallelic HTG4 and
   HMS3 markers widely used for parentage testing in Thoroughbred horses
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Equine; Linkage disequilibrium; Microsatellite; Parentage validation;
   Product rule; STR
ID GENETIC-CHARACTERIZATION; MICROSATELLITE LOCI; LINKAGE; POPULATION;
   MODELS; GENOME; SELECTION; MAP
AB Validation of parentage and horse breed registries through DNA typing relies on estimates of random match probabilities with DNA profiles generated from multiple polymorphic loci. Of the twenty-seven microsatellite loci recommended by the International Society for Animal Genetics for parentage testing in Thoroughbred horses, eleven are located on five chromosomes. An important aspect in determining combined exclusion probabilities is the ascertainment of the genetic linkage status of syntenic markers, which may affect reliable use of the product rule in estimating random match probabilities. In principle, linked markers can be in gametic phase disequilibrium (GD). We aimed at determining the extent, by frequency and strength, of GD between the HTG4 and HMS3 multiallelic loci, syntenic on chromosome 9. We typed the qualified offspring (n (1) = 27; n (2) = 14) of two Quarter Bred stallions (registered by the Brazilian Association of Quarter Horse Breeders) and 121 unrelated horses from the same breed. In the 41 informative meioses analyzed, the frequency of recombination between the HTG4 and HMS3 loci was 0.27. Consistent with genetic map distances, this recombination rate does not fit to the theoretical distribution for independently segregated markers. We estimated sign-based D' coefficients as a measure of GD, and showed that the HTG4 and HMS3 loci are in significant, yet partial and weak, disequilibrium, with two allele pairs involved (HTG4*M/HMS3*P, D'(+) = 0.6274; and HTG4*K/HMS3*P, D'(-) = -0.6096). These results warn against the inadequate inclusion of genetically linked markers in the calculation of combined power of discrimination for Thoroughbred parentage validation.
C1 [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Lab Biotecnol, Ctr Biociencias & Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, Filipe Brum] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Machado, Luana de Vasconcellos; Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Nucleo Diagnost & Invest Mol, BR-28035010 Campos Dos Goytacazes, RJ, Brazil.
   [Bydlowski, Cynthia Rachid] LinkGen Biotecnol Vet & Agropecuaria, BR-04005000 Sao Paulo, Brazil.
   [Bydlowski, Sergio Paulo] Univ Sao Paulo, Lab Genet & Hematol Mol, Fac Med, BR-05403000 Sao Paulo, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Lab Biotecnol, Ctr Biociencias & Biotecnol, Ave Alberto Lamego 2000,Parque California, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010;
   Bydlowski, Sergio Paulo/D-5171-2013; Complexos, INCT Fluidos/H-9172-2013
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Bydlowski, Sergio
   Paulo/0000-0002-7582-5942; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); Nucleo de Diagnostico e Investigacao
   Molecular of the Universidade Estadual do Norte Fluminense Darcy Ribeiro
FX This study was supported by grants and fellowships from CNPq (to EM-A),
   FAPERJ (to EM-A), FAPESP (to FBM) and Nucleo de Diagnostico e
   Investigacao Molecular of the Universidade Estadual do Norte Fluminense
   Darcy Ribeiro.
CR Bailey E, 1997, ANIM GENET, V28, P268, DOI 10.1111/j.1365-2052.1997.00152.x
   Behl R, 2006, J GENET, V85, P199, DOI 10.1007/BF02935331
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x
   Choi SK, 2008, J VET MED SCI, V70, P1111, DOI 10.1292/jvms.70.1111
   Corbin LJ, 2010, ANIM GENET, V41, P8, DOI 10.1111/j.1365-2052.2010.02092.x
   Dimsoski P, 2003, CROAT MED J, V44, P332
   Finno CJ, 2009, VET J, V179, P336, DOI 10.1016/j.tvjl.2008.03.016
   Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963
   Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227
   ISAG, 2008, EQ GEN PAR TEST STAN
   Lee SY, 2006, J VET SCI, V7, P63, DOI 10.4142/jvs.2006.7.1.63
   Lewis PO, 2001, GENETIC DATA ANAL CO
   LEWONTIN RC, 1988, GENETICS, V120, P849
   LEWONTIN RC, 1964, GENETICS, V50, P757
   LEWONTIN RC, 1964, GENETICS, V49, P49
   Luis C, 2002, GENET MOL BIOL, V25, P131, DOI 10.1590/S1415-47572002000200003
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Medina-Acosta E, 2011, MOL BIOL REP, V38, P4003, DOI 10.1007/s11033-010-0518-z
   Mueller LD, 2008, J GENET, V87, P101, DOI 10.1007/s12041-008-0016-4
   Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172
   Sun XB, 2006, MOL BIOL REP, V33, P167, DOI 10.1007/s11033-006-0013-8
   Swinbume JE, 2006, GENOMICS, V87, P1, DOI 10.1016/j.ygeno.2005.09.001
   Tozaki T, 2001, J VET MED SCI, V63, P1191, DOI 10.1292/jvms.63.1191
   van de Goor LHP, 2010, ANIM GENET, V41, P122, DOI 10.1111/j.1365-2052.2009.01975.x
   Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158
   Zabek Tomasz, 2005, Journal of Applied Genetics, V46, P299
   Zapata C, 2000, EVOLUTION, V54, P1809, DOI 10.1111/j.0014-3820.2000.tb00711.x
   Zapata C, 2001, GENETICS, V158, P1235
NR 29
TC 1
Z9 1
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD FEB
PY 2012
VL 39
IS 2
BP 1447
EP 1452
DI 10.1007/s11033-011-0881-4
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 871PX
UT WOS:000298751300078
PM 21607619
DA 2020-12-16
ER

PT J
AU Medina-Acosta, E
AF Medina-Acosta, Enrique
TI Evidence of partial and weak gametic disequilibrium across clusters of
   pericentromeric short tandem repeats loci on human X chromosome: Proceed
   with caution in forensic genetics
SO FORENSIC SCIENCE INTERNATIONAL-GENETICS
LA English
DT Letter
ID LINKAGE DISEQUILIBRIUM; POWERFUL TOOL; STR; PROVIDES; MARKERS; REGION
C1 Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Nucleo Diagnost & Invest Mol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Nucleo Diagnost & Invest Mol, Ave Alberto Lamego 2000,Parque Calif, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Branco CC, 2008, AM J HUM BIOL, V20, P364, DOI 10.1002/ajhb.20734
   Crawford DC, 2005, ANNU REV GENOM HUM G, V6, P287, DOI 10.1146/annurev.genom.6.080604.162309
   Edelmann J, 2008, FORENSIC SCI INT-GEN, V2, P41, DOI 10.1016/j.fsigen.2007.08.001
   Edelmann J, 2010, INT J LEGAL MED, V124, P83, DOI 10.1007/s00414-009-0328-9
   Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227
   HEDRICK PW, 1987, GENETICS, V117, P331
   Hundertmark T, 2008, INT J LEGAL MED, V122, P489, DOI 10.1007/s00414-008-0277-8
   Machado FB, 2009, FORENSIC SCI INT-GEN, V3, P202, DOI 10.1016/j.fsigen.2008.10.006
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Szibor R, 2005, INT J LEGAL MED, V119, P363, DOI 10.1007/s00414-005-0550-z
   Szibor R, 2003, INT J LEGAL MED, V117, P67, DOI 10.1007/s00414-002-0352-5
   Tariq M, 2009, INT J LEGAL MED, V123, P85, DOI 10.1007/s00414-008-0294-7
   Tillmar AO, 2008, FORENSIC SCI INT-GEN, V3, P37, DOI 10.1016/j.fsigen.2008.09.006
   Zapata C, 2000, EVOLUTION, V54, P1809, DOI 10.1111/j.0014-3820.2000.tb00711.x
   Zapata C, 2001, GENETICS, V158, P1235
NR 15
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1872-4973
EI 1878-0326
J9 FORENSIC SCI INT-GEN
JI Forensic Sci. Int.-Genet.
PD NOV
PY 2011
VL 5
IS 5
BP 545
EP 547
DI 10.1016/j.fsigen.2009.12.002
PG 3
WC Genetics & Heredity; Medicine, Legal
SC Genetics & Heredity; Legal Medicine
GA 812MN
UT WOS:000294297700030
PM 20457061
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   de Souza, TL
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   de Souza, Thais Louvain
   Medina-Acosta, Enrique
TI Role of maternal, transplacentally acquired HIV-1-specific neutralizing
   antibodies in protecting the uninfected offspring against HIV-1
   transmission via breast milk
SO FUTURE VIROLOGY
LA English
DT Article
DE neutralizing antibodies; vertical transmission
ID IMMUNODEFICIENCY-VIRUS TYPE-1; REGULATORY T-CELLS; ANTIRETROVIRAL DRUGS;
   ESCAPE VARIANTS; VIRAL LOAD; INFANTS; INFECTION; WOMEN; RISK; DELIVERY
AB Evaluation of: Lynch JB, Nduati R, Blish CA et al. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection. J. Virol. 85(11), 5252-5261 (2011). HIV-1-infected pregnant women may transfer anti-HIV-1 antibodies, at varying lengths, extents and specificities, to their babies during pregnancy via the placenta and after birth via breast milk. In vitro, most antibodies to many viral and bacterial agents, present at birth in the infant serum, are protective, but it is unclear whether the magnitude and breadth of the maternal passively acquired HIV-1-specific neutralizing antibodies constitute, in fact, a predictor variable of protection against mother-to-child HIV-1 transmission via breast milk. In their article, Lynch et al. addressed the issue using a rich source of repository samples from a cohort of pregnant women infected with HIV-1, enrolled before the availability of widespread antiretroviral treatment and management measures of intervention. This type of treasured samples enables us to dissect the significance of maternal passively acquired HIV-1-specific serum antibodies in highly exposed HIV-1-uninfected children for protection against HIV-1 infection via breast milk. Results showed no significant difference in breadth and potency of in vitro neutralizing antibodies between children who became HIV-1 infected and children who remained uninfected throughout the study period. The authors concluded that neither the breadth nor the potency of passively acquired HIV-1-specific neutralizing antibodies correlate with the risk of HIV-1 acquisition via breast milk. The study raises intriguing possibilities to speed the process of refining both in vitro methods to identify protective antibody responses and vaccine development strategies relevant at oral and gastrointestinal mucosal sites.
C1 [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Biotechnol Lab, Mol Identificat & Diag Unit, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, BR-28035580 Campos Dos Goytacazes, RJ, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, BR-28010140 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Biotechnol Lab, Mol Identificat & Diag Unit, Ave Alberto Lamego 2000,Parque California, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Louvain de Souza, Thais/G-2646-2014
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Louvain de Souza,
   Thais/0000-0002-0179-272X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX E Medina-Acosta is a National Research Council (CNPq) fellow and his
   research is supported by grants from the CNPq and Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript. This includes
   employment, consultancies, honoraria, stock ownership or options, expert
   testimony, grants or patents received or pending, or royalties. No
   writing assistance was utilized in the production of this manuscript.
CR Aldrovandi GM, 2010, J INFECT DIS, V202, pS366, DOI 10.1086/655972
   Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991
   Burgener Adam, 2010, Curr HIV/AIDS Rep, V7, P53, DOI 10.1007/s11904-010-0039-3
   Challacombe S J, 2011, Adv Dent Res, V23, P142, DOI 10.1177/0022034511400222
   Dickover R, 2006, J VIROL, V80, P6525, DOI 10.1128/JVI.02658-05
   Dioulasso B, 2011, CONTEMP CLIN TRIALS, V32, P74, DOI 10.1016/j.cct.2010.09.008
   Horvath T, 2009, COCHRANE DB SYST REV
   Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89
   Kuhn L, 2010, CLIN PERINATOL, V37, P843, DOI 10.1016/j.clp.2010.08.011
   Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102
   Lynch JB, 2011, J VIROL, V85, P5252, DOI 10.1128/JVI.02216-10
   Mofenson LM, 2010, ANTIVIR THER, V15, P537, DOI 10.3851/IMP1574
   Mofenson LM, 2010, NEW ENGL J MED, V362, P2316, DOI 10.1056/NEJMe1004406
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167
   Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0
   Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203
   Nogueira S A, 2001, Braz J Infect Dis, V5, P78
   Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201
   Thea DM, 2006, AIDS, V20, P1539, DOI 10.1097/01.aids.0000237370.49241.dc
   Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006
NR 21
TC 0
Z9 0
U1 0
U2 3
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
J9 FUTURE VIROL
JI Future Virol.
PD SEP
PY 2011
VL 6
IS 9
BP 1029
EP 1034
DI 10.2217/FVL.11.81
PG 6
WC Virology
SC Virology
GA 841EY
UT WOS:000296496500006
DA 2020-12-16
ER

PT J
AU Medina-Acosta, E
   Machado, FB
AF Medina-Acosta, Enrique
   Machado, Filipe Brum
TI Eyes wide open: the (mis)use of combined power of discrimination for
   X-linked short tandem repeats
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
ID LINKAGE DISEQUILIBRIUM; MARKERS; CHROMOSOME; GENETICS
C1 [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Nucleo Diagnost & Invest Mol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, Filipe Brum] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Ave Alberto Lamego 2000,Parque Calif, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Aler A, 2007, FORENSIC SCI INT, V173, P193, DOI 10.1016/j.forsciint.2006.10.023
   Bobillo C, 2011, FORENSIC SCI INT-GEN, V5, pE14, DOI 10.1016/j.fsigen.2009.11.005
   Brenner CH, 2010, FORENSIC SCI INT-GEN, V4, P281, DOI 10.1016/j.fsigen.2009.10.013
   Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x
   Fracasso T, 2008, INT J LEGAL MED, V122, P353, DOI 10.1007/s00414-008-0231-9
   Freitas NSC, 2010, INT J LEGAL MED, V124, P589, DOI 10.1007/s00414-010-0441-9
   Gusmao L, 2009, INT J LEGAL MED, V123, P227, DOI 10.1007/s00414-008-0309-4
   HEDRICK PW, 1987, GENETICS, V117, P331
   Hering S, 2010, INT J LEGAL MED, V124, P483, DOI 10.1007/s00414-009-0387-y
   Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000
   LEWONTIN RC, 1964, GENETICS, V49, P49
   Li L, 2010, FORENSIC SCI INT-GEN, V4, pE145, DOI 10.1016/j.fsigen.2010.04.004
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Medina-Acosta E, 2011, FORENSIC SCI INT-GEN, V5, P545, DOI 10.1016/j.fsigen.2009.12.002
   Nakamura Y, 2010, INT J LEGAL MED, V124, P405, DOI 10.1007/s00414-010-0467-z
   Pereira R, 2007, INT J LEGAL MED, V121, P192, DOI 10.1007/s00414-006-0144-4
   Pico A, 2008, INT J LEGAL MED, V122, P347, DOI 10.1007/s00414-007-0215-1
   Pinto N, 2011, FORENSIC SCI INT-GEN, V5, P27, DOI 10.1016/j.fsigen.2010.01.011
   Rodrigues EL, 2009, FORENSIC SCI INT-GEN, V4, pE23, DOI 10.1016/j.fsigen.2009.01.008
   Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247
   Tease C, 2002, AM J HUM GENET, V70, P1469, DOI 10.1086/340734
   Tie J, 2010, FORENSIC SCI INT-GEN, V4, pE105, DOI 10.1016/j.fsigen.2009.09.002
   Tillmar AO, 2008, FORENSIC SCI INT-GEN, V3, P37, DOI 10.1016/j.fsigen.2008.09.006
NR 23
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD AUG
PY 2011
VL 38
IS 6
BP 4003
EP 4006
DI 10.1007/s11033-010-0518-z
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 777WW
UT WOS:000291656800047
PM 21110111
DA 2020-12-16
ER

PT J
AU de Souza, TL
   Fernandes, RCDC
   Medina-Acosta, E
AF de Souza, Thais Louvain
   de Souza Campos Fernandes, Regina Celia
   Medina-Acosta, Enrique
TI Maternal HIV Infection and Antibody Responses in Uninfected Infants
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Letter
ID VACCINE
C1 [de Souza, Thais Louvain; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, Campos Dos Goytacazes, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, Campos Dos Goytacazes, Brazil.
RP de Souza, TL (corresponding author), Univ Estadual Norte Fluminense, Mol Identificat & Diag Unit, Campos Dos Goytacazes, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Louvain de Souza, Thais/G-2646-2014
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Louvain de Souza,
   Thais/0000-0002-0179-272X
CR Hanson LA, 2001, PEDIAT ALLERG IMM-UK, V12, P15, DOI 10.1034/j.1399-3038.2001.121404.x
   Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376
   Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100
   Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea
   PABST HF, 1990, LANCET, V336, P269, DOI 10.1016/0140-6736(90)91802-H
NR 5
TC 1
Z9 1
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 18
PY 2011
VL 305
IS 19
BP 1964
EP 1964
DI 10.1001/jama.2011.638
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA 764WO
UT WOS:000290665500014
PM 21586709
DA 2020-12-16
ER

PT J
AU Machado, FB
   Da Silva, AFA
   Rossetti, LC
   De Brasi, CD
   Medina-Acosta, E
AF Machado, F. B.
   Da Silva, A. F. Alves
   Rossetti, L. C.
   De Brasi, C. D.
   Medina-Acosta, E.
TI Informativeness of a novel multiallelic marker-set comprising an F8
   intron 21 and three tightly linked loci for haemophilia A carriership
   analysis
SO HAEMOPHILIA
LA English
DT Article
DE F8; GAB3; gametic disequilibrium; MPP1; recombination hotspot; X-STRs
ID FACTOR-VIII GENE; RECOMBINATION HOT-SPOTS; LINKAGE-PHYSICAL MAP; TANDEM
   REPEAT LOCI; DINUCLEOTIDE REPEAT; CPG-ISLANDS; DIAGNOSIS; MUTATION;
   HUMAN-CHROMOSOME-21; DISEQUILIBRIUM
AB The extraordinary heterogeneous nature of the deleterious mutations in the F8 gene that lead to functional deficiency of clotting factor VIII in haemophilia A makes routine direct mutation profiling difficult. When direct mutation analysis cannot be performed or a causative/candidate mutation is not found, a second-line approach to track the defective F8 gene within at-risk families is linkage genetic analysis with, tried-and-tested, F8-intragenic and/or extragenic non-recombining multiallelic short tandem repeats (STR). Although several typing STR loci within and around F8 have been described, there is need for improving assessment, because the combined informativeness of available assays rarely reaches 100%. Here, we characterized a newly identified 0.28 cM-resolution marker-set, consisting of a dinucleotide STR located on F8 intron 21 (F8Int21; [AC](n)) and three extragenic tetranucleotide STR located on GAB3 intron 1 (GAB3Int1; [TAAA](n)) and TMLHE intron 1 (TMLHEInt1.1; [GAAA](n) and TMLHEInt1.3; [ATTC](n)). Heterozygosity rates determined in 100 unrelated females ranged from 0.25 (GAB3Int1) to 0.63 (F8Int21). The set rendered a combined informativeness of 0.91 for at least one marker and 0.60 for a minimum of two loci, with at least one F8-intragenic. Multiallelic interlocus non-random association analysis revealed that GAB3Int1 is not in significant gametic disequilibrium (GD) with F8Int21, F8Int9.2, TMLHEInt1.3 or TMLHEInt1.1. Gametic disequilibrium breakdown attests historical recombination between GAB3Int1 and the F8 gene. Through computational analysis of reference assembly sequence data, we note in the GD breakdown region and in the F8 gene a higher than average density of the 13-mer CCNCCNTNNCCNC consensus motif, commonly associated with recombination hotspots.
C1 [Medina-Acosta, E.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, F. B.; Da Silva, A. F. Alves] Hosp Escola Alvaro Alvim, Campos Dos Goytacazes, RJ, Brazil.
   [Rossetti, L. C.; De Brasi, C. D.] Acad Nacl Med Buenos Aires, Dept Genet, Secc Genet Mol Hemofilia, Buenos Aires, DF, Argentina.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Ave Alberto Lamego 2000,Parque California, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; De Brasi, Carlos
   Daniel/0000-0003-2379-4379
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E25/111.917/2008]; Agencia Nacional de Promocion
   Cientifica y Tecnologica ANPCyTANPCyT; National Research Council
   CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET); Rene Baron Foundation of Argentina
FX This study was funded in part by the Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) research grant no E25/111.917/2008 to
   EM-A, and grants from the Agencia Nacional de Promocion Cientifica y
   Tecnologica ANPCyT, the National Research Council CONICET and the Rene
   Baron Foundation of Argentina to CDDB. The authors are grateful to the
   volunteers who participated and donated samples for the study.
CR Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168
   Bowen DJ, 2002, J CLIN PATHOL-MOL PA, V55, P1, DOI 10.1136/mp.55.1.1
   Brandstrom M, 2008, MOL BIOL EVOL, V25, P2579, DOI 10.1093/molbev/msn201
   Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x
   De Brasi CD, 2008, J THROMB HAEMOST, V6, P1822, DOI 10.1111/j.1538-7836.2008.03094.x
   Edelmann J, 2008, FORENSIC SCI INT-GEN, V2, P41, DOI 10.1016/j.fsigen.2007.08.001
   FRASER A, 1967, GENETICS, V55, P505
   Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227
   GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0
   HOYER LW, 1994, NEW ENGL J MED, V330, P38, DOI 10.1056/NEJM199401063300108
   Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565
   Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216
   KOCHHAN L, 1994, BLOOD COAGUL FIBRIN, V5, P497
   LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236
   LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S
   LALLOZ MRA, 1994, BRIT J HAEMATOL, V86, P804
   Laurie AD, 2010, J THROMB HAEMOST, V8, P783, DOI 10.1111/j.1538-7836.2010.03768.x
   Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820
   Lewis PO, 2001, GENETIC DATA ANAL CO
   Liu Q, 1998, BLOOD, V92, P1458, DOI 10.1182/blood.V92.4.1458.splL4_1458_1459
   Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0
   Machado FB, 2009, HAEMOPHILIA, V15, P1135, DOI 10.1111/j.1365-2516.2009.02056.x
   Machado FB, 2009, HAEMOPHILIA, V15, P613, DOI 10.1111/j.1365-2516.2008.01977.x
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Medina-Acosta E, 2010, HAEMOPHILIA, V16, P525, DOI 10.1111/j.1365-2516.2009.02161.x
   Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213
   NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773
   NEI M, 1981, GENETICS, V97, P145
   Pavlova A, 2009, J THROMB HAEMOST, V7, P976, DOI 10.1111/j.1538-7836.2009.03346.x
   *PROM, 1999, POWERSTATS VERS 12
   Renault NK, 2007, EUR J HUM GENET, V15, P628, DOI 10.1038/sj.ejhg.5201799
   Rossetti LC, 2008, J THROMB HAEMOST, V6, P830, DOI 10.1111/j.1538-7836.2008.02926.x
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sanchez-Garcia JF, 2005, THROMB HAEMOSTASIS, V94, P1099, DOI 10.1160/TH05-05-0360
   Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178
   Sigurdsson MI, 2009, GENOME RES, V19, P581, DOI 10.1101/gr.086181.108
   Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099
   Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070
   Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099
   Zhao ZM, 2009, BIOCHEM BIOPH RES CO, V382, P643, DOI 10.1016/j.bbrc.2009.03.076
NR 41
TC 4
Z9 4
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD MAR
PY 2011
VL 17
IS 2
BP 257
EP 266
DI 10.1111/j.1365-2516.2010.02404.x
PG 10
WC Hematology
SC Hematology
GA 723RQ
UT WOS:000287524900015
PM 21070487
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   Medina-Acosta, Enrique
TI Contraindication of BCG Vaccination in Children Exposed and/or Infected
   by HIV
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Letter
ID ANTIRETROVIRAL THERAPY
C1 [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, Dept Pediat, Rio De Janeiro, Brazil.
   [Medina-Acosta, Enrique] State Univ N Fluminense Darcy Ribeiro, Dept Biotechnol, Rio De Janeiro, Brazil.
RP Fernandes, RCDC (corresponding author), Municipal Program Surveillance Sexually Transmitt, Rio De Janeiro, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Bannister C, 2009, J TROP PEDIATRICS, V55, P78, DOI 10.1093/tropej/fmp018
   Chokephaibulkit K, 2007, CLIN INFECT DIS, V45, P1016, DOI 10.1086/521929
   Fernandes RCDC, 2009, EUR J PEDIATR, V168, P691, DOI 10.1007/s00431-008-0822-y
   MSELLATI P, 1992, WKLY EPIDEMIOL REC, V67, P129
   Nuttall JJ, 2008, INT J INFECT DIS, V12, pE99, DOI 10.1016/j.ijid.2008.06.014
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P645, DOI 10.1097/01.inf.0000225786.00940.37
NR 6
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD FEB
PY 2011
VL 57
IS 1
BP 72
EP 73
DI 10.1093/tropej/fmq034
PG 2
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA 724IG
UT WOS:000287568700015
PM 20525775
OA Bronze
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Ribas, GF
   Silva, DPE
   Gomes, AM
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   Ribas, Gustavo Fernandes
   Pires e Silva, Danielli
   Gomes, Alexandre Machado
   Medina-Acosta, Enrique
TI Persistent operational challenges lead to non-reduction in
   maternal-infant transmission of HIV
SO JORNAL DE PEDIATRIA
LA English
DT Article
ID TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; PREVENTION; RISK;
   BRAZIL; STATE
AB Objective: To determine impediments to the effective reduction of maternal-infant transmission of HIV in the municipality of Campos dos Goytacazes, RI, Brazil.
   Methods: This is a cohort study, with medical follow-up, of pregnant women with confirmed diagnosis of HIV infection, and their infant children, assisted at the Municipal Specialized Service of Sexually Transmitted Diseases/AIDS from January 2004 to April 2007. Information regarding exposure and outcome variables was collected from their medical records. Frequencies of variables were determined and bivariate analysis performed for exposure factors and transmission of HIV. Relative risks of HIV transmission associated with exposure variables were calculated using 95% confidence intervals. Statistical significance of risk associations was evaluated.
   Results: Seventy-eight mother-child pairs were studied; the rate of maternal-infant transmission of HIV was 7.7%. Variables showing significant association with maternal-infant transmission of HIV were the non-utilization of antiretrovirals for prophylaxis or treatment during pregnancy (RR = 21.00; 95%CI 2.64-166.74, p = 0.001) and diagnosis of maternal disease after pregnancy (RR = 6.80; 95%CI 1.59-29.17, p = 0.025). New pregnancies in women with other children also exposed to HIV occurred in 19.12 % (15/78) of cases.
   Conclusions: There was no reduction in the rate of maternal-infant transmission of HIV in the period 2004-2007 in relation to the preceding triennium. The following were recognized as impediments to the effective reduction of maternal-infant transmission of HIV: low prenatal screening coverage of maternal HIV infection, impairing maternal treatment or prophylaxis; and the incorrect use of the rapid screening test at admission for delivery.
C1 [de Souza Campos Fernandes, Regina Celia; Ribas, Gustavo Fernandes] FMC, Campos Dos Goytacazes, RJ, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Programa Municipal DST AIDS Campos dos Goytacazes, Campos Dos Goytacazes, RJ, Brazil.
   [Pires e Silva, Danielli] Hosp Coracao, Sao Paulo, Brazil.
   [Gomes, Alexandre Machado] Hosp Escola Alvaro Alvim, Serv Clin Med, Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Campos Dos Goytacazes, RJ, Brazil.
RP Fernandes, RCDC (corresponding author), Rua Conselheiro Otaviano 241, BR-28010140 Campos Dos Goytacazes, RJ, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Secretaria Municipal de Saude de Campos; Programa Nacional de DST/AIDS
   de Campos dos Goytacazes; Brazilian Ministry of Health; UNESCO
FX Financial support: Secretaria Municipal de Saude de Campos, Programa
   Nacional de DST/AIDS de Campos dos Goytacazes, Brazilian Ministry of
   Health. UNESCO.
CR Aebi C, 2000, AIDS, V14, P2913
   ARAUJO LC, 2006, PREVALENCIA INFECCAO
   de Araujo LC, 2005, EPIDEMIOL SERV SAUDE, V14, P85
   Fernandes RCDC, 2009, BRAZ J INFECT DIS, V13, P70, DOI 10.1590/S1413-86702009000100015
   de Souza PRB, 2004, REV SAUDE PUBL, V38, P764, DOI 10.1590/S0034-89102004000600003
   Fernandes Regina Célia de Souza Campos, 2005, Cad. Saúde Pública, V21, P1153, DOI 10.1590/S0102-311X2005000400017
   Fernandez-Ibieta M, 2007, An Pediatr (Barc), V67, P109
   Grosch-Woerner I, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00520.x
   Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979
   Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6
   LAURITSEN B, 2005, EPIDATA ENTRY VERSIO
   Matida LH, 2005, AIDS, V19, pS37, DOI 10.1097/01.aids.0000191489.59112.13
   *MIN SAUD BRAS SEC, SIST INF NASC VIV SI
   *MIN SAUD BRAS SEC, 2007, B EP AIDS DST
   *MIN SAUD BRAS SEC, 2002, B EP AIDS DST
   *MIN SAUD BRAS SEC, 2003, PROGR NAC DST AIDS R
   Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484
   NEWELL ML, 1994, LANCET, V343, P1464
   Nogueira S A, 2001, Braz J Infect Dis, V5, P78
   Patel D, 2010, ANTIVIR THER, V15, P41, DOI 10.3851/IMP1489
   Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201
   SUCCI RC, 2002, C INT INF PEL HIV MU, P6
   Townsend CL, 2010, ANTIVIR THER, V15, P775, DOI 10.3851/IMP1613
   Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2
   Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001
   World Health Organization [WHO], 2009, RAP ADV REV WHO PRIN
   Zhou ZQ, 2010, JAIDS-J ACQ IMM DEF, V53, pS15, DOI 10.1097/QAI.0b013e3181c7d47b
NR 27
TC 3
Z9 4
U1 0
U2 2
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD NOV-DEC
PY 2010
VL 86
IS 6
BP 503
EP 508
DI 10.2223/JPED.2040
PG 6
WC Pediatrics
SC Pediatrics
GA 710CH
UT WOS:000286488000010
PM 21076798
OA Bronze
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Medina-Acosta, E
AF de Souza Campos Fernandes, R. C.
   Medina-Acosta, E.
TI BCG-itis in two antiretroviral-treated HIV-infected infants
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Article
DE BCG; antiretroviral therapy; HIV infection; HAART; IRIS
ID IMMUNE RECONSTITUTION SYNDROME; BACILLUS-CALMETTE-GUERIN; CHILDREN;
   THERAPY; DISEASE; INITIATION
AB Although vaccination with Bacille Calmette-Guerin (BCG) is considered safe, adverse regional (BCG-itis) and disseminated (BCG-osis) diseases preferentially occur in the immunocompromised host. The infection with human immunodeficiency virus (HIV) by mother-to-child transmission leads to impaired cellular immune responses, a situation that poses a great challenge regarding the universal use of BCG vaccine. World Health Organization recommends that children who are known to be HIV-infected, even if asymptomatic, should no longer be immunized with BCG. Many of the complications of BCG vaccination occur in severely immunosuppressed HIV-infected children and are related to late institution of antiretroviral and antimycobacterial therapy. We report two cases of BCG-itis in HIV-infected infants, who fulfilled clinical criteria of immune reconstitution inflammatory syndrome: axillary adenitis, one with suppuration, and both temporally associated with precocious restoration of immunity elicited by the use of antiretroviral therapy. Isoniazid (10 mg/kg/day) was offered until regression of adenopathies, and lesions were not handled.
C1 [Medina-Acosta, E.] State Univ N Fluminense Darcy Ribeiro, Campos Goytacazes, Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, R. C.] Municipal Program Surveillance Sexually Transmitt, Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, R. C.] Fac Med Campos, Rio De Janeiro, Brazil.
RP Fernandes, RCDC (corresponding author), Campos Goytacazes, Rua Rafael Danuncio Damiano 277, BR-28013035 Rio De Janeiro, Brazil.
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Municipal Health Department of the city of Campos dos Goytacazes;
   National Program for STD/AIDS; Ministry of Ministry of Health/UNESCO
FX The authors would like to thank the children and their families who
   consented to this report. The authors are grateful to the members of the
   Specialized Assistance Service for HIV/AIDS, the Voluntary Counselling
   and Testing Centre for HIV and AIDS of the Municipal Program for the
   Surveillance of STD and AIDS of the city of Campos of Goytacazes for
   their support. This study was financed by the Municipal Health
   Department of the city of Campos dos Goytacazes, the National Program
   for STD/AIDS and by a grant from the Ministry of Ministry of
   Health/UNESCO to E.M-A.
CR [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193
   Azzopardi P, 2009, INT J TUBERC LUNG D, V13, P1331
   Bannister C, 2009, J TROP PEDIATRICS, V55, P78, DOI 10.1093/tropej/fmp018
   Boulware DR, 2008, CURR OPIN HIV AIDS, V3, P461, DOI 10.1097/COH.0b013e3282fe9693
   French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06
   Hesseling AC, 2004, PEDIATR INFECT DIS J, V23, P476, DOI 10.1097/01.inf.0000126593.21006.ac
   Puthanakit T, 2005, CLIN INFECT DIS, V41, P1049, DOI 10.1086/433177
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P645, DOI 10.1097/01.inf.0000225786.00940.37
NR 8
TC 4
Z9 4
U1 0
U2 1
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0956-4624
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD SEP 10
PY 2010
VL 21
IS 9
BP 662
EP 663
DI 10.1258/ijsa.2010.010267
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 697RA
UT WOS:000285531900014
PM 21097744
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   Medina-Acosta, Enrique
TI Complications of bacillus Calmette-Guerin immunization in children
   treated with highly-active antiretroviral therapy
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID IMMUNE RECONSTITUTION SYNDROME; HIV-INFECTION; BCG DISEASE; VACCINE;
   INITIATION
C1 [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, BR-28013035 Rio De Janeiro, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] State Univ N Fluminense Darcy Ribeiro, Campos Dos Goytacazes, RJ, Brazil.
RP Fernandes, RCDC (corresponding author), Municipal Program Surveillance Sexually Transmitt, Rua Rafael Danuncio Damiano 277,Campos Goytacazes, BR-28013035 Rio De Janeiro, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Alexander A, 2007, J PEDIATR SURG, V42, P549, DOI 10.1016/j.jpedsurg.2006.10.059
   [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193
   *BRAZ MIN HLTH, MAN EV ADV POS VAC S
   Fernandes RCDC, 2009, INT J TUBERC LUNG D, V13, P1188
   Fernandes RCDC, 2009, EUR J PEDIATR, V168, P691, DOI 10.1007/s00431-008-0822-y
   Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953
   Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020
   Nuttall JJ, 2008, INT J INFECT DIS, V12, pE99, DOI 10.1016/j.ijid.2008.06.014
   Puthanakit T, 2005, CLIN INFECT DIS, V41, P1049, DOI 10.1086/433177
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P645, DOI 10.1097/01.inf.0000225786.00940.37
NR 10
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD SEP
PY 2010
VL 14
SU 3
BP E361
EP E361
DI 10.1016/j.ijid.2009.11.017
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 660LA
UT WOS:000282643000095
PM 20207181
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Medina-Acosta, E
AF Medina-Acosta, E.
TI Interlocus non-random association of multiallelic polymorphisms spanning
   the coagulation factor VIII gene on human chromosome distalmost Xq28
SO HAEMOPHILIA
LA English
DT Article
DE D' coefficient; F8 gene; gametic disequilibrium; haemophilia A;
   haplotype splitting; microsatellite; Xq28; X-short tandem repeats
ID LINKAGE-PHYSICAL MAP; HEMOPHILIA-A; GAMETIC DISEQUILIBRIUM;
   MICROSATELLITE; PATTERNS; PHYLOGEOGRAPHY; POPULATIONS; HAPLOTYPES;
   SELECTION; WORLDWIDE
AB The most common severe hereditary bleeding disorder phenotype in humans, the coagulation factor VIII (F8) deficiency haemophilia A (HEMA), maps on Xq28 band, a region that comprises 11.7% of genes and 14.2% of phenotypes on X chromosome. Information about the distribution and extent of gametic disequilibrium (GD) covering the F8 gene is scarce, despite its relevance for linkage and association studies. The aim of this study was to determine the patterns, by frequency and strength, of non-random multiallelic interallelic associations between two-locus combinations of seven microsatellite loci (REN90833, F8Int25.2, F8Int22, F8Int13.2, HEMA154311.3, TMLHEInt5 and HEMA154507.3, in that physical order) spanning 0.813 Mb on distalmost Xq28. We measured sign-based interallelic D' coefficients in 106 men and in 100 women drawn from a single unrelated Brazilian population. Significance and patterns of GD using haploid and phased diploid sample probabilities were close to conformity. Only 9.18% of the variance of D' could be accounted for by changes in length, indicating that GD is not a monotonically decreasing function of length. We defined two regions of overlapping long-range GD extending 698 735 base pairs (bp) (REN90833/TMLHEInt5 block) and 689 900 bp (F8Int13.2/HEMA154507.3 block) The extent of GD overlap is 575 637 bp (F8Int13.2/TMLHEInt5 interstice). Extended haplotype homozygosity analysis centred at the F8 intronic loci revealed that the most frequent core haplotypes decay the least in the flanking GD. The F8 intronic loci attend distinct non-random association forces; F8Int13.2 serves at maintenance of the long-range overlapping pattern of GD, whereas F8Int25.2 and F8Int22 serve at lessening it in force or effect.
C1 Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Nucleo Diagnost & Invest Mol, BR-28013602 Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Nucleo Diagnost & Invest Mol, Ave Alberto Lamego 2000,Parque California,Campos, BR-28013602 Rio De Janeiro, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E25/111.917/2008]; Universidade Estadual do Norte
   Fluminense Darcy Ribeiro and the Hospital Escola Alvaro Alvim [020]
FX This study was funded in part by the Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) research grant no. E25/111.917/2008 to
   EM-A, and the inter-institutional agreement no. 020 between the
   Universidade Estadual do Norte Fluminense Darcy Ribeiro and the Hospital
   Escola Alvaro Alvim. EM-A is a recipient of a productivity fellowship
   from the Fundacao Benedito Pereira Nunes. The author is grateful to the
   members of the laboratory for help and useful discussions.
CR Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777
   Bagnall RD, 2005, J THROMB HAEMOST, V3, P2598, DOI 10.1111/j.1538-7836.2005.01566.x
   Bowen DJ, 2000, BRIT J HAEMATOL, V111, P544, DOI 10.1046/j.1365-2141.2000.02373.x
   Brandstrom M, 2008, MOL BIOL EVOL, V25, P2579, DOI 10.1093/molbev/msn201
   CAMERINO G, 1985, HUM GENET, V71, P79, DOI 10.1007/BF00295673
   Crawford DC, 2005, ANNU REV GENOM HUM G, V6, P287, DOI 10.1146/annurev.genom.6.080604.162309
   De Brasi CD, 2008, J THROMB HAEMOST, V6, P1822, DOI 10.1111/j.1538-7836.2008.03094.x
   Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906
   FRASER A, 1967, GENETICS, V55, P505
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
   Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227
   HEDRICK PW, 1987, GENETICS, V117, P331
   Howarth A, 1998, HAEMOPHILIA, V4, P812
   Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820
   LAVERGNE JM, 1991, BLOOD COAGUL FIBRIN, V2, P293, DOI 10.1097/00001721-199104000-00012
   Lewis PO, 2001, GENETIC DATA ANAL CO
   LEWONTIN RC, 1988, GENETICS, V120, P849
   LEWONTIN RC, 1964, GENETICS, V50, P757
   LEWONTIN RC, 1964, GENETICS, V49, P49
   Machado FB, 2009, HAEMOPHILIA, V15, P1135, DOI 10.1111/j.1365-2516.2009.02056.x
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   MACHADO FB, 2008, HEMAPSTR VERSION 1 4
   Machado FB, 2009, FORENSIC SCI INT-GEN, V3, P202, DOI 10.1016/j.fsigen.2008.10.006
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355
   Mueller JC, 2004, BIOINFORMATICS, V20, P786, DOI 10.1093/bioinformatics/btg481
   NEI M, 1981, GENETICS, V97, P145
   Payseur BA, 2008, AM J HUM GENET, V82, P1039, DOI 10.1016/j.ajhg.2008.02.018
   Pereira RW, 2006, GENETICA, V126, P243, DOI 10.1007/s10709-005-1453-0
   Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590
   Rodrigues EL, 2009, FORENSIC SCI INT-GEN, V4, pE23, DOI 10.1016/j.fsigen.2009.01.008
   Sabatti C, 2002, GENETICS, V160, P1707
   Sanchez-Garcia JF, 2005, THROMB HAEMOSTASIS, V94, P1099, DOI 10.1160/TH05-05-0360
   Santos-Lopes SS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000557
   Singh M, 2009, CLIN APPL THROMB-HEM, V15, P334, DOI 10.1177/1076029607308872
   Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55
   Taillon-Miller P, 2000, NAT GENET, V25, P324
   Taillon-Miller P, 2004, GENOMICS, V84, P899, DOI 10.1016/j.ygeno.2004.08.009
   Tillmar AO, 2008, FORENSIC SCI INT-GEN, V3, P37, DOI 10.1016/j.fsigen.2008.09.006
   VANDEWATER NS, 1991, J MED GENET, V28, P171, DOI 10.1136/jmg.28.3.171
   Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005
   Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099
   Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123
   Wessa P, 2009, FREE STAT SOFTWARE V
   Xiong MM, 1999, AM J HUM GENET, V64, P629, DOI 10.1086/302231
   Zapata C, 2000, EVOLUTION, V54, P1809, DOI 10.1111/j.0014-3820.2000.tb00711.x
   Zapata C, 2001, GENETICS, V158, P1235
NR 47
TC 3
Z9 3
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD MAY
PY 2010
VL 16
IS 3
BP 525
EP 537
DI 10.1111/j.1365-2516.2009.02161.x
PG 13
WC Hematology
SC Hematology
GA 587OC
UT WOS:000277001100018
PM 20050928
DA 2020-12-16
ER

PT J
AU Rodrigues, EL
   Machado, FB
   Arruda, MM
   de Moura-Neto, RS
   Medina-Acosta, E
AF Rodrigues, Eduardo Leal
   Machado, Filipe Brum
   Arruda, Marilia Mothe
   de Moura-Neto, Rodrigo Soares
   Medina-Acosta, Enrique
TI Genetic data on 15 STR autosomal loci for a sample population of the
   Northern Region of the State of Rio de Janeiro, Brazil
SO FORENSIC SCIENCE INTERNATIONAL-GENETICS
LA English
DT Article
DE Autosomal DNA marker; Brazilian population; Genetic distance; Short
   tandem repeat; STR
ID ALLELE FREQUENCIES DATA; STATISTIC PARAMETERS; D13S317; D16S539; D7S820;
   TH01; TPOX; VWA; FESFPS; F13A01
AB Allele frequencies data, paternity and forensic parameters for 15 autosomal short tandem repeat (STR) autosomal markers (D8S1179, D21S11, D7S820, CSF1PO, D5S818, D3S1358, TH01, D13S317, D16S539, D2S1338, TPOX, D19S433, vWA, D18S51, FGA) were determined for a sample of 494 unrelated individuals undergoing kinship analysis and molecular cytogenetic testing from the population of the city of Campos dos Goytacazes, Northern State of Rio de Janeiro, Brazil. The loci with the highest polymorphism information content were D18S51 (0.874), D2S1338 (0.853), FGA (0.852), D21S11 (0.838). The combined power of discrimination and the combined power of exclusion were 0.999999999999999 and 0.999526684, respectively. At the available common loci CSF1PO, TH01, TPOX, vWA, D16S539, D7S820 and D13S317, allele frequencies were compared with population databases from State of Alagoas, State of Amazonas, State of Sao Paulo (Brazilian mulattoes, descendants of Europeans, Africans or Asians), State of Mato Grosso do Sul and State of Rio de Janeiro. No significant distances were observed. The interpopulation genetic distance (Fst coefficients) to the present database, ranged 0.0022 (p = 0.446) (Northern State Rio de Janeiro-State of Sao Paulo European-descendants) to 0.0138 (p = 0.993) (Northern State Rio de Janeiro-State of Sao Paulo Asian- descendants). The Asian-descendants Brazilians are the least admixed. All other groups are admixed as one unique population. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Rodrigues, Eduardo Leal; Machado, Filipe Brum; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, NUDIM, BR-29013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, Filipe Brum; Arruda, Marilia Mothe] Hosp Escola Alvaro Alvim, BR-28035010 Campos Dos Goytacazes, RJ, Brazil.
   [de Moura-Neto, Rodrigo Soares] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, BR-21941910 Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, NUDIM, BR-29013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Moura-Neto, Rodrigo S/F-6770-2012; Medina-Acosta, Enrique/G-3041-2010;
   Rodrigues, Eduardo/ABB-8950-2020; Machado, Filipe/G-5497-2012
OI Moura-Neto, Rodrigo S/0000-0002-4292-6878; Medina-Acosta,
   Enrique/0000-0002-2529-0548; 
FU Universidade Estadual do Norte Fluminense Darcy Ribeiro and the Hospital
   Escola Alvaro Alvim [020]
FX This study was funded by the inter-institutional agreement no. 020
   between the Universidade Estadual do Norte Fluminense Darcy Ribeiro and
   the Hospital Escola Alvaro Alvim. The authors are grateful to the
   volunteers who participated and donated samples for the study.
CR Brenner CH, 1997, GENETICS, V145, P535
   Bydlowski SP, 2003, FORENSIC SCI INT, V135, P67, DOI 10.1016/S0379-0738(03)00174-9
   da Silva LAF, 2002, FORENSIC SCI INT, V130, P187
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003
   Goes ACD, 2004, FORENSIC SCI INT, V140, P131, DOI 10.1016/j.forsciint.2003.11.023
   LEWIS PO, 2008, GENETIC DATA ANAL CO
   Lincoln P, 2000, FORENSIC SCI INT, V110, P3
   OTA T, 2003, DISPAN GENETIC DISTA
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Rodrigues EMR, 2007, FORENSIC SCI INT, V168, P244, DOI 10.1016/j.forsciint.2006.03.003
   Silva DA, 2004, FORENSIC SCI INT, V139, P173, DOI 10.1016/j.forsciint.2003.10.017
   Silva R, 2004, FORENSIC SCI INT, V142, P51, DOI 10.1016/j.forsciint.2004.02.019
   Tereba A., 1999, PROFILES DNA, V2, P14, DOI DOI 10.1016/J.FSIGEN.2012.11.011
NR 13
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1872-4973
EI 1878-0326
J9 FORENSIC SCI INT-GEN
JI Forensic Sci. Int.-Genet.
PD DEC
PY 2009
VL 4
IS 1
BP E23
EP E24
DI 10.1016/j.fsigen.2009.01.008
PG 2
WC Genetics & Heredity; Medicine, Legal
SC Genetics & Heredity; Legal Medicine
GA 537XL
UT WOS:000273147500015
PM 19948317
DA 2020-12-16
ER

PT J
AU Machado, FB
   Duarte, LP
   Medina-Acosta, E
AF Machado, F. B.
   Duarte, L. P.
   Medina-Acosta, E.
TI Improved criterion-referenced assessment in indirect tracking of
   haemophilia A using a 0.23 cM-resolution dense polymorphic marker set
SO HAEMOPHILIA
LA English
DT Article
DE F8 gene; haemophilia A; haplotype diversity; X-STRs; Xq28
ID DINUCLEOTIDE REPEAT; TANDEM REPEATS; DIAGNOSIS; PCR
AB In haemophilia A, linkage analysis with coagulation factor VIII (F8) intragenic and/or neighbouring extragenic short tandem repeats (STRs) enables indirect tracking F8 pathogenic allelic variant-carriers. Even where DNA sequencing is available, linkage analysis still has a role if no causative or candidate mutation is unveiled. The cumulative heterozygosity rate of the available multiplexed STRs haplotyping assays rarely reaches 100%. This means that in a proportion of women these loci are uninformative. The norm-referenced assessment is based on at least one informative marker criterion. We reasoned that by typing a dense market set, spanning a small fraction of recombination, we should be able to improve assessment. The aim of this study was to improve criterion-referenced assessment in polymorphism segregation analyses using a low-recombination fraction and dense informative STRs set. The multiplex quantitative fluorescence PCR assay comprises four novel tetranucleotide and pentanucleotide STRs distant < 0.15 cM from the F8 gene, and three F8 intragenic dinucleotide STRs, mapped to a 0.23 cM interval spanning the F8 on human chromosome band Xq28. We determined heterozygosity rates and allele frequencies from 100 unrelated healthy females. To investigate about segregation stability, we typed 50 true trios (mother, daughter and father) and 50 true mother-and-son duos from the general population. The heterozygosity rates for the extragenic markers ranged 0.49-0.76. The 0.23 cM-resolution heptaplex rendered a cumulative heterozygosity of 0.89 for a minimum of two informative markers, with at least one F8 intragenic. The heptaplex assay enabled improving the criterion-referenced assessment in indirect carrier-detection.
C1 [Medina-Acosta, E.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Biotechnol Lab, Nucleo Diagnost & Invest Mol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, F. B.] Hosp Escola Alvaro Alvim, Campos Dos Goytacazes, RJ, Brazil.
   [Duarte, L. P.] Hosp Ferreira Machado, Hemoctr Reg Campos, Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Biotechnol Lab, Nucleo Diagnost & Invest Mol, Ave Alberto Lamego 2000,Parque California, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Fundacao de Amparo Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E25/111.917/2008]; Universidade Estadual do Norte
   Fluminense Darcy Ribeiro; Hospital Escola Alvaro Alvim; Hemocentro
   Regional de Campos do Hospital Ferreira Machado
FX This study was funded in part by the Fundacao de Amparo Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) research grant no. E25/111.917/2008 to
   EM-A, the inter-institutional agreement no 020 between the Universidade
   Estadual do Norte Fluminense Darcy Ribeiro and the Hospital Escola
   Alvaro Alvim, and a sponsorship from the Hemocentro Regional de Campos
   do Hospital Ferreira Machado. The authors are grateful to the volunteers
   who participated and donated samples for the study.
CR Bacher J, 1998, PROFILES DNA, V2, P3
   BRENNER CH, 1989, DNA VIEW SYMBOLIC KI
   Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348
   Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249
   Fang Y, 2006, HAEMOPHILIA, V12, P62, DOI 10.1111/j.1365-2516.2005.01162.x
   GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0
   Harraway JR, 2006, J THROMB HAEMOST, V4, P587, DOI 10.1111/j.1538-7836.2006.01790.x
   Klein I, 2001, HAEMOPHILIA, V7, P306, DOI 10.1046/j.1365-2516.2001.00497.x
   KOCHHAN L, 1994, BLOOD COAGUL FIBRIN, V5, P497
   LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S
   LALLOZ MRA, 1994, BRIT J HAEMATOL, V86, P804
   Laurie AD, 2007, HAEMOPHILIA, V13, P420, DOI 10.1111/j.1365-2516.2007.01487.x
   Lavery S, 2009, BRIT J HAEMATOL, V144, P303, DOI 10.1111/j.1365-2141.2008.07391.x
   Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285
   Lin SR, 2000, BRIT J HAEMATOL, V111, P1256, DOI 10.1046/j.1365-2141.2000.02490.x
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   MACHADO FB, 2009, HAEMOPHILIA, V156, P13
   NEI M, 1981, GENETICS, V97, P145
   Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707
   *PROM, 1999, POWERSTATS VER 12
   RICKHAM PP, 1964, BRIT MED J, V2, P173
   Sanchez-Garcia JF, 2005, THROMB HAEMOSTASIS, V94, P1099, DOI 10.1160/TH05-05-0360
   Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178
   Surin V L, 2007, Genetika, V43, P831
   Tomi D, 2005, J HISTOCHEM CYTOCHEM, V53, P277, DOI 10.1369/jhc.4B6393.2005
   Vainer M, 1997, GENOMICS, V41, P1, DOI 10.1006/geno.1997.4608
   Vencesla A, 2008, HAEMOPHILIA, V14, P489, DOI 10.1111/j.1365-2516.2008.01698.x
   Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238
NR 28
TC 6
Z9 6
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD SEP
PY 2009
VL 15
IS 5
BP 1135
EP 1142
DI 10.1111/j.1365-2516.2009.02056.x
PG 8
WC Hematology
SC Hematology
GA 488RP
UT WOS:000269367800020
PM 19624762
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   Medina-Acosta, Enrique
TI Disseminated BCG disease and the full contraindication to BCG
   vaccination for children exposed to and/or infected by HIV
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Letter
C1 [de Souza Campos Fernandes, Regina Celia] Municipal Programme Surveillance STD & AIDS, Campos Dos Goytacazes, RJ, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] State Univ N Fluminense Darcy Ribeiro, Campos Dos Goytacazes, RJ, Brazil.
RP Fernandes, RCDC (corresponding author), Municipal Programme Surveillance STD & AIDS, Campos Dos Goytacazes, RJ, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Fernandes RCDC, 2009, EUR J PEDIATR, V168, P691, DOI 10.1007/s00431-008-0822-y
   FALLO A, 2005, INT AIDS SOC C 24 27
   Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376
   Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953
   Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020
NR 5
TC 4
Z9 5
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD SEP
PY 2009
VL 13
IS 9
BP 1188
EP 1189
PG 2
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 484JD
UT WOS:000269039600026
PM 19723415
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   de Araujo, LC
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   de Araujo, Luciana Cordeiro
   Medina-Acosta, Enrique
TI Reduced rate of adverse reactions to the BCG vaccine in children exposed
   to the vertical transmission of HIV infection and in HIV-infected
   children from an endemic setting in Brazil
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE BCG disease; HIV; Immune reconstitution inflammatory syndrome
ID BACILLE-CALMETTE-GUERIN; IMMUNE RECONSTITUTION SYNDROME; RIO-DE-JANEIRO;
   ANTIRETROVIRAL THERAPY; INDUCED DISEASE; TUBERCULOSIS; INITIATION; BOVIS
AB We report on the adverse reactions to the Bacillus Calmette-Gu,rin (BCG) vaccine in BCG-vaccinated children. We examined children exposed to the vertical transmission of human immunodeficiency virus (HIV) (n = 141), who participated in a prevention program of vertical transmission, and HIV-infected children (n = 66) in a setting endemic for HIV and tuberculosis (TB) in Brazil from August 2000 to February 2008. No cases of disseminated BCG disease occurred in either group of children. While no cases of regional BCG disease were noted in exposed/uninfected children, the rate of regional BCG disease in HIV-infected children was 4.5% (3/66); the three events occurred in < 1-year-old children (3/17; 17.6%). One case was associated with severe immunodepression before highly active antiretroviral therapy (HAART). Two cases were manifestations of immune reconstitution inflammatory syndrome (IRIS). Among the HIV-infected children, the accrued benefits of potentially preventing severe TB outweighed the risks associated with the use of the BCG vaccine.
C1 [de Souza Campos Fernandes, Regina Celia] Municipal Program Surveillance Sexually Transmitt, BR-28010140 Campos Dos Goytacazes, RJ, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Fac Med Campos, BR-2803458 Campos Dos Goytacazes, RJ, Brazil.
   [de Araujo, Luciana Cordeiro] Guarus Municipal Gen Hosp, BR-28080790 Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] State Univ N Fluminense Darcy Ribeiro, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
RP Fernandes, RCDC (corresponding author), Rua Rafael Danuncio Damiano 277, BR-28013035 Campos Dos Goytacazes, RJ, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Municipal Health Department of the city of Campos dos Goytacazes;
   STD/AIDS; Ministry of Health/UNESCOMinistry of Health-Singapore
FX The authors would like to thank the children and their families who
   participated in this study. The authors are grateful to the members of
   the Specialized Assistance Service for HIV/AIDS, the Voluntary
   Counselling and Testing Centre for HIV and AIDS of the Municipal Program
   for the Surveillance of STD and AIDS of the city of Campos of
   Goytacazes, for their support. This study was financed by the Municipal
   Health Department of the city of Campos dos Goytacazes, the National
   Program for STD/AIDS and by a grant from the Ministry of Health/UNESCO
   to E.M.-A.
CR Alexander A, 2007, J PEDIATR SURG, V42, P549, DOI 10.1016/j.jpedsurg.2006.10.059
   [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193
   Archibald LK, 2003, CLIN MICROBIOL INFEC, V9, P234, DOI 10.1046/j.1469-0691.2003.00517.x
   Benevolo-de-Andrade TC, 2005, MEM I OSWALDO CRUZ, V100, P459, DOI 10.1590/S0074-02762005000500002
   *BRAZIL, 2007, GUID CLIN TREATM PED
   *BRAZIL, 2005, MAN ADV EV POSTV
   *BRAZIL, 2007, REC PROPH VERT TRANS
   Campos JMS, 1996, PEDIATR AIDS HIV INF, V7, P429
   Darnaud R, 2006, MEDICINA-BUENOS AIRE, V66, P119
   de Araujo LC, 2005, EPIDEMIOL SERV SAUDE, V14, P85
   de Souza PRB, 2004, REV SAUDE PUBL, V38, P764, DOI 10.1590/S0034-89102004000600003
   Fernandes Regina Célia de Souza Campos, 2005, Cad. Saúde Pública, V21, P1153, DOI 10.1590/S0102-311X2005000400017
   FitzGerald JM, 2000, CLIN INFECT DIS, V31, pS75, DOI 10.1086/314074
   Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441
   GONZALEZ B, 1989, PEDIATR INFECT DIS J, V8, P201
   Grumach AS, 1997, J CLIN IMMUNOL, V17, P340, DOI 10.1023/A:1027335000994
   Hesseling AC, 2007, VACCINE, V25, P6565, DOI 10.1016/j.vaccine.2007.06.045
   Hesseling AC, 2006, CLIN INFECT DIS, V42, P548, DOI 10.1086/499953
   Hesseling AC, 2003, CLIN INFECT DIS, V37, P1226, DOI 10.1086/378298
   Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020
   Jacob CMA, 1996, J INVEST ALLERG CLIN, V6, P202
   Kampmann B, 2006, AIDS, V20, P1011, DOI 10.1097/01.aids.0000222073.45372.ce
   Puthanakit T, 2005, CLIN INFECT DIS, V41, P1049, DOI 10.1086/433177
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P645, DOI 10.1097/01.inf.0000225786.00940.37
   Sharp MJ, 1998, PEDIATR INFECT DIS J, V17, P660, DOI 10.1097/00006454-199807000-00021
   Siberry GK, 2006, PEDIATR INFECT DIS J, V25, P648, DOI 10.1097/01.inf.0000224316.36588.0f
   SILVESTRI F, 1897, B MUSEI ZOOLOGIA ANA, V12, P1
   STOP TB, 2007, INT J TUBERC LUNG D, V11, P134
   Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642
   Thaithumyanon Pimolrat, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P482
   [Anonymous], 2001, MMWR Recomm Rep, V50, P1
   Turnbull FM, 2002, CLIN INFECT DIS, V34, P447, DOI 10.1086/338462
   von Reyn CF, 2006, CLIN INFECT DIS, V42, P559, DOI 10.1086/499959
   Waddell RD, 2001, AIDS, V15, P55, DOI 10.1097/00002030-200101050-00009
   *WHO, 2004, WKLY EPIDEMIOL REC, V79, P27
   *WHO, 2006, BACC CALM GUER VACC
   *WHO, 2007, WKLY EPIDEMIOL REC, V82, P252
   WHO, 2007, WKLY EPIDEMIOL REC, V82, P18
NR 38
TC 10
Z9 10
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD JUN
PY 2009
VL 168
IS 6
BP 691
EP 696
DI 10.1007/s00431-008-0822-y
PG 6
WC Pediatrics
SC Pediatrics
GA 455RG
UT WOS:000266780700009
PM 18766374
DA 2020-12-16
ER

PT J
AU Machado, FB
   Medina-Acosta, E
AF Machado, Filipe Brurn
   Medina-Acosta, Enrique
TI Genetic map of human X-linked microsatellites used in forensic practice
SO FORENSIC SCIENCE INTERNATIONAL-GENETICS
LA English
DT Letter
DE Linkage analysis; Microsatellite; Polymorphism; Recombination; STR
ID MARKERS; STRS; POPULATION; REGION
C1 [Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, Filipe Brurn] Hosp Escola Alvaro Alvim, BR-28035010 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Ave Alberto Lamego 2000,Parque Calif, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br; nudim@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Machado, Filipe/G-5497-2012
OI Medina-Acosta, Enrique/0000-0002-2529-0548; 
CR Dorit BA, 2008, FORENSIC SCI INT-GEN, V2, P69, DOI 10.1016/j.fsigen.2007.08.013
   Bini C, 2005, FORENSIC SCI INT, V153, P231, DOI 10.1016/j.forsciint.2005.05.013
   Edelmann J, 2003, FORENSIC SCI INT, V136, P73, DOI 10.1016/S0379-0738(03)00257-3
   Edelmann J, 2008, FORENSIC SCI INT-GEN, V2, P41, DOI 10.1016/j.fsigen.2007.08.001
   Hering S, 2006, INT J LEGAL MED, V120, P337, DOI 10.1007/s00414-005-0061-y
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Poetsch M, 2006, INT J LEGAL MED, V120, P61, DOI 10.1007/s00414-005-0003-8
   Shin SH, 2005, FORENSIC SCI INT, V147, P35, DOI 10.1016/j.forsciint.2004.04.012
   Szibor R, 2003, INT J LEGAL MED, V117, P67, DOI 10.1007/s00414-002-0352-5
   Szibor R, 2007, FORENSIC SCI INT-GEN, V1, P93, DOI 10.1016/j.fsigen.2007.03.003
   Yu B, 2005, FORENSIC SCI INT, V153, P269, DOI 10.1016/j.forsciint.2004.12.009
NR 11
TC 15
Z9 15
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1872-4973
EI 1878-0326
J9 FORENSIC SCI INT-GEN
JI Forensic Sci. Int.-Genet.
PD JUN
PY 2009
VL 3
IS 3
SI SI
BP 202
EP 204
DI 10.1016/j.fsigen.2008.10.006
PG 3
WC Genetics & Heredity; Medicine, Legal
SC Genetics & Heredity; Legal Medicine
GA 455YT
UT WOS:000266805700010
PM 19414170
DA 2020-12-16
ER

PT J
AU Machado, FB
   Duarte, LP
   Medina-Acosta, E
AF Machado, F. B.
   Duarte, L. P.
   Medina-Acosta, E.
TI A novel informative dinucleotide microsatellite marker located on human
   factor VIII intron 25
SO HAEMOPHILIA
LA English
DT Letter
ID HEMOPHILIA-A DIAGNOSIS; REPEAT; GENE
C1 [Medina-Acosta, E.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, BR-28013602 Rio De Janeiro, Brazil.
   [Machado, F. B.] Hosp Escola Alvaro Alvim, Rio De Janeiro, Brazil.
   [Duarte, L. P.] Hemoctr Reg Campos Hosp Ferreira Machado, Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Ave Alberto Lamego 2000,Parque Calif, BR-28013602 Rio De Janeiro, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010; Machado, Filipe/G-5497-2012
OI Medina-Acosta, Enrique/0000-0002-2529-0548; 
CR Kim JW, 2005, HAEMOPHILIA, V11, P38, DOI 10.1111/j.1365-2516.2005.01064.x
   KOCHHAN L, 1994, BLOOD COAGUL FIBRIN, V5, P497
   LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S
   Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x
   Vencesla A, 2008, HAEMOPHILIA, V14, P489, DOI 10.1111/j.1365-2516.2008.01698.x
NR 5
TC 3
Z9 3
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD MAR
PY 2009
VL 15
IS 2
BP 613
EP 614
DI 10.1111/j.1365-2516.2008.01977.x
PG 2
WC Hematology
SC Hematology
GA 424DY
UT WOS:000264546900028
PM 19187187
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Vasconcellos, VP
   de Araujo, LC
   Medina-Acosta, E
AF de Souza Campos Fernandes, Regina Celia
   Vasconcellos, Vanessa Perez
   de Araujo, Luciana Cordeiro
   Medina-Acosta, Enrique
TI Vertical Transmission of HIV and Toxoplasma by Reactivation in a
   Chronically Infected Woman
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Congenital toxoplasmosis; reactivation; HIV infection
ID MANIFESTATIONS
AB Prevention of mother-to-child transmission of HIV and Toxoplasma dual infections in the immunocompromised patient remains a healthcare challenge. We report a case of congenital toxoplasmosis resulting from reactivation of latent infection in a severely immunodepressed HIV-infected pregnant woman, who had poor adherence to therapy; this case illustrates the difficulties encountered in management of such a rare condition.
C1 [de Souza Campos Fernandes, Regina Celia; Vasconcellos, Vanessa Perez] Municipal Program Surveillance Sexually Transmitt, Campos Dos Goytacazes, RJ, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Sch Med Campos, Campos Dos Goytacazes, RJ, Brazil.
   [de Araujo, Luciana Cordeiro] Guarus Municipal Gen Hosp, Campos Dos Goytacazes, RJ, Brazil.
   [Medina-Acosta, Enrique] State Univ N Fluminense Darcy Ribeiro, Campos Dos Goytacazes, RJ, Brazil.
RP Fernandes, RCDC (corresponding author), Rua Rafael Danuncio Damiano 277,Campos Goytacazes, BR-28013035 Rio De Janeiro, Brazil.
EM reg.fernandes@bol.com.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Municipal Health Department of the city of Campos dos Goytacazes;
   National Program for STD/AIDS; Ministry of Health/UNESCO
FX The authors thank the child and mother who participated in this study.
   This study was financed by the Municipal Health Department of the city
   of Campos dos Goytacazes, the National Program for STD/AIDS and by a
   grant from Ministry of Health/UNESCO to E.M-A.
CR Abrams EJ, 2000, PEDIATR CLIN N AM, V47, P79, DOI 10.1016/S0031-3955(05)70196-6
   [Anonymous], 1996, Eur J Obstet Gynecol Reprod Biol, V68, P93
   Bachmeyer C, 2006, J Infect, V52, pe55, DOI 10.1016/j.jinf.2005.05.004
   Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55
   BIEDERMANN K, 1995, J PERINAT MED, V23, P191, DOI 10.1515/jpme.1995.23.3.191
   Luft, 2000, Curr Infect Dis Rep, V2, P358, DOI 10.1007/s11908-000-0016-x
   Minkoff H, 1997, AM J OBSTET GYNECOL, V176, P555, DOI 10.1016/S0002-9378(97)70547-7
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Nogueira Susie Andries, 2002, Braz J Infect Dis, V6, P201, DOI 10.1590/S1413-86702002000400008
   Remington J.S., 2001, INFECT DIS FETUS NEW, P205
   Thiebaut R, 2007, LANCET, V369, P115
   Van Rie A, 2007, EUR J PAEDIATR NEURO, V11, P1, DOI 10.1016/j.ejpn.2006.10.006
NR 12
TC 12
Z9 13
U1 0
U2 1
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD FEB
PY 2009
VL 13
IS 1
BP 70
EP 71
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA 466ZB
UT WOS:000267703200015
PM 19578634
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Biselli, JM
   Machado, FB
   Zampieri, BL
   Da Silva, AFA
   Goloni-Bertollo, EM
   Haddad, R
   Eberlin, MN
   Vannucchi, H
   Carvalho, VM
   Medina-Acosta, E
   Pavarino-Bertelli, EC
AF Biselli, J. M.
   Machado, F. B.
   Zampieri, B. L.
   Da Silva, A. F. Alves
   Goloni-Bertollo, E. M.
   Haddad, R.
   Eberlin, M. N.
   Vannucchi, H.
   Carvalho, V. M.
   Medina-Acosta, E.
   Pavarino-Bertelli, E. C.
TI DOUBLE ANEUPLOIDY (48,XXY,+21) OF MATERNAL ORIGIN IN A CHILD BORN TO A
   13-YEAR-OLD MOTHER: EVALUATION OF THE MATERNAL FOLATE METABOLISM
SO GENETIC COUNSELING
LA English
DT Article
DE Aneuploidy; Down syndrome; Folic acid; Genetic Nondisjunction; Genetic
   Polymorphisms; Klinefelter syndrome
ID RAPID PRENATAL-DIAGNOSIS; RISK-FACTORS; DOWN-SYNDROME; DNA
   HYPOMETHYLATION; POLYMORPHISMS; GENE; AGE; RECOMBINATION; HOMOCYSTEINE;
   ACID
AB Double aneuploidy, (48,XXY,+21) of maternal origin in a child born to a 13-year-old mother: evoluation of the maternal folate metabolism: The occurrence of non-mosaic double trisomy is exceptional in newborns. In this paper, a 48,XXY,+21 child, the parental origin of the extra chromosomes and the evaluation of the maternal folate metabolism are presented. The infant was born to a 13-year-old mother and presented with the typical clinical features of Down syndrome (DS). The origin of the additional chromosomes was maternal and most likely resulted from errors during the first meiotic division. Molecular analysis of 12 genetic polymorphisms involved in the folate metabolism revealed that the mother is heterozygous for the MTHFR C677T and TC2 A67G polymorphisms, and homozygous for the mutant MTRR A66G polymorphism. The maternal homocysteine concentration was 4.7 mu mol/L, a value close to the one considered as a risk factor for DS in our previous study. Plasma methylmalonic acid and serum folate concentrations were 0.17 mu mol/L and 18.4 ng/mL, respectively. It is possible that the presence of allelic variants for the folate metabolism and Hey concentration might have favored errors in chromosomal disjunction (hiring gametogenesis in this young mother. To our knowledge, this is the first patient with non-mosaic Down-Klinefelter born to a teenage mother, resulting from a rare fertilization event combining an abnormal 25,XX,+21 oocyte and a 23,Y spermatozoon.
C1 [Biselli, J. M.; Zampieri, B. L.; Goloni-Bertollo, E. M.; Pavarino-Bertelli, E. C.] Fac Med Sao Jose do Rio Preto FAMERP, Dept Biol Mol, Unidade Pesquisa Genet & Biol Mol UPGEM, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Machado, F. B.; Medina-Acosta, E.] Univ Estadual Norte Fluminense, NUDIM, Campos dos Goytacazes, RJ, Brazil.
   [Machado, F. B.; Da Silva, A. F. Alves] Hosp Escola Alvaro Alvim, Fundacao Benedito Pereira Nunes, Campos dos Goytacazes, RJ, Brazil.
   [Haddad, R.; Eberlin, M. N.] Univ Estadual Campinas, UNICAMP, Dept Quim Organ, Inst Quim, Campinas, SP, Brazil.
   [Vannucchi, H.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
   [Carvalho, V. M.] Ctr Med Diagnost Fleury, Sao Paulo, Brazil.
RP Pavarino-Bertelli, EC (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Dept Biol Mol, Unidade Pesquisa Genet & Biol Mol UPGEM, Ave Brigadeiro Faria Lima 5416,Bloco U-6, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM erika@famerp.br
RI Biselli, Joice Matos/B-6913-2014; Machado, Filipe/G-5497-2012; Pavarino,
   Erika C/L-5899-2016; Goloni-Bertollo, Eny Maria/B-8405-2012; Carvalho,
   Valdemir M/C-5816-2008; Eberlin, Marcos/B-8106-2012; Pavarino, Erika
   C/L-1119-2014; Zampieri, Bruna/F-7120-2012; Vannucchi,
   Helio/B-8060-2013; Medina-Acosta, Enrique/G-3041-2010
OI Pavarino, Erika C/0000-0003-0959-0695; Goloni-Bertollo, Eny
   Maria/0000-0002-2622-4673; Carvalho, Valdemir M/0000-0002-9816-8615;
   Zampieri, Bruna/0000-0003-0091-1894; Vannucchi,
   Helio/0000-0003-4161-3228; Medina-Acosta, Enrique/0000-0002-2529-0548
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES; National Council
   for Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Universidade Estadual
   do Norte Fluminense Darcy Ribeiro; Fundacao Benedito Pereira Nunes
   (FBPN); Hospital Escola Alvaro Alvim (HEAA)
FX The authors are thankful to the patient and family for participating in
   this study and to Faculdade de Medicina de Sao Jose do Rio Preto
   (FAMERP) / Fundacao Faculdade Regional de Medicina (FUN-FARME) and
   Ding-Down workgroup - FAMERP. This work was supported by grants from the
   Sao Paulo State Research Foundation (FAPESP), Coordination for the
   Improvement of Higher Education Personnel (CAPES), National Council for
   Scientific and Technological Development (CNPq) and the Cooperative
   Agreement no 020 between Universidade Estadual do Norte Fluminense Darcy
   Ribeiro, Fundacao Benedito Pereira Nunes (FBPN) and Hospital Escola
   Alvaro Alvim (HEAA).
CR Afman LA, 2002, EUR J HUM GENET, V10, P433, DOI 10.1038/sj.ejhg.5200830
   Akbas E, 2008, GENET COUNSEL, V19, P59
   Alvarenga M. P. S., 2008, J BIOMOT TECH, V19, P103
   Bianca S, 2005, EUR J MED GENET, V48, P75, DOI 10.1016/j.ejmg.2005.01.010
   Biselli JM, 2008, GENET MOL RES, V7, P33, DOI 10.4238/vol7-1gmr388
   Biselli JM, 2008, BRAZ J MED BIOL RES, V41, P34, DOI 10.1590/S0100-879X2006005000195
   Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491
   Bosco P, 2003, AM J MED GENET A, V121A, P219, DOI 10.1002/ajmg.a.20234
   *BRAZ HLTH MIN, DAT UN HLTH SYST DAT
   Brunaud L, 2003, DIGESTION, V68, P133, DOI 10.1159/000075307
   Carvalho VM, 2008, ANAL BIOCHEM, V381, P67, DOI 10.1016/j.ab.2008.06.023
   Coppede F, 2006, AM J MED GENET A, V140A, P1083, DOI 10.1002/ajmg.a.31217
   de Andrade CR, 2006, EUR J PHARMACOL, V543, P83, DOI 10.1016/j.ejphar.2006.06.003
   Dutta S, 2005, BEHAV BRAIN FUNCT, V25, P1
   Fodinger M, 2003, J AM SOC NEPHROL, V14, P1314, DOI 10.1097/01.ASN.0000064949.67401.D3
   FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111
   Glass IA, 2006, EUR J MED GENET, V49, P346, DOI 10.1016/j.ejmg.2005.12.005
   Goodman SI, 1998, AM J HUM GENET, V63, P1541
   Haddad R, 2001, ANALYST, V126, P1212, DOI 10.1039/b104038n
   HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x
   Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055
   Hol FA, 1998, CLIN GENET, V53, P119
   James SJ, 1999, AM J CLIN NUTR, V70, P495
   James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S
   Jyothy A, 2001, J HUM GENET, V46, P347, DOI 10.1007/s100380170071
   Karaman Ali, 2008, Congenital Anomalies, V48, P45, DOI 10.1111/j.1741-4520.2007.00174.x
   Kimura M, 2004, J NUTR, V134, P48
   Lamb NE, 2005, AM J HUM GENET, V76, P91, DOI 10.1086/427266
   LI OY, 2005, CONGENIT ANOM, V45, P21
   LORDASANCHEZ I, 1992, HUM GENET, V89, P524
   Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224
   Mann K, 2001, LANCET, V358, P1057, DOI 10.1016/S0140-6736(01)06183-9
   Meguid NA, 2008, DIS MARKERS, V24, P19, DOI 10.1155/2008/214027
   Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2
   Muller F, 2000, HUM GENET, V106, P340, DOI 10.1007/s004390051047
   Ogilvie CM, 2005, J HISTOCHEM CYTOCHEM, V53, P285, DOI 10.1369/jhc.4B6409.2005
   Pietrzykl JJ, 2003, MOL GENET METAB, V80, P364, DOI 10.1016/S1096-7192(03)00131-8
   RAJANGAM S, 1996, J CLIN GENET TRIBAL, V2, P126
   Reddy KS, 1997, HUM GENET, V101, P339, DOI 10.1007/s004390050638
   Schmidt W, 2000, MOL HUM REPROD, V6, P855, DOI 10.1093/molehr/6.9.855
   Sciandrello G, 2004, CARCINOGENESIS, V25, P413, DOI 10.1093/carcin/bgh029
   Sherman SL, 2005, CYTOGENET GENOME RES, V111, P273, DOI 10.1159/000086900
   Thomas NS, 2003, HUM REPROD UPDATE, V9, P309, DOI 10.1093/humupd/dmg028
   Wang SS, 2008, J ZHEJIANG UNIV-SC B, V9, P93, DOI 10.1631/jzus.B0710599
   Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7
NR 45
TC 5
Z9 5
U1 0
U2 3
PU MEDECINE ET HYGIENE
PI CHENE-BOURG
PA CH DE LA MOUSSE 46, CASE POSTALE 475, CH-1225 CHENE-BOURG, SWITZERLAND
SN 1015-8146
J9 GENET COUNSEL
JI Genet. Couns.
PY 2009
VL 20
IS 3
BP 225
EP 234
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medical
   Ethics; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Medical
   Ethics; Research & Experimental Medicine
GA 505EC
UT WOS:000270670900003
PM 19852428
DA 2020-12-16
ER

PT J
AU Machado, FB
   Medina-Acosta, E
AF Machado, F. B.
   Medina-Acosta, E.
TI High-resolution combined linkage physical map of short tandem repeat
   loci on human chromosome band Xq28 for indirect haemophilia A carrier
   detection
SO HAEMOPHILIA
LA English
DT Article
DE F8 gene; haemophilia A; microsatellite; polymorphism; short tandem
   repeat; Xq28
ID FACTOR-VIII GENE; DINUCLEOTIDE-REPEAT; POLYMORPHIC MARKERS;
   PRENATAL-DIAGNOSIS; MOLECULAR-BASIS; IDENTIFICATION
AB Haemophilia A, the most common severe hereditary bleeding disorder in humans, is chiefly caused by mutations in the coagulation factor VIII F8 gene, which maps on chromosome band Xq28. Linkage analysis with F8 intragenic and/or closely located extragenic short tandem repeat (STR) elements is an effective method for indirect tracing of F8 pathogenic allelic variants in at-risk families. STR profiling is currently limited to 14 markers, 11 of which are dinucleotide elements. The aim of this study was to define novel polymorphic STR loci for haemophilia A carrier screening. The combined linkage physical map was restricted to a 2.4-Mb region on Xq28 that hosts 81 annotated genes, F8 inclusive. The inventory was in silico through comparative analyses with three X chromosome reference sequences, using microsatellite mining and validation computer software. Genetic distances for unmapped markers were interpolated on the Rutgers map of the human genome. The effort yielded 94 STR loci: 53 extragenic and 41 intragenic (14 STR elements map on the F8 gene; the other 27 on 19 further genes). The distribution per repeat period size was 61.7% di-, 5.3% tri-, 26.6% tetra- and 6.4% pentanucleotide loci. The success rate of validation of polymorphism for the new STR loci was 56.3%. For STR elements 0.78 Mb equidistant of the F8 gene, the interpolated downstream genetic length is 3.27 times the upstream genetic length. The inventory represents a 5.7-fold increase in polymorphic STR loci useful in carrier detection. Genotyping with the upstream extragenic tetra- and pentanucleotide markers is thus apprized.
C1 [Medina-Acosta, E.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Biotechnol Lab, Nucleo Diagnost & Invest, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Machado, F. B.] Hosp Escola Alvaro, Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Biotechnol Lab, Nucleo Diagnost & Invest, Ave Alberto Lamego 2000,Parque Calif, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU Universidade Estadual do Norte Fluminense Darcy Ribeiro; Fundacao
   Benedito Pereira Nunes (FBPN); Hospital Escola Alvaro Alvim (HEAA);
   FBPN/HEAA
FX This work was supported by a Cooperative Agreement n<SUP>o</SUP> 020
   between the Universidade Estadual do Norte Fluminense Darcy Ribeiro, the
   Fundacao Benedito Pereira Nunes (FBPN) and the Hospital Escola Alvaro
   Alvim (HEAA). E M-A is a recipient of a research fellowship from the
   FBPN/HEAA.
CR Bacher J, 1998, PROFILES DNA, V2, P3
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x
   Chowdhury MR, 2000, HAEMOPHILIA, V6, P625, DOI 10.1046/j.1365-2516.2000.00442.x
   Collins JR, 2003, GENOMICS, V82, P10, DOI 10.1016/S0888-7543(03)00076-4
   Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2
   Dangerfield BTF, 1997, BRIT J HAEMATOL, V97, P558, DOI 10.1046/j.1365-2141.1997.892905.x
   Dardik R, 1996, HAEMOPHILIA, V2, P11, DOI 10.1111/j.1365-2516.1996.tb00003.x
   De Carvalho FM, 2007, HAEMOPHILIA, V13, P409, DOI 10.1111/j.1365-2516.2007.01475.x
   de Stahl TD, 2008, HUM MUTAT, V29, P398, DOI 10.1002/humu.20659
   El-Maarri O, 2006, BLOOD, V107, P2759, DOI 10.1182/blood-2005-09-3702
   Fang Y, 2006, HAEMOPHILIA, V12, P62, DOI 10.1111/j.1365-2516.2005.01162.x
   Giardina E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-457
   Gigarel N, 2004, HUM GENET, V114, P298, DOI 10.1007/s00439-003-1063-9
   GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0
   Goodeve AC, 2003, SEMIN THROMB HEMOST, V29, P23, DOI 10.1055/s-2003-37936
   Harraway JR, 2006, J THROMB HAEMOST, V4, P587, DOI 10.1111/j.1538-7836.2006.01790.x
   Jarjanazi H, 1998, BRIT J HAEMATOL, V100, P589, DOI 10.1046/j.1365-2141.1998.00588.x
   Jayandharan G, 2004, HAEMOPHILIA, V10, P553, DOI 10.1111/j.1365-2516.2004.00908.x
   KEMBALLCOOK G, 2005, STRUCTURE TEST RESOU
   Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234
   Kim JW, 2005, HAEMOPHILIA, V11, P38, DOI 10.1111/j.1365-2516.2005.01064.x
   KOCHHAN L, 1994, BLOOD COAGUL FIBRIN, V5, P497
   LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S
   LALLOZ MRA, 1994, BRIT J HAEMATOL, V86, P804
   Laurie AD, 2007, HAEMOPHILIA, V13, P420, DOI 10.1111/j.1365-2516.2007.01487.x
   Lin SR, 2000, BRIT J HAEMATOL, V111, P1256, DOI 10.1046/j.1365-2141.2000.02490.x
   Machado FB, 2008, HAEMOPHILIA, V14, P849, DOI 10.1111/j.1365-2516.2008.01768.x
   Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307
   Oldenburg J, 2004, HAEMOPHILIA, V10, P133, DOI 10.1111/j.1365-2516.2004.01005.x
   Pandey GS, 2002, INT J MOL MED, V10, P661
   Rabbani B, 2007, HAEMOPHILIA, V13, P740, DOI 10.1111/j.1365-2516.2007.01471.x
   Saha A, 2007, HAEMATOLOGICA, V92, P1725, DOI 10.3324/haematol.11545
   Sanchez-Garcia JF, 2005, THROMB HAEMOSTASIS, V94, P1099, DOI 10.1160/TH05-05-0360
   Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013
   Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178
   Soares RPS, 2001, HAEMOPHILIA, V7, P299, DOI 10.1046/j.1365-2516.2001.00508.x
   Surin V L, 2007, Genetika, V43, P831
   TANTRAVAHI U, 1986, CYTOGENET CELL GENET, V42, P75, DOI 10.1159/000132255
   Tizzano E, 2005, HAEMOPHILIA, V11, P142, DOI 10.1111/j.1365-2516.2005.01071.x
   Vencesla A, 2008, HAEMOPHILIA, V14, P489, DOI 10.1111/j.1365-2516.2008.01698.x
   WINDSOR S, 1994, BRIT J HAEMATOL, V86, P810, DOI 10.1111/j.1365-2141.1994.tb04834.x
   YIP B, 1994, BRIT J HAEMATOL, V88, P889, DOI 10.1111/j.1365-2141.1994.tb05134.x
NR 43
TC 17
Z9 17
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD JAN
PY 2009
VL 15
IS 1
BP 297
EP 308
DI 10.1111/j.1365-2516.2008.01866.x
PG 12
WC Hematology
SC Hematology
GA 394TK
UT WOS:000262470600039
PM 18752533
DA 2020-12-16
ER

PT J
AU Machado, FB
   Medina-Acosta, E
AF Machado, F. B.
   Medina-Acosta, E.
TI An IKBKG, and not a G6PD, short tandem repeat marker is used in indirect
   diagnosis of haemophilia A
SO HAEMOPHILIA
LA English
DT Letter
C1 [Machado, F. B.] Hosp Escola Alvaro Alvim, Campos Dos Goytacazes, RJ, Brazil.
   [Machado, F. B.; Medina-Acosta, E.] Univ Estadual Norte Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Nucl Diagnost & Invest Mol & Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Avenida Alberto Lamego 2000, BR-29013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Machado, Filipe/G-5497-2012; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Fang Y, 2006, HAEMOPHILIA, V12, P62, DOI 10.1111/j.1365-2516.2005.01162.x
   Gigarel N, 2004, HUM GENET, V114, P298, DOI 10.1007/s00439-003-1063-9
   Smahi A, 2000, NATURE, V405, P466
NR 3
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-8216
EI 1365-2516
J9 HAEMOPHILIA
JI Haemophilia
PD JUL
PY 2008
VL 14
IS 4
BP 849
EP 850
DI 10.1111/j.1365-2516.2008.01768.x
PG 2
WC Hematology
SC Hematology
GA 328JJ
UT WOS:000257794400028
PM 18510566
DA 2020-12-16
ER

PT J
AU Uhl, MVD
   Bottecchia, RJ
   Azevedo-Silva, J
   Antonio, DL
   Vieira-Da-Motta, O
   Mittmann, J
   Ribeiro, PD
   Fernandes, RCD
   Tavora, N
   Medina-Acosta, E
AF Uhl, MVD
   Bottecchia, RJ
   Azevedo-Silva, J
   Antonio, DL
   Vieira-Da-Motta, O
   Mittmann, J
   Ribeiro, PD
   Fernandes, RCD
   Tavora, N
   Medina-Acosta, E
TI Suitability of a recombinant Staphylococcus aureus enterotoxin C bovine
   variant for immunodiagnostics and therapeutic vaccine development
SO VACCINE
LA English
DT Article
DE countermeasure; diagnosis; enterotoxin; vaccination; therapy
ID MONOCLONAL-ANTIBODY; POLYACRYLAMIDE-GELS; MURINE MODEL; MOUSE MODEL;
   TOXIN; RECEPTOR; SHOCK; MICE; SUPERANTIGENS; PURIFICATION
AB Recombinant bovine variant of staphylococcal enterotoxin C (SECbovine), produced as a NH2-terminal histidine hexamer fusion protein (His(6)-tagged SECbovine), expressed at high levels (25%) in Escherichia coli and affinity purified to homogeneity (99.9%), was tested for its diagnostic and therapeutic potentials. His(6)-tagged SECbovine is antigenically authentic to native SECbovine across host species, as confirmed by antibody-based capture detection assays using human, mouse, rabbit and chicken hyperimmune sera. His6-tagged SECbmiw showed significant T-cell stimulation activity in vitro. His6-tagged SECbovine was immunogenic for IgG in mice (intragastric and intravenous routes) and rabbits (intramuscular and subcutaneous routes), dispensing immunoadjuvant coadministration. The formation of neutralizing antibodies reduced the severity of intoxication symptoms in immunized rabbits. Purified anti-recombinant SECbovine e rabbit polyclonal IgG neutralized the pyrexic and diarrhoeagenic effects of native SEC/SED and recombinant SEC, tested by the kitten and rabbit bioassays, respectively. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Estadual Norte Fluminense Darcy Ribeiro, Lab Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   Univ Estadual Norte Fluminense Darcy Ribeiro, Lab Sanidade Anim, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   Univ Estadual Norte Fluminense Darcy Ribeiro, Lab Biol Reconhecer, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   Hosp Estadul Ferreira Machado, BR-28051170 Campos Dos Goytacazes, RJ, Brazil.
   Hosp Escola Alvaro Alvim, BR-28035010 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro, Lab Biotecnol, Avenida Alberto Lamego 2000,Pk Calif, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM enrique@medina-acosta.com
RI Vieira-da-Motta, Olney/U-7146-2019; Mittmann, Josane/G-9704-2012;
   Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR ALBER G, 1990, J IMMUNOL, V144, P4501
   Anderson MR, 2001, CLIN IMMUNOL, V98, P85, DOI 10.1006/clim.2000.4960
   Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9
   Bavari S, 1996, J INFECT DIS, V174, P338, DOI 10.1093/infdis/174.2.338
   Bhatti AR, 1996, MICROBIOS, V86, P247
   BOHACH GA, 1988, INFECT IMMUN, V56, P400, DOI 10.1128/IAI.56.2.400-404.1988
   Chi YI, 2002, J BIOL CHEM, V277, P22839, DOI 10.1074/jbc.M201932200
   CLARK WG, 1968, J BACTERIOL, V96, P1940, DOI 10.1128/JB.96.6.1940-1946.1968
   EDWIN C, 1986, APPL ENVIRON MICROB, V52, P1247, DOI 10.1128/AEM.52.6.1247-1252.1986
   Fierabracci A, 1999, J AUTOIMMUN, V12, P305, DOI 10.1006/jaut.1999.0279
   Flores VMQ, 2002, PROTEIN EXPRES PURIF, V25, P16, DOI 10.1006/prep.2001.1604
   GIRARD AE, 1995, ANTIMICROB AGENTS CH, V39, P2210, DOI 10.1128/AAC.39.10.2210
   GROSSMAN D, 1991, J IMMUNOL, V147, P3274
   Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003
   HU YC, 1997, J FOOD PROTECT, V60, P195
   Jain RK, 2002, BIOCHEM J, V368, P605, DOI 10.1042/BJ20021195
   Kaempfer R, 2002, ISR MED ASSOC J, V4, P520
   Krarup A, 1999, LAB ANIM SCI, V49, P545
   Kum WWS, 2001, J INFECT DIS, V183, P1739, DOI 10.1086/320732
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Le Loir Yves, 2003, Genet Mol Res, V2, P63
   Lesieur C, 1999, J BIOL CHEM, V274, P36722, DOI 10.1074/jbc.274.51.36722
   LIGNON GB, 2000, COMMUNICADO TECNICO, V41, P2
   Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0
   LONDON E, 1992, MOL MICROBIOL, V6, P3277, DOI 10.1111/j.1365-2958.1992.tb02195.x
   Lowell GH, 1996, INFECT IMMUN, V64, P4686, DOI 10.1128/IAI.64.11.4686-4693.1996
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   Monday S.R., 1999, COMPREHENSIVE SOURCE, P589
   MORRISON DC, 1990, J INFECT DIS, V162, P1063, DOI 10.1093/infdis/162.5.1063
   Pang LTY, 2000, INFECT IMMUN, V68, P3261, DOI 10.1128/IAI.68.6.3261-3268.2000
   PETERSON EM, 1981, AM J MED TECHNOL, V47, P905
   RECK B, 1988, P NATL ACAD SCI USA, V85, P3170, DOI 10.1073/pnas.85.9.3170
   REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6
   Retamal CA, 1999, ANAL BIOCHEM, V268, P15, DOI 10.1006/abio.1998.2977
   ROBBINS R, 1974, APPL MICROBIOL, V28, P946, DOI 10.1128/AEM.28.6.946-950.1974
   SCHWARCZ SK, 1990, JAMA-J AM MED ASSOC, V264, P1413, DOI 10.1001/jama.264.11.1413
   Sero L, 1975, J Biol Chem, V250, P5026
   SPERO L, 1975, INFECT IMMUN, V12, P1018, DOI 10.1128/IAI.12.5.1018-1020.1975
   STELMA GN, 1982, BIOCHEM BIOPH RES CO, V105, P121, DOI 10.1016/S0006-291X(82)80019-3
   Stiles BG, 2001, INFECT IMMUN, V69, P2031, DOI 10.1128/IAI.69.4.2031-2036.2001
   SUGIYAMA H, 1966, P SOC EXP BIOL MED, V121, P278, DOI 10.3181/00379727-121-30758
   Tenover FC, 2000, GRAM-POSITIVE PATHOGENS, P414
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Ulrich RG, 1998, VACCINE, V16, P1857, DOI 10.1016/S0264-410X(98)00176-5
   Vieira-da-Motta O, 2001, PEPTIDES, V22, P1621, DOI 10.1016/S0196-9781(01)00497-1
   VIEIRADAMOTTA O, 2002, THESIS U ESTADUAL NO
   WATSON JW, 1995, BRIT J PHARMACOL, V115, P84, DOI 10.1111/j.1476-5381.1995.tb16324.x
   Woody MA, 1997, VACCINE, V15, P133, DOI 10.1016/S0264-410X(96)00166-1
   Wright A, 2000, INFECT IMMUN, V68, P2386, DOI 10.1128/IAI.68.4.2386-2389.2000
   Yin T, 1999, WORLD J GASTROENTERO, V5, P209
NR 50
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 22
PY 2004
VL 22
IS 31-32
BP 4191
EP 4202
DI 10.1016/j.vaccine.2004.05.004
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 866FC
UT WOS:000224758200009
PM 15474709
DA 2020-12-16
ER

PT J
AU Ribeiro, PD
   Medina-Acosta, E
AF Ribeiro, PD
   Medina-Acosta, E
TI Prevention of lethal murine candidiasis using HP (2-20), an
   antimicrobial peptide derived from the N-terminus of Helicobacter pylori
   ribosomal protein L1
SO PEPTIDES
LA English
DT Article
DE antibacterial peptide; antifungal peptide; antimicrobial peptide;
   candidiasis
ID RIBOSOMAL-PROTEIN L1; RESISTANCE; INFECTIONS; ALBICANS; PATHOGENESIS;
   MECHANISMS; VIRULENCE; STRAIN; DESIGN
AB Peptide HP (2-20), A(2)KKVFKRLEKLFSKIQNDK(20), is a cationic antimicrobial peptide derived from the N-terminus of Helicobacter pylori ribosomal protein 1, HpRpL1. Native peptide HP (2-20) and its synthetic derivatives have been shown in vitro to exhibit potent killing activity against Gram-positive, Gram-negative and yeast cells, thus, making them promising candidates for treatment of polymicrobial infections. However, the therapeutic potential of peptide HP (2-20) or its synthetic derivatives in any animal model of either bacterial or fungal diseases has not yet been investigated. In this study, we demonstrate that synthetic peptide amide HP (2-20), administered in six doses (300 jig each; one intraperitoneal dose at the time of the infection, followed by five intravenous doses at 12 h intervals) to CBA/J male mice experimentally infected with a lethal inoculum (1x10(9) CFU) of Candida albicans, delayed the onset of disease, suppressed disease progression, and greatly increased survival rate and time (16.6% by day 14), as compared with the untreated infected control mice (100% mortality by day 5). Further, using isotonic buffer systems differing in ionic strength, peptide HP (2-20) was shown in vitro to exhibit an ionic strength-dependent hemolytic activity, previously not detected. Repeated intravenous administration of uninfected control CBA/J male mice with peptide HP (2-20), however, caused neither morbidity nor mortality. These findings strongly evidence the therapeutic efficacy and safety values of peptide HP (2-20) as a lead drug for the treatment of acquired candidiasis. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Estadual Norte Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Lab Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Lab Biotecnol, Avenida Alberto Lamego 2000, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM enrique@medina-acosta.com
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Arendrup M, 2002, INFECTION, V30, P286, DOI 10.1007/s15010-002-2131-0
   ASHMAN RB, 1988, IMMUNOL CELL BIOL, V66, P231, DOI 10.1038/icb.1988.29
   Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7
   Coast J, 2003, DRUG DISCOV TODAY, V8, P1, DOI 10.1016/S1359-6446(02)02542-4
   Colombo A L, 2000, Braz J Infect Dis, V4, P113
   De Lucca AJ, 1999, ANTIMICROB AGENTS CH, V43, P371, DOI 10.1128/AAC.43.2.371
   Dixon DM, 1996, PUBLIC HEALTH REP, V111, P226
   Ellis D, 2002, J ANTIMICROB CHEMOTH, V49, P1
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Gov Y, 2001, PEPTIDES, V22, P1609, DOI 10.1016/S0196-9781(01)00496-X
   Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000
   Haynes K, 2001, TRENDS MICROBIOL, V9, P591, DOI 10.1016/S0966-842X(01)02237-5
   Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1
   Koczulla AR, 2003, DRUGS, V63, P389, DOI 10.2165/00003495-200363040-00005
   KOLOTILA MP, 1987, J MED VET MYCOL, V25, P283
   Kullberg BJ, 2002, EUR J MED RES, V7, P183
   Lee DG, 2002, BBA-PROTEINS PROTEOM, V1598, P185, DOI 10.1016/S0167-4838(02)00373-4
   Lee DG, 2002, BIOCHEM BIOPH RES CO, V291, P1006, DOI 10.1006/bbrc.2002.6548
   Lee DG, 2002, J PEPT SCI, V8, P453, DOI 10.1002/psc.405
   Lupetti A, 2002, EXPERT OPIN INV DRUG, V11, P309, DOI 10.1517/13543784.11.2.309
   Martin MV, 1999, J ANTIMICROB CHEMOTH, V44, P429, DOI 10.1093/jac/44.4.429
   Muller R J, 2001, Oncology (Williston Park), V15, P21
   Oh JE, 1999, J PEPT RES, V54, P129, DOI 10.1034/j.1399-3011.1999.00094.x
   PAPADIMITRIOU JM, 1986, J PATHOL, V150, P257, DOI 10.1002/path.1711500405
   Pulimood S, 2002, DIAGN MICR INFEC DIS, V44, P353, DOI 10.1016/S0732-8893(02)00460-1
   Putsep K, 1999, NATURE, V398, P671, DOI 10.1038/19439
   Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0
   Singh N, 2001, CLIN MICROBIOL INFEC, V7, P1, DOI 10.1111/j.1469-0691.2001.tb00004.x
   Soll DR, 2002, ACTA TROP, V81, P101, DOI 10.1016/S0001-706X(01)00200-5
   World Health Organization, 2001, WHO GLOB STRAT CONT
NR 30
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-9781
EI 1873-5169
J9 PEPTIDES
JI Peptides
PD NOV
PY 2003
VL 24
IS 11
BP 1807
EP 1814
DI 10.1016/j.peptides.2003.08.021
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
GA 776HN
UT WOS:000189110700019
PM 15019213
DA 2020-12-16
ER

PT J
AU Ribeiro, PD
   Ribeiro, OD
   Marcolan, AM
   Medina-Acosta, E
AF Ribeiro, PD
   Ribeiro, OD
   Marcolan, AM
   Medina-Acosta, E
TI Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in
   acquired Staphylococcus aureus sepsis: a histopathological assessment
SO PEPTIDES
LA English
DT Article
DE quorum-sensing; RNAIII-inhibiting peptide; therapeutic peptide;
   Staphylococcus-induced histopathology
ID RECEPTOR-HISTIDINE KINASE; GLOBAL INHIBITOR; VIRULENCE; RIP;
   PATHOGENESIS; PREVENTION; BIOFILM; TARGET; MODEL; LOCUS
AB The quorum-sensing interfering RNAIII-inhibiting peptide (RIP) YSPXTNF and its synthetic analogues YSPWTNF and YSPITNF have been shown to prevent and suppress diseases caused by Staphylococcus aureus at different body sites in different animal models. This study was designed to investigate histopathologically the therapeutic efficacy of lead peptide RIP YSPWTNF-NH2 in the subcutaneous air sac murine model of acquired S. aureus sepsis. Two experimental protocols were evaluated: an infection/therapy protocol, for which twenty BALB/c mice per group were infected with a subcutaneous inoculum of S. aureus strain ATCC 25923 (2x10(9) colony forming units) that were either pretreated or not with 150 mug of peptide RIP, and a safety protocol, for which three uninfected mice per group received treatment with either 150 mug of peptide RIP or saline. Therapeutic efficacy was assessed by clinical examination for a period of 20 days and histopathology at 12, 24, 36, 48, 96 and 168 h after inoculation. Treatment safety was assessed histopathologically at 24, 48 and 264 h after inoculation. Subcutaneous administration of uninfected control mice with a single dose of peptide RIP YSPWTNF caused no significant histopathology in most organs examined, except for slight to moderate lung and liver congestions. In contrast to the situation with the untreated infected control group mice that presented with histopathological alterations consistent with the diagnosis of rapidly progressive and highly erosive disease (100% mortality by day 3), treatment of infected animals with peptide RIP YSPWTNF had a profound therapeutic effect on survival rate (67% by day 20) and on disease progression. The histopathological examination confirmed the clinical findings showing that extensive tissue damage at the site of the infection and in organs were greatly suppressed in the peptide RIP-treated animals. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Estadual Norte Fluminense Darcy Ribeiro, Lab Biotecnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   Inst Patol Passo Fundo, BR-99010901 Passo Fundo, RS, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro, Lab Biotecnol, Avenida Lamego 2000, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM enrique@medina-acosta.com
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Balaban N, 2000, PEPTIDES, V21, P1301, DOI 10.1016/S0196-9781(00)00272-2
   Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879
   Balaban N, 2003, KIDNEY INT, V63, P340, DOI 10.1046/j.1523-1755.2003.00733.x
   BALABAN N, 1995, P NATL ACAD SCI USA, V92, P1619, DOI 10.1073/pnas.92.5.1619
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200
   Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9
   Bayer MG, 1996, J BACTERIOL, V178, P4563, DOI 10.1128/jb.178.15.4563-4570.1996
   BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992
   Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000
   Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469
   Gov Y, 2001, PEPTIDES, V22, P1609, DOI 10.1016/S0196-9781(01)00496-X
   Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1
   Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Lichtenberg J, 1999, PHARMACOL TOXICOL, V84, P34, DOI 10.1111/j.1600-0773.1999.tb02108.x
   Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330
   Lyon GJ, 2002, BIOCHEMISTRY-US, V41, P10095, DOI 10.1021/bi026049u
   Lyon GJ, 2002, J BIOL CHEM, V277, P6247, DOI 10.1074/jbc.M109989200
   Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645
   NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x
   PORTLOCK SH, 1990, BIOCHIM BIOPHYS ACTA, V1030, P1, DOI 10.1016/0005-2736(90)90231-C
   SABERWAL G, 1994, BBA-REV BIOMEMBRANES, V1197, P109, DOI 10.1016/0304-4157(94)90002-7
   Vieira-da-Motta O, 2001, PEPTIDES, V22, P1621, DOI 10.1016/S0196-9781(01)00497-1
   Yau YH, 2001, ANTIMICROB AGENTS CH, V45, P2820, DOI 10.1128/AAC.45.10.2820-2825.2001
NR 27
TC 11
Z9 13
U1 3
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-9781
EI 1873-5169
J9 PEPTIDES
JI Peptides
PD NOV
PY 2003
VL 24
IS 11
BP 1829
EP 1836
DI 10.1016/j.peptides.2003.08.022
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
GA 776HN
UT WOS:000189110700022
PM 15019216
DA 2020-12-16
ER

PT J
AU de Almeida, CMC
   Quintana-Flores, VM
   Medina-Acosta, E
   Schriefer, A
   Barral-Netto, M
   da Silva, WD
AF de Almeida, CMC
   Quintana-Flores, VM
   Medina-Acosta, E
   Schriefer, A
   Barral-Netto, M
   da Silva, WD
TI Egg yolk anti-BfpA antibodies as a tool for recognizing and identifying
   enteropathogenic Escherichia coli
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID BUNDLE-FORMING PILUS; LOCALIZED ADHERENCE; CHILDHOOD DIARRHEA; CLASSIC
   SEROTYPES; HELA-CELLS; EXPRESSION; PURIFICATION; INFANTS;
   IMMUNOGLOBULINS; EPIDEMIOLOGY
AB Enteropathogenic Escherichia coli (EPEC) is a major aetiological agent of childhood diarrhoea in developing countries. The structural repeating protein A subunit, BfpA, found in the bundle-forming pilus, is one of the virulent factors for EPEC pathogenesis. Recombinant BfpA in laying hens elicited sustained and vigorous antibody production. Immunoglobulin Y (IgY) anti-BfpA antibodies were recovered from egg yolk, purified and characterized. Immunoadsorption with whole extracts of the isogenic E. coli EPEC adherence factor (EAF) strain that lacks BfpA rendered the resulting IgY preparations capable of: (a) recognizing purified or recombinant BfpA proteins in a dose-dependent fashion; (b) blocking the colonization of HeLa cells by EPEC EAF(+) , in vitro ; (c) specifically identifying E. coli bearing EAF(+) ; and (d) inhibiting the growth of E. coli EAF(+) but not the EAF strain. IgY anti-BfpA is potentially useful as a specific, low-cost immunobiological reagent to screen human faecal specimens for the presence of EPEC.
C1 Univ Estadual Norte Fluminense, Lab Biol Reconhecer, Ctr Biociencias & Biotecnol, BR-28013600 Rio De Janeiro, Brazil.
   Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgar Santos, Salvador, BA, Brazil.
   Ctr Pesquisas Goncalo Moniz, LIMI, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
RP da Silva, WD (corresponding author), Univ Estadual Norte Fluminense, Lab Biol Reconhecer, Ctr Biociencias & Biotecnol, Ave Alberto Lamego 2000,Campos Goytacazes, BR-28013600 Rio De Janeiro, Brazil.
RI Medina-Acosta, Enrique/G-3041-2010; Barral-Netto, Manoel/B-3904-2009
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Barral-Netto,
   Manoel/0000-0002-5823-7903
CR AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x
   Almeida CMC, 1998, VET REC, V143, P579, DOI 10.1136/vr.143.21.579
   BAILEY JL, 1967, TECHNIQUES PROTEIN C, P341
   BLACK RE, 1993, VACCINE, V11, P100, DOI 10.1016/0264-410X(93)90002-F
   Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961
   COBELJIC M, 1989, EPIDEMIOL INFECT, V103, P53, DOI 10.1017/S0950268800030351
   COLIGAN JE, 1997, CURRENT PROTOCOLS IM, pCH2
   CRAVIOTO A, 1991, LANCET, V337, P262, DOI 10.1016/0140-6736(91)90868-P
   CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439
   DINNENBERG MS, 1992, INFECT IMMUN, V67, P25
   DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x
   Flores VMQ, 2002, PROTEIN EXPRES PURIF, V25, P16, DOI 10.1006/prep.2001.1604
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   GOMES TAT, 1989, J CLIN MICROBIOL, V27, P266, DOI 10.1128/JCM.27.2.266-269.1989
   GOMES TAT, 1991, J INFECT DIS, V164, P331, DOI 10.1093/infdis/164.2.331
   HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7
   KAIN KC, 1991, J CLIN MICROBIOL, V29, P90, DOI 10.1128/JCM.29.1.90-95.1991
   KNUTTON S, 1987, INFECT IMMUN, V55, P78, DOI 10.1128/IAI.55.1.78-85.1987
   LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550
   LEVINE MM, 1984, EPIDEMIOL REV, V6, P31, DOI 10.1093/oxfordjournals.epirev.a036274
   LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANGIA AHR, 1993, J TROP PEDIATRICS, V39, P365, DOI 10.1093/tropej/39.6.365
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   NATARO JP, 1985, INFECT IMMUN, V48, P378, DOI 10.1128/IAI.48.2.378-383.1985
   NATARO JP, 1987, INFECT IMMUN, V55, P2370, DOI 10.1128/IAI.55.10.2370-2377.1987
   NETER E, 1955, PEDIATRICS, V16, P801
   POLSON A, 1985, IMMUNOL INVEST, V14, P323, DOI 10.3109/08820138509022667
   Remfry J., 1987, LAB ANIMALS INTRO NE, P5
   RILEY LW, 1987, INFECT IMMUN, V55, P2052, DOI 10.1128/IAI.55.9.2052-2056.1987
   ROTHBAUM RJ, 1983, ULTRASTRUCT PATHOL, V4, P291, DOI 10.3109/01913128309140582
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984
   Schriefer A, 1999, VACCINE, V17, P770, DOI 10.1016/S0264-410X(98)00261-8
   SENERWA D, 1989, J CLIN MICROBIOL, V27, P1307, DOI 10.1128/JCM.27.6.1307-1311.1989
   SOHEL I, 1993, MOL MICROBIOL, V7, P563, DOI 10.1111/j.1365-2958.1993.tb01147.x
   STEINER LA, 1967, J EXP MED, V126, P1161, DOI 10.1084/jem.126.6.1161
   STEINER LA, 1967, J EXP MED, V126, P1185, DOI 10.1084/jem.126.6.1185
   Thoren A, 1983, Scand J Infect Dis Suppl, V37, P1
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385
   ULSHEN MH, 1980, NEW ENGL J MED, V302, P99, DOI 10.1056/NEJM198001103020207
   VUOPIOVARKILA J, 1991, J EXP MED, V174, P1167, DOI 10.1084/jem.174.5.1167
NR 43
TC 11
Z9 13
U1 0
U2 0
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0300-9475
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD JUN
PY 2003
VL 57
IS 6
BP 573
EP 582
DI 10.1046/j.1365-3083.2003.01243.x
PG 10
WC Immunology
SC Immunology
GA 687GJ
UT WOS:000183367900010
PM 12791096
OA Bronze, Green Published
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Flores, VMQ
   de Macedo, ZS
   Medina-Acosta, E
AF Fernandes, RCDC
   Flores, VMQ
   de Macedo, ZS
   Medina-Acosta, E
TI Coproantibodies to the enteropathogenic Escherichia coli vaccine
   candidates BfpA and EspB in breastfed and artificially fed children
SO VACCINE
LA English
DT Article
DE BfpA; diarrhea; EPEC; EspB
ID BUNDLE-FORMING PILUS; SECRETORY IMMUNOGLOBULIN-A; OUTER-MEMBRANE
   PROTEINS; EARLY-LIFE VACCINOLOGY; HUMAN COLOSTRUM; HEP-2 CELLS;
   VIRULENCE DETERMINANTS; EPEC ADHERENCE; HELA-CELLS; MILK
AB A diagnostic test was developed to discriminate active from past enteropathogenic Escherichia coli (EPEC) infection, which uses the affinity-purified recombinant proteins BfpA (bundle-forming pilus (BFP) structural repeating subunit A) and EspB (pore-forming secreted protein B) as reliable markers of virulence to detect antigen-specific coproantibodies by immunoblot analysis, and verification of active typical EPEC infection by gene-specific (bfpA and espB) PCR amplification using DNA extracted directly from specimens and/or culture-enriched preparations. To begin addressing the potential protective role of anti-EPEC antibodies at early age, the prevalence of IgA coproantibodies to these antigens was determined in either breastfed or artificially fed children <2 years of age hospitalized for watery diarrhea. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Lab Biotechnol, Microbial Biotechnol Sect, BR-28013600 Campos Dos Goytacazes, RJ, Brazil.
   Univ Fed Rio de Janeiro, Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil.
   Hosp Estadual Ferreira Machado, Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Lab Biotechnol, Microbial Biotechnol Sect, Avenida Lamego 2000, BR-28013600 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR CAMARA LM, 1995, ADV EXP MED BIOL, V371, P673
   Carbonare SB, 1996, J DIARRHOEAL DIS RES, V14, P90
   Clemens J, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e3
   Corthesy B, 1999, BIOL CHEM, V380, P1251, DOI 10.1515/BC.1999.160
   COSTACARVALHO BT, 1994, ACTA PAEDIATR, V83, P870, DOI 10.1111/j.1651-2227.1994.tb13160.x
   CRAVIOTO A, 1991, J INFECT DIS, V163, P1247, DOI 10.1093/infdis/163.6.1247
   da Silva JV, 2002, VACCINE, V20, P2091, DOI 10.1016/S0264-410X(02)00057-9
   de Andrade J A, 1999, Rev Assoc Med Bras (1992), V45, P121
   Delneri MT, 1997, EUR J PEDIATR, V156, P493, DOI 10.1007/s004310050646
   FIGUEROA G, 1983, J HYG-CAMBRIDGE, V91, P499, DOI 10.1017/S002217240006054X
   Flores VMQ, 2002, PROTEIN EXPRES PURIF, V25, P16, DOI 10.1006/prep.2001.1604
   GIRON JA, 1993, J INFECT DIS, V168, P1037, DOI 10.1093/infdis/168.4.1037
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4
   KAPER JB, 1999, PATHOGENICITY ISLAND, P33
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lakritz J, 2000, AM J VET RES, V61, P1021, DOI 10.2460/ajvr.2000.61.1021
   Loureiro I, 1998, J PEDIATR GASTR NUTR, V27, P166, DOI 10.1097/00005176-199808000-00007
   Manjarrez-Hernandez HA, 2000, INFECT IMMUN, V68, P5030, DOI 10.1128/IAI.68.9.5030-5036.2000
   Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403
   Palma Domingos, 1997, Arquivos de Gastroenterologia, V34, P186
   Parissi-Crivelli A, 2000, J CLIN MICROBIOL, V38, P2696, DOI 10.1128/JCM.38.7.2696-2700.2000
   Pelayo JS, 1999, J MED MICROBIOL, V48, P41, DOI 10.1099/00222615-48-1-41
   Quiroga Marina, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P9, DOI 10.1590/S0036-46652000000100002
   RILEY LW, 1987, INFECT IMMUN, V55, P2052, DOI 10.1128/IAI.55.9.2052-2056.1987
   Rosa ACP, 1998, J MED MICROBIOL, V47, P781, DOI 10.1099/00222615-47-9-781
   ROWLAND MGM, 1980, J HYG-CAMBRIDGE, V85, P405, DOI 10.1017/S0022172400063476
   Sambrook J., 1989, MOL CLONING LAB MANU, V3
   Sanches MI, 2000, J PEDIATR GASTR NUTR, V30, P73, DOI 10.1097/00005176-200001000-00021
   Schriefer A, 1999, VACCINE, V17, P770, DOI 10.1016/S0264-410X(98)00261-8
   Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7
   Stinear TP, 2001, LANCET, V357, P855, DOI 10.1016/S0140-6736(00)04206-9
   Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x
   Tacket CO, 2000, INFECT IMMUN, V68, P3689, DOI 10.1128/IAI.68.6.3689-3695.2000
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821
NR 38
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 2
PY 2003
VL 21
IS 15
BP 1725
EP 1731
AR PII S0264-410X(02)00525-X
DI 10.1016/S0264-410X(02)00525-X
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 663LX
UT WOS:000182008000021
PM 12639496
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Flores, VMQ
   Medina-Acosta, E
AF Fernandes, RCDC
   Flores, VMQ
   Medina-Acosta, E
TI Prevalent transfer of human colostral IgA antibody activity for the
   enteropathogenic Escherichia coli bundle-forming pilus structural
   repeating subunit A in neonates
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE colostral IgA; BfpA; EPEC; coproantibodies
ID BREAST-FED INFANT; HEP-2 CELLS; HUMAN-MILK; GASTROINTESTINAL-TRACT;
   HELA-CELLS; VIRULENCE; INHIBITION; ADHERENCE; ADHESION; PROTEINS
AB The frequency of IgA antibody activity to the structural protein subunit BfpA of the enteropathogenic Escherichia coli bundle-forming pilus was determined in 40 mother-infant pairs by immunoblot analysis using affinity purified recombinant BfpA to monitor for IgA in maternal colostrum and in feces of the neonates. Fecal samples were collected from exclusively breastfed term infants < 24-h after the first breastmilk feeding and colostral samples from their mothers. Infants were monitored prospectively with monthly visits to ascertain dietary practices and diarrheal illnesses. The percentage of colostral anti-BfpA IgA positive patients that were also coproantibody positive was 67.5%. The median duration of lactation was 108 days and the incidence of infantile diarrheal disease was 7.5%. Thus, colostral anti-BfpA IgA antibody activity survives passage through the gut of breastfed neonates, persisting in their feces. It is suggested that oral passive immunotherapy may be used to prevent and/or treat typical EPEC infection during infancy. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Univ Estadual Norte Fluminense Darcy Ribeiro, Campos Dos Goytacazes, Brazil.
   Fed Univ Rio de Janeiro, Rio De Janeiro, Brazil.
   Hosp Plantadores Cana, Campos Dos Goytacazes, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro, Campos Dos Goytacazes, Brazil.
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001
   Adu-Bobie J, 1998, INFECT IMMUN, V66, P5643, DOI 10.1128/IAI.66.12.5643-5649.1998
   Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114
   BLUM PM, 1981, PEDIATR RES, V15, P1256, DOI 10.1203/00006450-198109000-00006
   CAMARA LM, 1994, INT ARCH ALLERGY IMM, V103, P307, DOI 10.1159/000236645
   Carbonare SB, 1997, J DIARRHOEAL DIS RES, V15, P53
   Carbonare SB, 1996, J DIARRHOEAL DIS RES, V14, P90
   Clemens J, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e3
   CRAVIOTO A, 1991, J INFECT DIS, V163, P1247, DOI 10.1093/infdis/163.6.1247
   DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x
   Delneri MT, 1997, EUR J PEDIATR, V156, P493, DOI 10.1007/s004310050646
   FLORES VMQ, 2002, PROTEIN EXPRES PURIF, V20, P2091
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   Hanson LA, 1998, ANN ALLERG ASTHMA IM, V81, P523, DOI 10.1016/S1081-1206(10)62704-4
   HILPERT H, 1987, J INFECT DIS, V156, P158, DOI 10.1093/infdis/156.1.158
   Khursigara C, 2001, INFECT IMMUN, V69, P6573, DOI 10.1128/IAI.69.11.6573-6579.2001
   KITOKO PM, 2000, CAD SAUDE PUBLICA, V16, P111
   LIEBHABER M, 1977, J PEDIATR-US, V91, P897, DOI 10.1016/S0022-3476(77)80885-8
   Loureiro I, 1998, J PEDIATR GASTR NUTR, V27, P166, DOI 10.1097/00005176-199808000-00007
   Marques NM, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e66
   MELLANDER L, 1986, CLIN EXP IMMUNOL, V63, P555
   MIETENS C, 1979, EUR J PEDIATR, V132, P239, DOI 10.1007/BF00496847
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403
   Pacyna J, 2001, J PEDIATR GASTR NUTR, V32, P162, DOI 10.1097/00005176-200102000-00013
   Parissi-Crivelli A, 2000, J CLIN MICROBIOL, V38, P2696, DOI 10.1128/JCM.38.7.2696-2700.2000
   Passos MC, 2000, REV SAUDE PUBL, V34, P617, DOI 10.1590/S0034-89102000000600009
   Pelayo JS, 1999, J MED MICROBIOL, V48, P41, DOI 10.1099/00222615-48-1-41
   Sanches MI, 2000, J PEDIATR GASTR NUTR, V30, P73, DOI 10.1097/00005176-200001000-00021
   SILVA MLM, 1992, ACTA PAEDIATR, V81, P266, DOI 10.1111/j.1651-2227.1992.tb12219.x
   Sohel I, 1996, J BACTERIOL, V178, P2613, DOI 10.1128/jb.178.9.2613-2628.1996
   Tacket CO, 2000, INFECT IMMUN, V68, P3689, DOI 10.1128/IAI.68.6.3689-3695.2000
   Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821
NR 32
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD DEC
PY 2002
VL 44
IS 4
BP 331
EP 336
AR PII S0732-8893(02)00463-7
DI 10.1016/S0732-8893(02)00463-7
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 639VD
UT WOS:000180649300003
PM 12543537
DA 2020-12-16
ER

PT J
AU Fernandes, RCDC
   Flores, VMQ
   de Macedo, ZS
   Medina-Acosta, E
AF Fernandes, RCDC
   Flores, VMQ
   de Macedo, ZS
   Medina-Acosta, E
TI Antibody responsiveness to the enteropathogenic Escherichia coli
   bundle-forming pilus subunit A in lactating mothers and asymptomatic
   children
SO EUROPEAN JOURNAL OF PEDIATRICS
LA English
DT Article
DE bundle-forming pilus subunit A; colostrum; enteropathogenic Escherichia
   coli
ID HUMAN COLOSTRUM; BREAST-MILK; VIRULENCE DETERMINANTS; HEP-2 CELLS;
   HELA-CELLS; INHIBITION; SERUM; IMMUNOGLOBULIN; INFECTION; ADHESION
AB The objective of this study was to examine the antibody responsiveness to the bundle-forming pilus subunit A of enteropathogenic Escherichia coli in human colostrum (n = 36) and serum (n = 90) of paediatric ambulatory patients, 3-24 months of age. Affinity purified recombinant bundle-forming pilus subunit A was used in immunoblot analysis to detect antigen-specific serum immunoglobulins G and A, and colostrum immunoglobulin A. Circulating immunoglobulin G antibody activity to the bundle-forming pilus subunit A was readily detected in all children. The frequency of immunoglobulin A antibody activity to the bundle-forming pilus subunit A in serum was 83.3%. Immunoglobulin A antibody activity to the bundle-forming pilus subunit A was detected in 75% of colostrum samples. The high frequency of immunoglobulin A antibody activity to the bundle-forming pilus subunit A observed in serum reveals a predominance of typical enteropathogenic Escherichia coli priming/infection in the study population. Conclusion: these findings demonstrate that the bundle-forming pilus subunit A is immunogenic, for both immunoglobulins G and A, in both pregnant/lactating women and asymptomatic children.
C1 Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, BR-28015620 Campos Dos Goytacazes, RJ, Brazil.
   Hosp Plantadores Cana, Ctr Crianca & Adolescente, Campos Dos Goytacazes, RJ, Brazil.
   Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Avenida Alberto Lamego 2000, BR-28015620 Campos Dos Goytacazes, RJ, Brazil.
EM enrique@medina-acosta.com
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR BARROS HC, 1995, BRAZ J MED BIOL RES, V28, P83
   Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114
   COSTACARVALHO BT, 1994, ACTA PAEDIATR, V83, P870, DOI 10.1111/j.1651-2227.1994.tb13160.x
   CRAVIOTO A, 1991, J INFECT DIS, V163, P1247, DOI 10.1093/infdis/163.6.1247
   da Silva JV, 2002, VACCINE, V20, P2091, DOI 10.1016/S0264-410X(02)00057-9
   Delneri MT, 1997, EUR J PEDIATR, V156, P493, DOI 10.1007/s004310050646
   Donnenberg MS, 1998, INFECT IMMUN, V66, P52, DOI 10.1128/IAI.66.1.52-58.1998
   Flores VMQ, 2002, PROTEIN EXPRES PURIF, V25, P16, DOI 10.1006/prep.2001.1604
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   Loureiro I, 1998, J PEDIATR GASTR NUTR, V27, P166, DOI 10.1097/00005176-199808000-00007
   Manjarrez-Hernandez HA, 2000, INFECT IMMUN, V68, P5030, DOI 10.1128/IAI.68.9.5030-5036.2000
   Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403
   Parissi-Crivelli A, 2000, J CLIN MICROBIOL, V38, P2696, DOI 10.1128/JCM.38.7.2696-2700.2000
   Pelayo JS, 1999, J MED MICROBIOL, V48, P41, DOI 10.1099/00222615-48-1-41
   RILEY LW, 1987, INFECT IMMUN, V55, P2052, DOI 10.1128/IAI.55.9.2052-2056.1987
   Sanches MI, 2000, J PEDIATR GASTR NUTR, V30, P73, DOI 10.1097/00005176-200001000-00021
   Schriefer A, 1999, VACCINE, V17, P770, DOI 10.1016/S0264-410X(98)00261-8
   Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x
   Tacket CO, 2000, INFECT IMMUN, V68, P3689, DOI 10.1128/IAI.68.6.3689-3695.2000
NR 20
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6199
EI 1432-1076
J9 EUR J PEDIATR
JI Eur. J. Pediatr.
PD SEP
PY 2002
VL 161
IS 9
BP 471
EP 474
DI 10.1007/s00431-002-0995-8
PG 4
WC Pediatrics
SC Pediatrics
GA 598XY
UT WOS:000178303200001
PM 12200604
DA 2020-12-16
ER

PT J
AU Flores, VMQ
   Fernandes, RCCD
   de Macedo, ZS
   Medina-Acosta, E
AF Flores, VMQ
   Fernandes, RCCD
   de Macedo, ZS
   Medina-Acosta, E
TI Expression and purification of the recombinant enteropathogenic
   Escherichia coli vaccine candidates BfpA and EspB
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
ID BUNDLE-FORMING PILUS; HUMAN COLOSTRUM; VIRULENCE DETERMINANTS;
   POLYACRYLAMIDE-GELS; EPITHELIAL-CELLS; ADHERENCE FACTOR; ANTIBODIES;
   INFECTION; PROTEINS; GENE
AB BfpA, the structural repeating protein subunit A of the bundle-forming pilus and EspB, a type-III-secreted pore-forming protein of enteropathogenic Escherichia coli (EPEC), both virulence factors central for EPEC pathogenesis, were overexpressed in E. coli DH5alpha and M15 laboratory strains, respectively, using the pQE-30 cloning expression system, as chimeric fusions to a NH2-terminal histidine hexapeptide (His(6)-tag) sequence. After isopropyl,beta-D-thiogalactoside induction, the expression levels achieved were 11 and 40% of total soluble protein for BfpA and EspB, respectively. The His(6)-tagged recombinant proteins were purified (up to 98% homogeneity) by Ni-agarose affinity chromatography and produced yields varying from 0.65 to 3.1 mg of recombinant protein per gram of wet weight cells. The immunogenicity and antigenicity of the final products were tested in rabbits and using fecal specimens obtained from children suffering from acute watery diarrhea, respectively. The recombinant products correspond to antigenically authentic protein standards, useful in future epidemiological and neonatal vaccinology studies. (C) 2002 Elsevier Science (USA).
C1 Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, BR-28015620 Campos Dos Goytacazes, RJ, Brazil.
   Hosp Estadual Ferreira Machado, BR-28015620 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Ave Alberto Lamego 2000, BR-28015620 Campos Dos Goytacazes, RJ, Brazil.
EM enrique@medina.acosta.com
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001
   Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114
   DONNENBERG MS, 1993, J CLIN INVEST, V92, P1412, DOI 10.1172/JCI116717
   FOUBISTER V, 1994, INFECT IMMUN, V62, P3038, DOI 10.1128/IAI.62.7.3038-3040.1994
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x
   KAPER JB, 1999, PATHOGENICITY ISLAND, P33
   Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7
   Khursigara C, 2001, INFECT IMMUN, V69, P6573, DOI 10.1128/IAI.69.11.6573-6579.2001
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000
   Loureiro I, 1998, J PEDIATR GASTR NUTR, V27, P166, DOI 10.1097/00005176-199808000-00007
   Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549
   MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983
   Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403
   Parissi-Crivelli A, 2000, J CLIN MICROBIOL, V38, P2696, DOI 10.1128/JCM.38.7.2696-2700.2000
   Pelayo JS, 1999, J MED MICROBIOL, V48, P41, DOI 10.1099/00222615-48-1-41
   Retamal CA, 1999, ANAL BIOCHEM, V268, P15, DOI 10.1006/abio.1998.2977
   RILEY LW, 1990, MOL MICROBIOL, V4, P1661, DOI 10.1111/j.1365-2958.1990.tb00543.x
   Sanches MI, 2000, J PEDIATR GASTR NUTR, V30, P73, DOI 10.1097/00005176-200001000-00021
   Schriefer A, 1999, VACCINE, V17, P770, DOI 10.1016/S0264-410X(98)00261-8
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Sohel I, 1996, J BACTERIOL, V178, P2613, DOI 10.1128/jb.178.9.2613-2628.1996
   Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x
   Tacket CO, 2000, INFECT IMMUN, V68, P3689, DOI 10.1128/IAI.68.6.3689-3695.2000
   Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799
   Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821
NR 30
TC 10
Z9 10
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD JUN
PY 2002
VL 25
IS 1
BP 16
EP 22
DI 10.1006/prep.2001.1604
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 569GG
UT WOS:000176592400003
PM 12071694
DA 2020-12-16
ER

PT J
AU da Silva, JV
   Garcia, AB
   Flores, VMQ
   de Macedo, ZS
   Medina-Acosta, E
AF da Silva, JV
   Garcia, AB
   Flores, VMQ
   de Macedo, ZS
   Medina-Acosta, E
TI Phytosecretion of enteropathogenic Escherichia coli pilin subunit A in
   transgenic tobacco and its suitability for early life vaccinology
SO VACCINE
LA English
DT Article
DE recombinant BfpA; drinkable vaccine; phytosecretion
ID BUNDLE-FORMING PILUS; B SURFACE-ANTIGEN; HUMAN COLOSTRUM; ORAL
   IMMUNIZATION; VIRULENCE DETERMINANTS; RECOMBINANT PROTEINS;
   POLYACRYLAMIDE-GELS; PLANTS; EXPRESSION; ANTIBODIES
AB A plant expression cassette system was engineered to efficiently target proteins to the default secretory pathway, allowing the expression of DNA inserts in three frames as, fusion proteins containing a synthetic tobacco calreticulin cleavable signal peptide sequence, with the advantage of producing the recombinant proteins by phytosecretion. As one approach to develop a vaccine to enteropathogenic Escherichia coli (EPEC) infection, the oral immunogenicity of phytosecreted BfpA, the structural subunit A of the bundle-forming pilus. expressed at high levels (7.7% of soluble protein) in transgenic tobacco tissues, was demonstrated in BALB/c mice by the induction and detection of fecal anti-BfpA antibodies. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Estadual Norte Fluminense, Microbial Biotechnol Sect, Lab Biotechnol, Ctr Biosci & Biotechnol, BR-28015620 Campos Dos Goytacazes, Brazil.
   Univ Estadual Norte Fluminense, Plant Biotechnol Sect, Lab Biotechnol, Ctr Biosci & Biotechnol, BR-28015620 Campos Dos Goytacazes, Brazil.
RP Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Microbial Biotechnol Sect, Lab Biotechnol, Ctr Biosci & Biotechnol, Ave Alberto Lamego 2000, BR-28015620 Campos Dos Goytacazes, Brazil.
EM enrique@medina-acosta.com
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
CR Adu-Bobie J, 1998, INFECT IMMUN, V66, P5643, DOI 10.1128/IAI.66.12.5643-5649.1998
   Akiyama H, 2001, IMMUNOL LETT, V78, P1, DOI 10.1016/S0165-2478(01)00229-2
   Arakawa T, 1998, NAT BIOTECHNOL, V16, P292, DOI 10.1038/4381
   Arakawa T, 1997, TRANSGENIC RES, V6, P403, DOI 10.1023/A:1018487401810
   Arntzen CJ, 1998, NAT MED, V4, P502, DOI 10.1038/nm0598supp-502
   BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711
   Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427
   Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466
   CAMARA LM, 1995, ADV EXP MED BIOL, V371, P673
   Carbonare SB, 1997, J DIARRHOEAL DIS RES, V15, P53
   Danner K, 1997, COMP IMMUNOL MICROB, V20, P3, DOI 10.1016/S0147-9571(96)00032-X
   de Andrade J A, 1999, Rev Assoc Med Bras (1992), V45, P121
   Dearman RJ, 2001, TOXICOL LETT, V120, P181, DOI 10.1016/S0378-4274(01)00276-4
   DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777
   Delneri MT, 1997, EUR J PEDIATR, V156, P493, DOI 10.1007/s004310050646
   Fagundes-Neto U, 2000, Sao Paulo Med J, V118, P21, DOI 10.1590/S1516-31802000000100006
   Gil F, 2001, FEBS LETT, V488, P13, DOI 10.1016/S0014-5793(00)02405-4
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   Gomez N, 1998, VIROLOGY, V249, P352, DOI 10.1006/viro.1998.9315
   HAQ TA, 1995, SCIENCE, V268, P714, DOI 10.1126/science.7732379
   HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9
   JERSE AE, 1991, INFECT IMMUN, V59, P3869, DOI 10.1128/IAI.59.11.3869-3875.1991
   Kelly D, 2000, P NUTR SOC, V59, P177, DOI 10.1017/S0029665100000197
   Komarnytsky S, 2000, PLANT PHYSIOL, V124, P927, DOI 10.1104/pp.124.3.927
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Loureiro I, 1998, J PEDIATR GASTR NUTR, V27, P166, DOI 10.1097/00005176-199808000-00007
   Martinez MB, 1999, J INFECT DIS, V179, P269, DOI 10.1086/314549
   Mason HS, 1998, VACCINE, V16, P1336, DOI 10.1016/S0264-410X(98)80020-0
   MASON HS, 1995, TRENDS BIOTECHNOL, V13, P388, DOI 10.1016/S0167-7799(00)88986-6
   MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745
   Mason HS, 1996, P NATL ACAD SCI USA, V93, P5335, DOI 10.1073/pnas.93.11.5335
   Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7
   Parissi-Crivelli A, 2000, J CLIN MICROBIOL, V38, P2696, DOI 10.1128/JCM.38.7.2696-2700.2000
   Retamal CA, 1999, ANAL BIOCHEM, V268, P15, DOI 10.1006/abio.1998.2977
   Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153
   Sanches MI, 2000, J PEDIATR GASTR NUTR, V30, P73, DOI 10.1097/00005176-200001000-00021
   Schriefer A, 1999, VACCINE, V17, P770, DOI 10.1016/S0264-410X(98)00261-8
   Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7
   Streatfield SJ, 2001, VACCINE, V19, P2742, DOI 10.1016/S0264-410X(00)00512-0
   Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619
   Walmsley AM, 2000, CURR OPIN BIOTECH, V11, P126, DOI 10.1016/S0958-1669(00)00070-7
NR 43
TC 10
Z9 12
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 15
PY 2002
VL 20
IS 16
BP 2091
EP 2101
AR PII S0264-410X(02)00057-9
DI 10.1016/S0264-410X(02)00057-9
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 558VQ
UT WOS:000175988000011
PM 11972978
DA 2020-12-16
ER

PT J
AU Vieira-da-Motta, O
   Ribeiro, PD
   da Silva, WD
   Medina-Acosta, E
AF Vieira-da-Motta, O
   Ribeiro, PD
   da Silva, WD
   Medina-Acosta, E
TI RNAIII Inhibiting Peptide (RIP) inhibits agr-regulated toxin production
SO PEPTIDES
LA English
DT Article
DE enterotoxin; hemolysin; IgY; quorum sensing; Staphylococcus
ID STAPHYLOCOCCUS-AUREUS; SAR LOCUS; GENE-EXPRESSION; VIRULENCE; BACTERIA;
   GROWTH; TRANSDUCTION; AUTOINDUCER; PHEROMONE; SYSTEM
AB Staphylococcal enterotoxins (SEs) are emetic toxins that cause food poisoning. SEs also function as powerful pyrogenic toxin superantigens that stimulate non-specific T-cell proliferation. Together with the hemolysins, SEs have been largely implicated as virulence factors in multiple infection models. Recent biochemical and genetic analyses have demonstrated that production of some of these toxins is partially regulated by quorum sensing mechanisms where proteins and peptides activate the accessory gene regulator (agr). Because toxin production is central to bacterial pathogenesis, therapeutic strategies alternative to antibiotics, and based on rational interference of the quorum sensing systems involved, are currently being developed. This approach would lead to repression of toxin production and, thus, to disease prevention. Here we provide evidence to conclude that synthetic analogs of the RNAIII inhibiting peptide (RIP) and antibodies to its target molecule TRAP function in vitro as efficient suppressors of agr-regulated exotoxin production by Staphylococcus aureus. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biol Reconhecer, Norte Fluminense, Brazil.
   Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Norte Fluminense, Brazil.
RP Medina-Acosta, E (corresponding author), Ave Alberto Lamego 2000,Campos Goytacazes, BR-28015620 Goytacazes, Brazil.
RI Medina-Acosta, Enrique/G-3041-2010; Vieira-da-Motta, Olney/U-7146-2019
OI Medina-Acosta, Enrique/0000-0002-2529-0548; 
CR Almeida CMC, 1998, VET REC, V143, P579, DOI 10.1136/vr.143.21.579
   Balaban N, 2000, PEPTIDES, V21, P1301, DOI 10.1016/S0196-9781(00)00272-2
   BALABAN N, 1995, P NATL ACAD SCI USA, V92, P1619, DOI 10.1073/pnas.92.5.1619
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200
   Balandin A, 2000, PHYS LOW-DIMENS STR, V1-2, P1
   Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9
   Bayer MG, 1996, J BACTERIOL, V178, P4563, DOI 10.1128/jb.178.15.4563-4570.1996
   BETLEY MJ, 1992, CHEM IMMUNOL, V55, P1
   Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469
   CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994
   Cheung AL, 1997, J BACTERIOL, V179, P3963, DOI 10.1128/jb.179.12.3963-3971.1997
   CZOP JK, 1974, INFECT IMMUN, V9, P229, DOI 10.1128/IAI.9.2.229-235.1974
   Ferens WA, 1998, J NAT TOXINS, V7, P193
   GASKILL ME, 1988, J BIOL CHEM, V263, P6276
   Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7
   Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469
   Heinrichs JH, 1996, J BACTERIOL, V178, P418, DOI 10.1128/jb.178.2.418-423.1996
   Hellingwerf KJ, 1998, ANTON LEEUW INT J G, V74, P211, DOI 10.1023/A:1001738419877
   Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218
   NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645
   NYCHAS GJ, 1991, J APPL BACTERIOL, V70, P344, DOI 10.1111/j.1365-2672.1991.tb02947.x
   OTERO A, 1990, APPL ENVIRON MICROB, V56, P555, DOI 10.1128/AEM.56.2.555-559.1990
   Otto M, 1999, FEBS LETT, V450, P257, DOI 10.1016/S0014-5793(99)00514-1
   PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988
   RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517
   REGASSA LB, 1991, INFECT IMMUN, V59, P955, DOI 10.1128/IAI.59.3.955-962.1991
   SugitaKonishi Y, 1996, BIOSCI BIOTECH BIOCH, V60, P886, DOI 10.1271/bbb.60.886
   Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639
   TREMAINE MT, 1993, INFECT IMMUN, V61, P356, DOI 10.1128/IAI.61.1.356-359.1993
   Zhang SP, 2000, J BACTERIOL, V182, P2321, DOI 10.1128/JB.182.8.2321-2325.2000
NR 33
TC 42
Z9 47
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0196-9781
J9 PEPTIDES
JI Peptides
PD OCT
PY 2001
VL 22
IS 10
BP 1621
EP 1627
DI 10.1016/S0196-9781(01)00497-1
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
GA 480ZE
UT WOS:000171492600011
PM 11587790
DA 2020-12-16
ER

PT J
AU Balaban, N
   Collins, LV
   Cullor, JS
   Hume, EB
   Medina-Acosta, E
   da Motta, OV
   O'Callaghan, R
   Rossitto, PV
   Shirtliff, ME
   da Silveira, LS
   Tarkowski, A
   Torres, JV
AF Balaban, N
   Collins, LV
   Cullor, JS
   Hume, EB
   Medina-Acosta, E
   da Motta, OV
   O'Callaghan, R
   Rossitto, PV
   Shirtliff, ME
   da Silveira, LS
   Tarkowski, A
   Torres, JV
TI Prevention of diseases caused by Staphylococcus aureus using the peptide
   RIP
SO PEPTIDES
LA English
DT Article
ID GENE REGULATOR AGR; ALPHA-TOXIN; SEPTIC ARTHRITIS; VIRULENCE FACTORS;
   BOVINE MASTITIS; PATHOGENESIS; EXPRESSION; INFECTION; BACTERIA;
   OSTEOMYELITIS
AB Staphylococcus aureus causes many diseases including cellulitis, keratitis, osteomyelitis, septic arthritis and mastitis. The heptapeptide RIP has been shown to prevent cellulitis in mice, which was induced by S. aureus strain Smith diffuse. Here we show that RIP can also significantly reduce the overall pathology and delay the onset of disease symptoms in several other models of S. aureus infections, including: keratitis (tested in rabbits against S. aureus 8325-4), osteomyelitis (tested in rabbits against S. aureus MS), mastitis (tested in cows against S, aureus Newbould 305, AE-1, and environmental infections) and septic arthritis (tested in mice against S. aureus LS-1). These findings substantiate that RIP is not strain specific in its inhibitory activity and that RIP is an effective inhibitor of bacterial pathology at multiple body sites following diverse routes and doses of administration. These findings strongly evidence the potential value of RIP as a chemotherapeutic agent. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Univ Calif Davis, Dept Med Pathol, Davis, CA 95616 USA.
   Univ Gothenburg, Dept Rheumatol, S-41346 Gothenburg, Sweden.
   Univ Calif, Dairy Food Safety Lab, Vet Med Teaching & Res Ctr, Tulare, CA 93274 USA.
   Louisiana State Univ, Med Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.
   Univ Estadual Norte Fluminense, Biotechnol Lab, Ctr Biosci & Biotechnol, Rio De Janeiro, Brazil.
   Univ Texas, Med Branch, Dept Immunol & Microbiol, Galveston, TX 77555 USA.
   Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.
RP Balaban, N (corresponding author), Univ Calif Davis, Dept Med Pathol, Davis, CA 95616 USA.
RI Shirtliff, Mark E/H-2563-2017; Medina-Acosta, Enrique/G-3041-2010
OI Shirtliff, Mark E/0000-0002-8913-3445; Medina-Acosta,
   Enrique/0000-0002-2529-0548
CR Aarestrup FM, 1999, APMIS, V107, P425, DOI 10.1111/j.1699-0463.1999.tb01576.x
   Aarestrup FM, 1998, MICROB DRUG RESIST, V4, P247, DOI 10.1089/mdr.1998.4.247
   ABDELNOUR A, 1994, J INFECT DIS, V170, P94, DOI 10.1093/infdis/170.1.94
   ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993
   ASBELL P, 1982, ARCH OPHTHALMOL-CHIC, V100, P77, DOI 10.1001/archopht.1982.01030030079005
   BALABAN N, 1995, P NATL ACAD SCI USA, V92, P1619, DOI 10.1073/pnas.92.5.1619
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   BALABAN N, 2000, SCIENCE, V287, pA391
   Bayer MG, 1996, J BACTERIOL, V178, P4563, DOI 10.1128/jb.178.15.4563-4570.1996
   BREMELL T, 1990, ARTHRITIS RHEUM, V33, P1739, DOI 10.1002/art.1780331120
   BREMELL T, 1994, INFECT IMMUN, V62, P2334, DOI 10.1128/IAI.62.6.2334-2344.1994
   BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991
   Byrne PAC, 1998, CLIN RHEUMATOL, V17, P407, DOI 10.1007/BF01450904
   CALLEGAN MC, 1994, CLIN PHARMACOKINET, V27, P129, DOI 10.2165/00003088-199427020-00005
   CALLEGAN MC, 1994, INFECT IMMUN, V62, P2478, DOI 10.1128/IAI.62.6.2478-2482.1994
   Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469
   Chien YT, 1998, J BIOL CHEM, V273, P2645, DOI 10.1074/jbc.273.5.2645
   Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157
   GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995
   Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7
   Hardman AM, 1998, ANTON LEEUW INT J G, V74, P199, DOI 10.1023/A:1001178702503
   Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Jiang RS, 1999, AM J RHINOL, V13, P273, DOI 10.2500/105065899782102917
   Kantzanou M, 1999, J ANTIMICROB CHEMOTH, V43, P729, DOI 10.1093/jac/43.5.729
   Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x
   Kusachi S, 1999, SURG TODAY, V29, P724, DOI 10.1007/BF02482316
   Laughlin Richard T., 1994, Current Opinion in Rheumatology, V6, P401, DOI 10.1097/00002281-199407000-00009
   Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406
   Lina G, 1998, MOL MICROBIOL, V28, P655, DOI 10.1046/j.1365-2958.1998.00830.x
   Lindsay JA, 1999, MOL GEN GENET, V262, P323, DOI 10.1007/s004380051090
   LOPES CAD, 1990, BRIT VET J, V146, P443
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218
   Meyer D, 1998, AIDS RES HUM RETROV, V14, P751, DOI 10.1089/aid.1998.14.751
   MOERFELDT E, 1995, EMBO J, V14, P4569
   Moreau JM, 1997, CURR EYE RES, V16, P1221, DOI 10.1076/ceyr.16.12.1221.5022
   NEWBOULD FH, 1974, CAN J COMP MED, V38, P411
   Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999
   NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645
   NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x
   NOVICK RP, 2000, SCIENCE, V287, pA391
   OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997
   Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102
   Saad TF, 1999, AM J KIDNEY DIS, V34, P1114, DOI 10.1016/S0272-6386(99)70018-1
   Shirtliff ME, 1999, HDB ANIMAL MODELS IN, P581
   SUTRA L, 1994, J MED MICROBIOL, V40, P79, DOI 10.1099/00222615-40-2-79
   Timmins BS, 1999, FEMS MICROBIOL LETT, V172, P173
   Waage S, 1999, J DAIRY SCI, V82, P712, DOI 10.3168/jds.S0022-0302(99)75288-4
   Weiss CA, 1999, ARCH SURG-CHICAGO, V134, P1041, DOI 10.1001/archsurg.134.10.1041
   Weston VC, 1999, ANN RHEUM DIS, V58, P214, DOI 10.1136/ard.58.4.214
NR 51
TC 68
Z9 76
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN 0196-9781
J9 PEPTIDES
JI Peptides
PD SEP
PY 2000
VL 21
IS 9
BP 1301
EP 1311
DI 10.1016/S0196-9781(00)00272-2
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
GA 371WJ
UT WOS:000165202000001
PM 11072116
DA 2020-12-16
ER

PT J
AU Cupolillo, E
   Medina-Acosta, E
   Noyes, H
   Momen, H
   Grimaldi, G
AF Cupolillo, E
   Medina-Acosta, E
   Noyes, H
   Momen, H
   Grimaldi, G
TI A revised classification for Leishmania and Endotrypanum
SO PARASITOLOGY TODAY
LA English
DT Editorial Material
ID SP-N KINETOPLASTIDA; TRYPANOSOMATIDAE; EVOLUTION; COMPLEX
C1 FIOCRUZ, Lab Leishmaniose, Dept Immunol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   Univ Estadual Norte Fluminense, Campos, RJ, Brazil.
   Univ Liverpool, Liverpool Sch Trop Med, Dept Genet, Liverpool L3 5QA, Merseyside, England.
   FIOCRUZ, Inst Oswaldo Cruz, Dept Biochem & Mol Biol, Rio De Janeiro, Brazil.
RP Cupolillo, E (corresponding author), FIOCRUZ, Lab Leishmaniose, Dept Immunol, Inst Oswaldo Cruz, Av Braxil 4365, BR-21045900 Rio De Janeiro, Brazil.
RI Medina-Acosta, Enrique/G-3041-2010; Momen, Hooman/A-1850-2008;
   Cupolillo, Elisa/U-1667-2019; Noyes, Harry A/B-1151-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Momen,
   Hooman/0000-0002-2324-1515; Cupolillo, Elisa/0000-0002-0620-3250; Noyes,
   Harry A/0000-0002-0656-200X
CR Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45
   Chang K. P., 1985, Leishmaniasis. (Human Parasitic Diseases Vol.1.), P1
   Croan DG, 1997, MOL BIOCHEM PARASIT, V89, P149, DOI 10.1016/S0166-6851(97)00111-4
   CROFT SL, 1980, ANN TROP MED PARASIT, V74, P585, DOI 10.1080/00034983.1980.11687391
   Cupolillo E., 1998, Memorias do Instituto Oswaldo Cruz, V93, P186
   Cupolillo E, 1998, MEM I OSWALDO CRUZ, V93, P677, DOI 10.1590/S0074-02761998000500020
   FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608
   Franco AMR, 1996, PARASITOLOGY, V113, P39, DOI 10.1017/S0031182000066257
   GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993
   GRIMALDI G, 1992, MEM I OSWALDO CRUZ, V87, P221, DOI 10.1590/S0074-02761992000200009
   KREUTZER RD, 1991, AM J TROP MED HYG, V44, P662, DOI 10.4269/ajtmh.1991.44.662
   Lainson R, 1997, MEM I OSWALDO CRUZ, V92, P377, DOI 10.1590/S0074-02761997000300014
   LAINSON R, 1987, LEISHMANIASES BIOL M, V1, P1
   MCMAHONPRATT D, 1992, MOL BIOCHEM PARASIT, V50, P151, DOI 10.1016/0166-6851(92)90252-F
   MEDINAACOSTA E, 1994, EUR J BIOCHEM, V225, P333, DOI 10.1111/j.1432-1033.1994.00333.x
   Mesnil F, 1908, CR SOC BIOL, V65, P581
   Noyes HA, 1997, J EUKARYOT MICROBIOL, V44, P511, DOI 10.1111/j.1550-7408.1997.tb05732.x
   Noyes HA, 1996, MOL BIOCHEM PARASIT, V80, P119, DOI 10.1016/0166-6851(96)02679-5
   PACHECO RS, 1990, T ROY SOC TROP MED H, V84, P531, DOI 10.1016/0035-9203(90)90027-C
   Shaw Jeffrey J., 1992, Ciencia e Cultura (Sao Paulo), V44, P107
   SHAW JJ, 1969, LONDON SCH HYGIENE T, V13
   SOARES MJ, 1990, MEM I OSWALDO CRUZ, V86, P175
   WALTERS LL, 1993, J EUKARYOT MICROBIOL, V40, P196, DOI 10.1111/j.1550-7408.1993.tb04904.x
NR 23
TC 77
Z9 80
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0169-4758
J9 PARASITOL TODAY
JI Parasitol. Today
PD APR
PY 2000
VL 16
IS 4
BP 142
EP 144
DI 10.1016/S0169-4758(99)01609-9
PG 3
WC Parasitology
SC Parasitology
GA 299EA
UT WOS:000086181700006
PM 10725899
DA 2020-12-16
ER

PT J
AU Cupolillo, E
   Pereira, LOR
   Fernandes, O
   Catanho, MP
   Pereira, JC
   Medina-Acosta, E
   Grimaldi, G
AF Cupolillo, E
   Pereira, LOR
   Fernandes, O
   Catanho, MP
   Pereira, JC
   Medina-Acosta, E
   Grimaldi, G
TI Genetic data showing evolutionary links between Leishmania and
   Endotrypanum
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT 3rd International Meeting on Molecular Epidemiology and Evolutionary
   Genetics of Infectious Diseases
CY JUN 07-10, 1998
CL RIO JANEIRO, BRAZIL
SP ORSTOM, CNRS, Ctr Dis Control & Prevent, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, CNPq, Brazil, FAPERJ, Brazil, CAPES, Brazil, FNS, Brazil, INTERACTIVA Biotechnol Gmbh, Sigma Chem Co, Brazil
DE Leishmania colombiensis; Leishmania equatorensis; Endotrypanum;
   multilocus enzyme electrophoresis; molecular characterization; numerical
   analysis; sialidase activity; kDNA
ID SP-N KINETOPLASTIDA; SAND FLIES; NEW-WORLD; VIANNIA; TRYPANOSOMATIDAE;
   PARASITE; SLOTHS; CLASSIFICATION; HYBRIDIZATION; COLOMBIENSIS
AB Striking similarities at the morphological, molecular and biological levels exist between many trypanosomatids isolated from sylvatic insects and/or vertebrate reservoir hosts that make the identification of medically important parasites demanding. Some molecular data have pointed to the relationship between some Leishmania species and Endotrypanum, which has an important epidemiological significance and can be helpful to understand the evolution of those parasites. In this study, Mle have demonstrated a close genetic relationship between Endotrypanum and two new leishmanial species, L. (V.) colombiensis and L. (V.) equatorensis. We have used (a) numerical zymotaxonomy and (b) the variability of the internal transcribed spacers of the rRNA genes to examine relationships in this group. The evolutionary trees obtained, revealed high genetic similarity between L. (V.) colombiensis, L. (V.) equatorensis and Endotrypanum, for ming a tight cluster of parasites. Based on further results of (c) minicircle kDNA heterogeneity analysis and (d) measurement of the sialidase activity these parasites were also grouped together.
C1 Inst Oswaldo Cruz, Dept Imunol, Lab Leishmaniose, BR-21045900 Rio De Janeiro, RJ, Brazil.
   Inst Oswaldo Cruz, Dept Trop Med, BR-21045900 Rio De Janeiro, RJ, Brazil.
   Univ Estadual do Norte Fluminense, Lab Biotecnol, BR-28015620 Campos, RJ, Brazil.
RP Cupolillo, E (corresponding author), Inst Oswaldo Cruz, Dept Imunol, Lab Leishmaniose, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
RI Cupolillo, Elisa/U-1667-2019; Pereira, Luiza O R/P-7606-2018;
   Medina-Acosta, Enrique/G-3041-2010
OI Cupolillo, Elisa/0000-0002-0620-3250; Pereira, Luiza O
   R/0000-0002-8132-1724; Medina-Acosta, Enrique/0000-0002-2529-0548
CR ARIAS JR, 1985, AM J TROP MED HYG, V34, P1096
   CHRISTENSEN HA, 1976, J MED ENTOMOL, V13, P299, DOI 10.1093/jmedent/13.3.299
   CHRISTENSEN HA, 1979, J MED ENTOMOL, V16, P424, DOI 10.1093/jmedent/16.5.424
   Croan D, 1996, MOL BIOCHEM PARASIT, V79, P97, DOI 10.1016/0166-6851(96)02629-1
   Croan DG, 1997, MOL BIOCHEM PARASIT, V89, P149, DOI 10.1016/S0166-6851(97)00111-4
   CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296
   CUPOLILLO E, 1995, MOL BIOCHEM PARASIT, V73, P145, DOI 10.1016/0166-6851(95)00108-D
   Cupolillo E, 1997, ANN TROP MED PARASIT, V91, P617, DOI 10.1080/00034989760716
   DEANE LEONIDAS M., 1961, REV INST MED TROP SAO PAULO, V3, P15
   DELGADO O, 1993, AM J TROP MED HYG, V48, P145, DOI 10.4269/ajtmh.1993.48.145
   FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608
   Fernandes O, 1996, MEM I OSWALDO CRUZ, V91, P279, DOI 10.1590/S0074-02761996000300005
   FERNANDES O, 1995, ANN TROP MED PARASIT, V89, P81, DOI 10.1080/00034983.1995.11812932
   FLOCH H, 1954, ARCH I PASTEUR GUYAN, V15, P328
   Franco AMR, 1996, PARASITOLOGY, V113, P39, DOI 10.1017/S0031182000066257
   Franco AMR, 1997, MEM I OSWALDO CRUZ, V92, P63, DOI 10.1590/S0074-02761997000100013
   FRESH S, 1995, T ROY SOC TROP MED H, V89, P231, DOI 10.1016/0035-9203(95)90509-X
   GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993
   GRIMALDI G, 1992, MEM I OSWALDO CRUZ, V87, P221, DOI 10.1590/S0074-02761992000200009
   GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687
   HERRER A, 1971, J PARASITOL, V57, P626, DOI 10.2307/3277928
   KREUTZER RD, 1991, AM J TROP MED HYG, V44, P662, DOI 10.4269/ajtmh.1991.44.662
   KUMAR S, 1993, MEGA MOL EVOLUTIONAR
   LAINSON R, 1977, Acta Amazonica, V7, P51
   LAINSON R, 1972, BRIT MED BULL, V28, P44, DOI 10.1093/oxfordjournals.bmb.a070892
   LAINSON R, 1989, ANN PARASIT HUM COMP, V64, P200, DOI 10.1051/parasite/1989643200
   Lainson R, 1997, MEM I OSWALDO CRUZ, V92, P377, DOI 10.1590/S0074-02761997000300014
   MEDINAACOSTA E, 1994, EUR J BIOCHEM, V225, P333, DOI 10.1111/j.1432-1033.1994.00333.x
   Noyes HA, 1997, J EUKARYOT MICROBIOL, V44, P511, DOI 10.1111/j.1550-7408.1997.tb05732.x
   Noyes HA, 1996, MOL BIOCHEM PARASIT, V80, P119, DOI 10.1016/0166-6851(96)02679-5
   PACHECO RS, 1990, T ROY SOC TROP MED H, V84, P531, DOI 10.1016/0035-9203(90)90027-C
   PIPKIN AC, 1968, J MED ENTOMOL, V5, P107, DOI 10.1093/jmedent/5.1.107
   ROGERS WO, 1988, AM J TROP MED HYG, V39, P434, DOI 10.4269/ajtmh.1988.39.434
   Shaw J. J., 1981, Parasitological topics -- a presentation volume to P.C.C. Garnham, F.R.S. on the occasion of his 80th birthday, 1981., P232
   Shaw Jeffrey J., 1992, Ciencia e Cultura (Sao Paulo), V44, P107
   THOMAZSOCCOL V, 1993, ANN PARASIT HUM COMP, V68, P107
   TRAVI BL, 1989, J PARASITOL, V75, P218, DOI 10.2307/3282770
   ZELEDON R, 1975, AM J TROP MED HYG, V24, P706, DOI 10.4269/ajtmh.1975.24.706
NR 38
TC 11
Z9 11
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP-OCT
PY 1998
VL 93
IS 5
BP 677
EP 683
DI 10.1590/S0074-02761998000500020
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 119UJ
UT WOS:000075915900020
PM 9830537
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Jansen, AM
   Madeira, F
   Carreira, JC
   MedinaAcosta, E
   Deane, MP
AF Jansen, AM
   Madeira, F
   Carreira, JC
   MedinaAcosta, E
   Deane, MP
TI Trypanosoma cruzi in the opossum Didelphis marsupialis: A study of the
   correlations and kinetics of the systemic and scent gland infections in
   naturally and experimentally infected animals
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE opossum; marsupialia; didelphidae; Didelphis marsupialis; wild
   reservoir; kinetoplastida
ID EPIDEMIOLOGY
AB The genus Didelphis (Marsupialia, Didelphidae) has the unique capacity of supporting both multiplication cycles of Trypanosoma cruzi simultaneously; besides the intracellular forms, the epimastigotes can be found multiplying and differentiating abundantly in the lumen of the scent glands. The biological significance of the life cycle of T. cruzi within the scent glands of Didelphis marsupialis, as well as its contribution to the epidemiology of the disease, is presently unclear. In order to clarify the mechanisms involved in the colonization of this singular habitat by T. cruzi, as well as to understand its biological role, we have carried out a serological and parasitological follow-up of both natural and experimental infections of young and adult opossums. Although all natural infections were stable and long lasting, no infected scent glands were found, indicating that the stability of the systemic infections does not depend on the presence of flagellates in the scent gland. In 84% of the experimentally infected animals the colonization of the scent glands was preceded by a period of patent parasitemia. Parasitism of the scent glands was essentially permanent and bilateral, and its maintenance was independent of circulating parasites. Moreover, the course of the infection differed depending on the source (scent glands versus axenic culture-derived) of the metacyclic forms. Our results suggest that parasitism of the SG of D. marsupialis is most likely a secondary acquisition, a step toward independence from the insect vector, similarly to what is accepted for Trypanosoma equiperdum. (C) 1997 Academic Press.
C1 UENF,DEPT BIOTECHNOL,S JOSE CAMPOS,RJ,BRAZIL.
RP Jansen, AM (corresponding author), INST OSWALDO CRUZ,DEPT PROTOZOOL,AVE BRASIL 4365,BR-21040900 RIO JANEIRO,BRAZIL.
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Jansen, Ana
   Maria/0000-0001-5804-6210
CR CARREIRA JCA, 1990, THESIS O CRUZ I RIO
   CARREIRA JCA, 1983, ANN 10 ANN M BAS RES
   Deane M.P., 1984, Memorias do Instituto Oswaldo Cruz, V79, P513, DOI 10.1590/S0074-02761984000400021
   DEANE M P, 1988, Memorias do Instituto Oswaldo Cruz, V83, P273, DOI 10.1590/S0074-02761988000300002
   DEANE MP, 1990, J PROTOZOOL, V37, P44, DOI 10.1111/j.1550-7408.1990.tb01112.x
   FERNANDES A J, 1987, Memorias do Instituto Oswaldo Cruz, V82, P65
   FERNANDES AP, 1994, P NATL ACAD SCI USA, V90, P5776
   GALVAOQUINTAO L, 1991, MEMORIAS I O CRUZ S1, V86, P128
   Guimaraes F. M., 1943, Memorias do Instituto Oswaldo Cruz, V38, P437
   JANSEN A M, 1988, Memorias do Instituto Oswaldo Cruz, V83, P271, DOI 10.1590/S0074-02761988000300001
   Jansen A M, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P491, DOI 10.1590/S0074-02761988000500055
   JANSEN AM, 1985, T ROY SOC TROP MED H, V79, P474, DOI 10.1016/0035-9203(85)90069-0
   JANSEN AM, 1991, EXPT PARASITOLOGY, V79, P249
   LENZI HL, 1984, MEM I OSWALDO CRUZ S, V79, P7
   MCKEEVER S, 1958, J PARASITOL, V44, P583, DOI 10.2307/3274538
   MELLO GB, 1942, J PARASITOL, V56, P38
   MILES MA, 1983, T ROY SOC TROP MED H, V77, P5, DOI 10.1016/0035-9203(83)90004-4
   NAIFF RD, 1989, MEM I OSWALDO CRUZ, V84, P273, DOI 10.1590/S0074-02761989000200020
   NAIFF RD, 1987, ANN 10 M BRAS SOC PA, V165, P234
   PINHO RT, 1991, ACTA TROP, V50, P29, DOI 10.1016/0001-706X(91)90070-Z
   SOUZALEAO S, 1987, MEMORIAS I O CRUZ S, V82, P1967
   STEINDEL M, 1988, MEMORIAS I O CRUZ, V79, P513
   VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8
   ZELEDON R, 1970, J PARASITOL, V56, P38
NR 24
TC 14
Z9 15
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0014-4894
J9 EXP PARASITOL
JI Exp. Parasitol.
PD MAY
PY 1997
VL 86
IS 1
BP 37
EP 44
DI 10.1006/expr.1997.4144
PG 8
WC Parasitology
SC Parasitology
GA WY119
UT WOS:A1997WY11900005
PM 9149239
DA 2020-12-16
ER

PT J
AU MEDINAACOSTA, E
   FRANCO, AMR
   JANSEN, AM
   NEVES, N
   SAMPOL, M
   PONTESDECARVALHO, L
   GRIMALDI, G
   NUSSENZWEIG, V
AF MEDINAACOSTA, E
   FRANCO, AMR
   JANSEN, AM
   NEVES, N
   SAMPOL, M
   PONTESDECARVALHO, L
   GRIMALDI, G
   NUSSENZWEIG, V
TI TRANS-SIALIDASE AND SIALIDASE ACTIVITIES DISCRIMINATE BETWEEN
   MORPHOLOGICALLY INDISTINGUISHABLE TRYPANOSOMATIDS
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; GENUS ENDOTRYPANUM; MAMMALIAN-CELLS; CRUZI;
   RANGELI; LEISHMANIA; INVASION; PROTOZOA; ACID; DNA
AB The expression of trans-sialidase and sialidase activities in the kinetoplastid protozoa was explored as a potential marker to discriminate between the morphologically indistinguishable flagellates isolated from human, insects and vertebrate reservoir hosts. By virtue of the differences observed in the ratios of these enzyme activities, a collection of 52 species and strains comprising the major taxa of these parasites could be separated into four expression types. Type-I parasites express comparable levels of both trans-sialidase and sialidase activities (Endotrypanum species and Trypanosoma lewisi). Type-II parasites express predominantly trans-sialidase activity (Trypanosoma cruzi and Trypanosoma conorhini). Type-III parasites express sialidase activity exclusively (Trypanosoma rangeli and Trypanosoma leeuwenhoeki). Type-IV parasites do not express either activity (Leishmania species and Trypanoplasma borreli). The measurement of trans-sialidase and sialidase activities thus permits the differentiation of parasites frequently found in the same insect vectors that are difficult to distinguish, such as T. cruzi and T. rangeli, or in the same sylvatic vertebrate and invertebrate hosts, such as Leishmania and Endotrypanum.
C1 NYU,MED CTR,DEPT PATHOL,MICHAEL HEIDELBERGER DIV IMMUNOL,NEW YORK,NY 10016.
   INST OSWALDO CRUZ,RIO JANEIRO,BRAZIL.
   UFBA,INST CIENCIAS SAUDE,SALVADOR,BA,BRAZIL.
   FDN OSWALDO CRUZ,CTR PESQUISAS GONCALO MONIZ,RIO JANEIRO,BRAZIL.
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Jansen, Ana
   Maria/0000-0001-5804-6210; Ramos Franco, Antonia
   Maria/0000-0002-4300-5325
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI032966, R01AI032966, R01AI032966, R01AI032966, R01AI032966,
   R01AI032966, R01AI032966, R01AI032966, R01AI032966, R01AI032966] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI32966] Funding
   Source: Medline
CR ANTHONY RL, 1985, AM J TROP MED HYG, V34, P1085, DOI 10.4269/ajtmh.1985.34.1085
   ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098
   BRIONES MRS, 1994, IN PRESS J MOL EVOLU
   Brown WH, 1914, J EXP MED, V19, P406, DOI 10.1084/jem.19.4.406
   CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993
   CAZZULO JJ, 1992, FASEB J, V6, P3259
   CHRISTENSEN HA, 1976, J MED ENTOMOL, V13, P299, DOI 10.1093/jmedent/13.3.299
   CHRISTENSEN HA, 1982, AM J TROP MED HYG, V31, P243, DOI 10.4269/ajtmh.1982.31.243
   COLLI W, 1993, FASEB J, V7, P1257
   CROFT SL, 1980, ANN TROP MED PARASIT, V74, P585, DOI 10.1080/00034983.1980.11687391
   DALESSANDRO A, 1920, BIOL KINETOPLASTIDA, V1, P327
   DEANE MP, 1963, J PROTOZOOL, V10, P391, DOI 10.1111/j.1550-7408.1963.tb01694.x
   DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465
   DECARVALHO LCP, 1993, MOL BIOCHEM PARASIT, V62, P19
   EBERT F, 1986, TROP MED PARASITOL, V37, P251
   ENGSTLER M, 1993, MOL BIOCHEM PARASIT, V61, P1, DOI 10.1016/0166-6851(93)90153-O
   ENGSTLER M, 1993, PARASITOL TODAY, V9, P222, DOI 10.1016/0169-4758(93)90018-B
   FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608
   FERNANDES O, 1993, PARASITOLOGY, V107, P219, DOI 10.1017/S003118200007918X
   FRANCO AMR, 1993, MEM I O CRUZ, V88, P298
   GONCALVES AM, 1991, MEM I OSWALDO CRUZ, V86, P477, DOI 10.1590/S0074-02761991000400021
   GREIG SR, 1989, T ROY SOC TROP MED H, V83, P196, DOI 10.1016/0035-9203(89)90641-X
   GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993
   HENDRICKS LD, 1978, PARASITOLOGY, V76, P309, DOI 10.1017/S0031182000048186
   HUDSON L, 1987, ACTA TROP, V44, P387
   LANDWEBER LF, 1994, P NATL ACAD SCI USA, V91, P918, DOI 10.1073/pnas.91.3.918
   LOPES AHCS, 1989, J PROTOZOOL, V36, P354, DOI 10.1111/j.1550-7408.1989.tb05526.x
   LOPES AHDS, 1990, MOL BIOCHEM PARASIT, V40, P151
   MASLOV DA, 1994, NATURE, V368, P345, DOI 10.1038/368345a0
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   MEDINAACOSTA E, 1994, MOL BIOCHEM PARASIT, V64, P273, DOI 10.1016/0166-6851(94)00029-8
   MILES MA, 1983, AM J TROP MED HYG, V32, P1251, DOI 10.4269/ajtmh.1983.32.1251
   Molyneux DH, 1983, BIOL TRYPANOSOMA LEI
   MURTHY VK, 1992, MOL CELL PROBE, V6, P237, DOI 10.1016/0890-8508(92)90022-P
   NOVAK EM, 1993, MOL BIOCHEM PARASIT, V60, P273, DOI 10.1016/0166-6851(93)90138-N
   PACHECO RS, 1990, T ROY SOC TROP MED H, V84, P531, DOI 10.1016/0035-9203(90)90027-C
   PIRAS MM, 1987, MOL BIOCHEM PARASIT, V22, P135, DOI 10.1016/0166-6851(87)90043-0
   PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9
   REUTER G, 1987, GLYCOCONJUGATE J, V4, P339, DOI 10.1007/BF01048367
   SANTOS IKFD, 1984, AM J TROP MED HYG, V33, P839, DOI 10.4269/ajtmh.1984.33.839
   SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M
   SCHENKMAN S, 1991, INFECT IMMUN, V59, P645, DOI 10.1128/IAI.59.2.645-654.1991
   SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435
   SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567
   SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A
   SCHOTTELIUS J, 1982, TROPENMED PARASITOL, V33, P147
   SCHOTTELIUS J, 1984, ACTA TROP, V41, P29
   SCHOTTELIUS J, 1987, TROP MED PARASITOL, V38, P323
   Shaw Jeffrey J., 1992, Ciencia e Cultura (Sao Paulo), V44, P107
   SHAW JJ, 1963, NATURE, V201, P417
   SOARES MJ, 1990, MEM I OSWALDO CRUZ, V86, P175
   STEINDEL M, 1991, MEM I OSWALDO CRUZ, V86, P73, DOI 10.1590/S0074-02761991000100012
   TOMLINSON S, 1994, IN PRESS J IMMUNOL
   TRAVI BL, 1989, J PARASITOL, V75, P218, DOI 10.2307/3282770
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   VALLEJO GA, 1993, T ROY SOC TROP MED H, V87, P165, DOI 10.1016/0035-9203(93)90473-4
   Zeleclon R., 1974, CIBA F S, P51
   ZINGALES B, 1987, MOL BIOCHEM PARASIT, V26, P135, DOI 10.1016/0166-6851(87)90137-X
NR 58
TC 21
Z9 21
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD OCT 1
PY 1994
VL 225
IS 1
BP 333
EP 339
DI 10.1111/j.1432-1033.1994.00333.x
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA PJ532
UT WOS:A1994PJ53200036
PM 7925453
OA Green Published, Bronze
DA 2020-12-16
ER

PT J
AU MEDINAACOSTA, E
   PAUL, S
   TOMLINSON, S
   PONTESDECARVALHO, LC
AF MEDINAACOSTA, E
   PAUL, S
   TOMLINSON, S
   PONTESDECARVALHO, LC
TI COMBINED OCCURRENCE OF TRYPANOSOMAL SIALIDASE/TRANS-SIALIDASE ACTIVITIES
   AND LEISHMANIAL METALLOPROTEINASE GENE HOMOLOGS IN ENDOTRYPANUM SP
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
DE ENDOTRYPANUM; KINETOPLASTID; METALLOPROTEINASE; NEURAMINIDASE;
   TRANS-SIALIDASE; SLOTH
ID PROMASTIGOTE SURFACE PROTEASE; PROCYCLIC CULTURE FORMS; RIBOSOMAL-RNA
   GENE; TRANS-SIALIDASE; PROTEINASE GP63; GLYCERALDEHYDE-3-PHOSPHATE
   DEHYDROGENASE; HERPETOMONAS-SAMUELPESSOAI; NEURAMINIDASE ACTIVITIES;
   CRITHIDIA-FASCICULATA; CRUZI
AB Endotrypanum (order Kinetoplastida: family Trypanosomatidae) is a parasite of forest dwelling tree sloths (Edentata: genera Choleopus and Bradypus). Unique among the haemoflagellates. this protozoan has an intraerythrocytic phase in the mammalian host. Nevertheless, many striking similarities exist between Endotrypanum and the human pathogen Leishmania that make it a useful model for epidemiological and evolutionary aspects of the biology of trypanosomatids. Importantly, Endotrypanum species share both the insect vector and host reservoir with certain species of Leishmania (subgenus Viannia). Because mixed infections with Endotrypanum and Leishmania are common in sloths and, therefore, likely to occur in the sandfly vector, there is a need for adequate biochemical markers to distinguish Endotrypanum from Leishmania infections. In this paper we show that Endotrypanum promastigotes possess sialidase and trans-sialidase activities, which are absent from Leishmania, and which are not closely related to the previously described trypanosomal sialidase/trans-sialidase enzyme. We also document the occurrence in Endotrypanum of homologues of the leishmanial surface metalloproteinase gp63 genes. The combined occurrence of sialidase/trans-sialidase activities and gp63 gene homologues in a unique organism has important ramifications for both field and laboratory studies on the biology of trypanosomatids, especially those related to host infection and evolution.
C1 ROCKEFELLER UNIV, NEW YORK, NY 10021 USA.
   FDN OSWALDO CRUZ, CTR PESQUISAS GONCALO MONIZ, SALVADOR, BA, BRAZIL.
RP MEDINAACOSTA, E (corresponding author), NYU, MED CTR,DEPT PATHOL, MICHAEL HEIDELBERGER DIV IMMUNOL,MSB RM 131, 550 1ST AVE, NEW YORK, NY 10016 USA.
RI Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 21539, AI 22229, K11-AI 01071-02]
   Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI022229, R01AI022229, R01AI022229,
   R01AI022229, K11AI001071, R01AI022229, K11AI001071, R01AI022229,
   K11AI001071, K11AI001071, R01AI022229, R01AI022229, K11AI001071] Funding
   Source: NIH RePORTER
CR Baker J. R., 1965, P1
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BRIONES MRS, 1992, MOL BIOCHEM PARASIT, V53, P121, DOI 10.1016/0166-6851(92)90014-B
   BRUN R, 1979, ACTA TROP, V36, P289
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   CHAVES LB, 1993, MOL BIOCHEM PARASIT, V61, P97, DOI 10.1016/0166-6851(93)90162-Q
   CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125
   DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465
   DECARVALHO LCP, 1993, MOL BIOCHEM PARASIT, V62, P19
   ENGSTLER M, 1993, MOL BIOCHEM PARASIT, V61, P1, DOI 10.1016/0166-6851(93)90153-O
   ENGSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21, DOI 10.1016/0166-6851(92)90091-W
   ENGSTLER M, 1993, PARASITOL TODAY, V9, P222, DOI 10.1016/0169-4758(93)90018-B
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   HANNAERT V, 1992, MOL BIOCHEM PARASIT, V55, P115, DOI 10.1016/0166-6851(92)90132-4
   INVERSO JA, 1993, MOL BIOCHEM PARASIT, V57, P47, DOI 10.1016/0166-6851(93)90242-P
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0
   LAKE JA, 1988, P NATL ACAD SCI USA, V85, P4779, DOI 10.1073/pnas.85.13.4779
   LOPES AHDS, 1990, MOL BIOCHEM PARASIT, V40, P151
   LUMSDEN WHR, 1974, TRYPANOSOMIASIS LEIS, P3
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   MEDINAACOSTA E, 1993, INFECT AGENT DIS, V2, P25
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   MICHELS PAM, 1991, EUR J BIOCHEM, V198, P421, DOI 10.1111/j.1432-1033.1991.tb16031.x
   MING M, 1993, MOL BIOCHEM PARASIT, V59, P243, DOI 10.1016/0166-6851(93)90222-J
   PARODI AJ, 1992, EMBO J, V11, P1705, DOI 10.1002/j.1460-2075.1992.tb05221.x
   PEREIRA MEA, 1983, SCIENCE, V219, P1444, DOI 10.1126/science.6338592
   POWELL LD, 1986, ANAL BIOCHEM, V157, P179, DOI 10.1016/0003-2697(86)90211-3
   Reutter W, 1982, CELL BIOL MONOGR, P263
   ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x
   ROGGENTIN P, 1988, FEBS LETT, V238, P31, DOI 10.1016/0014-5793(88)80219-9
   RUSSELL DG, 1989, IMMUNOL TODAY, V10, P328, DOI 10.1016/0167-5699(89)90188-6
   RUSSELL DG, 1986, J IMMUNOL, V136, P2613
   SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M
   SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567
   SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A
   SCHNEIDER P, 1993, MOL BIOCHEM PARASIT, V58, P277, DOI 10.1016/0166-6851(93)90049-4
   SCUDDER P, 1993, J BIOL CHEM, V268, P9886
   Shaw Jeffrey J., 1992, Ciencia e Cultura (Sao Paulo), V44, P107
   TAKLE GB, 1991, MOL BIOCHEM PARASIT, V48, P185, DOI 10.1016/0166-6851(91)90114-L
   UEMURA H, 1992, EMBO J, V11, P3837, DOI 10.1002/j.1460-2075.1992.tb05476.x
   VICKERMAN K, 1976, BIOL KENETOPLASTIDA
   WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4
   ZINGALES B, 1987, MOL BIOCHEM PARASIT, V26, P135, DOI 10.1016/0166-6851(87)90137-X
NR 44
TC 19
Z9 20
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
EI 1872-9428
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD APR
PY 1994
VL 64
IS 2
BP 273
EP 282
DI 10.1016/0166-6851(94)00029-8
PG 10
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA NP202
UT WOS:A1994NP20200009
PM 7935605
OA Green Published
DA 2020-12-16
ER

PT J
AU CONNELL, ND
   MEDINAACOSTA, E
   MCMASTER, WR
   BLOOM, BR
   RUSSELL, DG
AF CONNELL, ND
   MEDINAACOSTA, E
   MCMASTER, WR
   BLOOM, BR
   RUSSELL, DG
TI EFFECTIVE IMMUNIZATION AGAINST CUTANEOUS LEISHMANIASIS WITH RECOMBINANT
   BACILLE CALMETTE-GUERIN EXPRESSING THE LEISHMANIA SURFACE PROTEINASE
   GP63
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID T-CELLS; GLYCOPROTEIN; INFECTION; IMMUNITY; MICE; BCG; IMMUNOTHERAPY;
   AMASTIGOTE; RESPONSES; INDUCTION
AB Leishmania parasites cause a spectrum of diseases that afflict the populations of 86 countries in the world. The parasites can survive within the lysosomal compartments of the host's macrophages, unless those macrophages are appropriately activated. Despite the fact that protective immunity can be induced by vaccination with crude parasite preparations, little progress has been made toward a defined vaccine for humans. In this study the gene encoding the Leishmania surface proteinase gp63 was cloned and expressed as a cytoplasmic protein in a bacille Calmette-Guerin (BCG) vaccine strain. BALB/c and CBA/J mice were inoculated with a single dose of recombinant BCG and challenged with infective Leishmania major or Leishmania mexicana promastigotes. Significant protection was observed in both mouse strains against L. mexicana and in CBA/J against L. major, whereas only a delay in L. major growth was seen in BALB/c mice. Recombinant BCG also engendered a strong protective response against challenge with amastigotes of L. mexicana, demonstrating that the induced immune response recognized the intracellular form of the parasite. The results support the view that recombinant BCG expressing gp63 may prove a useful vaccine for inducing protective cell-mediated immune responses to Leishmania species causing American cutaneous leishmaniasis.
C1 YESHIVA UNIV ALBERT EINSTEIN COLL MED, HOWARD HUGHES MED INST, 1300 MORRIS PK AVE, BRONX, NY 10461 USA.
   YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MICROBIOL & IMMUNOL, BRONX, NY 10461 USA.
   ROCKEFELLER UNIV, MOLEC PARASITOL LAB, NEW YORK, NY 10021 USA.
   UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER V6T 1W5, BC, CANADA.
   WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA.
RI Medina-Acosta, Enrique/G-3041-2010; Russell, David G/N-5280-2019;
   Russell, David G/D-4533-2009
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Russell, David
   G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI23545, AI26491, AI26889] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P01AI026491, R37AI023545, P01AI026491, R01AI023545,
   R01AI023545, P01AI026491, P01AI026491, P01AI026491, P01AI026491,
   P01AI026491, P01AI026491, R01AI026889, P01AI026491, P01AI026491,
   R01AI026889, P01AI026491, R37AI023545, R37AI023545, P01AI026491,
   R37AI023545, P01AI026491, R37AI023545, R37AI023545, P01AI026491,
   R01AI023545, P01AI026491, R01AI023545, R01AI023545, P01AI026491,
   P01AI026491, P01AI026491, R01AI026889, R01AI023545, P01AI026491,
   P01AI026491, P01AI026491, P01AI026491, R01AI023545, P01AI026491,
   R37AI023545, R01AI023545, P01AI026491, P01AI026491, P01AI026491,
   P01AI026491, P01AI026491, P01AI026491, P01AI026491, P01AI026491,
   R01AI026889, P01AI026491, P01AI026491, P01AI026491, R01AI023545,
   R37AI023545, P01AI026491, R01AI023545, R37AI023545, P01AI026491,
   R01AI026889, R37AI023545] Funding Source: NIH RePORTER
CR BAHR V, 1993, MOL BIOCHEM PARASIT, V58, P107, DOI 10.1016/0166-6851(93)90095-F
   BUTTON LL, 1991, MOL BIOCHEM PARASIT, V44, P213, DOI 10.1016/0166-6851(91)90007-S
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   CONVIT J, 1989, J INFECT DIS, V160, P104, DOI 10.1093/infdis/160.1.104
   CONVIT J, 1987, LANCET, V1, P401
   FORTIER AH, 1987, INFECT IMMUN, V55, P1707, DOI 10.1128/IAI.55.7.1707-1714.1987
   FROMMEL TO, 1990, MOL BIOCHEM PARASIT, V38, P25, DOI 10.1016/0166-6851(90)90201-V
   HOLADAY BJ, 1991, J IMMUNOL, V147, P1653
   ILG T, 1993, FEBS LETT, V327, P103, DOI 10.1016/0014-5793(93)81049-6
   JACOBS WR, 1990, CURR TOP MICROBIOL, V155, P153
   JARDIM A, 1990, J EXP MED, V172, P645, DOI 10.1084/jem.172.2.645
   LEZAMADAVILA CM, 1992, PARASITE IMMUNOL, V14, P37, DOI 10.1111/j.1365-3024.1992.tb00004.x
   LIEW FY, 1989, IMMUNOL TODAY, V10, P40, DOI 10.1016/0167-5699(89)90302-2
   LIEW FY, 1992, CHEM IMMUNOL, V54, P117
   LIEW FY, 1985, CURR TOP MICROBIOL, V122, P122
   LOCKSLEY RM, 1991, RES IMMUNOL, V142, P28, DOI 10.1016/0923-2494(91)90007-6
   LOCKSLEY RM, 1991, IMMUNOL TODAY, V12, P58
   LOHMAN KL, 1990, P NATL ACAD SCI USA, V87, P8393, DOI 10.1073/pnas.87.21.8393
   MEDINAACOSTA E, 1993, INFECT AGENT DIS, V2, P25
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   MOLYNEUX DH, 1983, BIOL TRYPANOSOMA LEI, P185
   MULLER I, 1989, ANNU REV IMMUNOL, V7, P561, DOI 10.1146/annurev.iy.07.040189.003021
   RACHAMIM N, 1993, J IMMUNOL, V150, P2322
   RUSSELL DG, 1988, J IMMUNOL, V140, P1274
   RUSSELL DG, 1992, J CELL SCI, V103, P1193
   RUSSO DM, 1993, J IMMUNOL, V150, P932
   SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I
   SCHNEIDER P, 1992, EXP PARASITOL, V75, P196, DOI 10.1016/0014-4894(92)90179-E
   SMITH LE, 1991, J EXP MED, V174, P499, DOI 10.1084/jem.174.3.499
   STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0
   YANG DM, 1990, J IMMUNOL, V145, P2281
NR 32
TC 184
Z9 187
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 15
PY 1993
VL 90
IS 24
BP 11473
EP 11477
DI 10.1073/pnas.90.24.11473
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA MM515
UT WOS:A1993MM51500009
PM 8265576
OA Green Published, Bronze
DA 2020-12-16
ER

PT J
AU MEDINAACOSTA, E
   CROSS, GAM
AF MEDINAACOSTA, E
   CROSS, GAM
TI RAPID ISOLATION OF DNA FROM TRYPANOSOMATID PROTOZOA USING A SIMPLE
   MINI-PREP PROCEDURE
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Note
DE DNA ISOLATION; TRYPANOSOMA; LEISHMANIA; LEPTOMONAS; CRITHIDIA
ID GENES
AB Although several methods for isolating genomic DNA from trypanosomatid protozoa exist [1-3], all are time-consuming and cumbersome. Faster, simpler and efficient protocols for preparation of DNA from these protozoa are needed to ease the screening of mutants and transfectants. We describe the use of a bacterial lysis method to isolate chromosomal DNA from a wide range of trypanosomatids. The method is based on the finding reported by He et al. [4], who noticed that phenol/chloroform treatment of Escherichia coli cells in the presence of LiCl and Triton X-100 solubilizes plasmid DNA, while precipitating unwanted chromosomal DNA and denatured cellular proteins. In applying this lysis method to the isolation of episomal DNA from transfected trypanosomatids, we found that, unlike bacterial genomic DNA, chromosomal DNA of trypanosomatids was soluble in the phenol/chloroform/Triton/LiCl mixture. This observation prompted us to use the bacterial lysis method as a routine protocol for extraction of DNA from trypanosomatids.
RP MEDINAACOSTA, E (corresponding author), ROCKEFELLER UNIV,MOLEC PARASITOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.
RI Cross, George/B-7444-2011; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Cross,
   George/0000-0003-1374-6955
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 22229, AI 21539] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI022229, R01AI022229, R01AI022229, R01AI022229,
   R01AI022229, R01AI022229, R01AI022229, R01AI022229] Funding Source: NIH
   RePORTER
CR BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3
   HE M, 1990, NUCLEIC ACIDS RES, V18, P1660, DOI 10.1093/nar/18.6.1660
   LANDFEAR SM, 1983, MOL CELL BIOL, V3, P1070, DOI 10.1128/MCB.3.6.1070
   MANIATIS T, 1982, MOL CLONING
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P5905, DOI 10.1093/nar/10.19.5905
NR 6
TC 217
Z9 220
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD JUN
PY 1993
VL 59
IS 2
BP 327
EP 329
DI 10.1016/0166-6851(93)90231-L
PG 3
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA LE849
UT WOS:A1993LE84900016
PM 8341329
DA 2020-12-16
ER

PT J
AU FIELD, MC
   MEDINAACOSTA, E
   CROSS, GAM
AF FIELD, MC
   MEDINAACOSTA, E
   CROSS, GAM
TI INHIBITION OF GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS IN
   LEISHMANIA-MEXICANA BY MANNOSAMINE
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROMASTIGOTE SURFACE PROTEASE; PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR;
   N-LINKED OLIGOSACCHARIDES; TRYPANOSOMA-BRUCEI; DONOVANI
   LIPOPHOSPHOGLYCAN; GLYCOPROTEIN; IDENTIFICATION; GLYCOLIPIDS; PROTEINS;
   GP63
AB In several Leishmania species, glycosylated inositol phospholipids exist as free lipids, as membrane protein anchors, and as the membrane-binding moieties of the lipophosphoglycans. Both the glycolipid-anchored cell surface metalloproteinase, gp63, and the lipophosphoglycans have been proposed to be involved in cell invasion. Moreover, the lipophosphoglycans have been implicated in the survival of Leishmania in the parasitophorous vacuole of the host macrophage. In this report we show that mannosamine effectively inhibits the biosynthesis of both free glycosylated inositol phospholipids and the lipophosphoglycans of Leishmania mexicana. [H-3]Mannosamine is incorporated into glycosylated inositol phospholipids, but not significantly into lipophosphoglycans when added as a radiochemical tracer at a subinhibitory concentration. The reversible inhibitory effect of mannosamine may be useful for studying precursor/product relationships during the biosynthesis of free glycosylated inositol phospholipids, glycolipid anchors, and the lipophosphoglycans. The implications of these data for the mode of action of mannosamine are discussed.
C1 ROCKEFELLER UNIV, MOLEC PARASITOL LAB, 1230 YORK AVE, NEW YORK, NY 10021 USA.
RI Cross, George/B-7444-2011; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Cross,
   George/0000-0003-1374-6955; Field, Mark/0000-0002-4866-2885
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI21513] Funding Source: Medline
CR ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x
   BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324
   BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988
   BOUVIER J, 1987, MOL BIOCHEM PARASIT, V24, P73, DOI 10.1016/0166-6851(87)90117-4
   BRUN R, 1979, ACTA TROP, V36, P289
   CARVER MA, 1991, J BIOL CHEM, V266, P10974
   CHANG KP, 1983, INT REV CYTOL, P267
   CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245
   DIECKMANNSCHUPP.A, 1992, IN PRESS EUR J BIOCH
   DOERING TL, 1989, J BIOL CHEM, V264, P11168
   FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285
   FIELD MC, 1991, J BIOL CHEM, V266, P8392
   FIELD MC, 1991, MOL BIOCHEM PARASIT, V48, P227, DOI 10.1016/0166-6851(91)90118-P
   FIELD MC, 1992, LIPID MODIFICATIONS, P155
   HANDMAN E, 1985, EMBO J, V4, P329, DOI 10.1002/j.1460-2075.1985.tb03633.x
   ILG T, 1992, J BIOL CHEM, V267, P6834
   KELLEHER M, 1992, P NATL ACAD SCI USA, V89, P6, DOI 10.1073/pnas.89.1.6
   KING DL, 1988, MOL BIOCHEM PARASIT, V28, P285, DOI 10.1016/0166-6851(88)90013-8
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LISANTI MP, 1991, EMBO J, V10, P1969, DOI 10.1002/j.1460-2075.1991.tb07726.x
   LOW P, 1991, J BIOL CHEM, V266, P19250
   MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3
   MAYOR S, 1990, J BIOL CHEM, V265, P6164
   MCCONVILLE MJ, 1992, J BIOL CHEM, V267, P5855
   MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385
   MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170
   MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611
   MCNEELY TB, 1990, J IMMUNOL, V144, P2745
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x
   MOSSER DM, 1992, J CELL BIOL, V116, P511, DOI 10.1083/jcb.116.2.511
   OLAFSON RW, 1990, J BIOL CHEM, V265, P12240
   ORLANDI PA, 1987, J BIOL CHEM, V262, P10384
   ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796
   PALADINI AC, 1952, BIOCHEM J, V51, P426, DOI 10.1042/bj0510426
   PAN YT, 1992, J BIOL CHEM, V267, P8991
   PAN YT, 1992, J BIOL CHEM, V267, P21250
   PAN YT, 1985, ARCH BIOCHEM BIOPHYS, V242, P447, DOI 10.1016/0003-9861(85)90229-2
   RUSSELL DG, 1988, J EXP MED, V168, P279, DOI 10.1084/jem.168.1.279
   SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955
   SCHWARZ RT, 1989, BIOCHEM SOC T, V17, P746, DOI 10.1042/bst0170746
   SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119
   TALAMASROHANA P, 1990, J IMMUNOL, V144, P4817
   THOMAS JR, 1992, J BIOL CHEM, V267, P6829
   TURCO SJ, 1987, BIOCHEMISTRY-US, V26, P6233, DOI 10.1021/bi00393a042
NR 45
TC 22
Z9 22
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 5
PY 1993
VL 268
IS 13
BP 9570
EP 9577
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LA689
UT WOS:A1993LA68900065
PM 8387500
DA 2020-12-16
ER

PT J
AU MEDINAACOSTA, E
   BEVERLEY, SM
   RUSSELL, DG
AF MEDINAACOSTA, E
   BEVERLEY, SM
   RUSSELL, DG
TI EVOLUTION AND EXPRESSION OF THE LEISHMANIA SURFACE PROTEINASE (GP63)
   GENE LOCUS
SO INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY
LA English
DT Review
DE LEISHMANIA; SURFACE PROTEINASE; GENE LOCUS
ID CUTANEOUS LEISHMANIASIS; MEMBRANE GLYCOPROTEIN; PROTEASE; MEXICANA;
   ANTIGENS; MOLECULE; STRAINS; LIPOPHOSPHOGLYCAN; ENDOPEPTIDASE;
   HETEROGENEITY
AB The Leishmania surface proteinase, gp63, is the most abundant, surface-exposed protein on the promastigote form of the parasite. It is the product of a multigene family that, in some Leishmania species, shows marked heterogeneity among its members. The differential expression of structurally distinct gp63 genes shows circumstantial correlation with the differential processing and localization of the protein in the intracellular, amastigote form of Leishmania mexicana. The recent cloning and sequencing of a homologous gene in the monoxenous trypanosomatid, Crithidia fasciculata, provides a reference sequence for comparison with ten Leishmania gp63 genes sequenced to date. The amino terminal and the carboxy terminal regions of the protein sequences suggest different evolutionary histories within some of the genes. The evolutionary significance of the structure, organization, and regulation of the gp63 genes from different Leishmania species is described and speculated upon.
C1 WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,660 S EUCLID AVE,ST LOUIS,MO 63110.
   ROCKEFELLER UNIV,MOLEC PARASITOL LAB,NEW YORK,NY 10021.
   HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115.
RI Russell, David G/D-4533-2009; Medina-Acosta, Enrique/G-3041-2010;
   Russell, David G/N-5280-2019
OI Russell, David G/0000-0002-9748-750X; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Russell, David G/0000-0002-9748-750X;
   Beverley, Stephen/0000-0001-5319-0811
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI21531, AI26889, AI22229] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI021531, R01AI022229, R01AI021531, R01AI026889,
   R01AI021531, R01AI021531, R01AI021531, R01AI022229, R01AI026889,
   R01AI021531, R01AI026889, R01AI021531, R01AI021531, R01AI021531,
   R01AI022229, R01AI021531, R01AI021531, R01AI021531, R01AI022229,
   R01AI026889, R01AI026889, R01AI022229, R01AI022229, R01AI022229,
   R01AI022229] Funding Source: NIH RePORTER
CR BAHR V, 1993, IN PRESS MOL BIOCH P
   BEVERLEY SM, 1987, P NATL ACAD SCI USA, V84, P484, DOI 10.1073/pnas.84.2.484
   BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988
   BOUVIER J, 1990, BIOCHEMISTRY-US, V29, P10113, DOI 10.1021/bi00495a015
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   BRIONES MRS, 1992, MOL BIOCHEM PARASIT, V53, P121, DOI 10.1016/0166-6851(92)90014-B
   BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   CAMPBELL DA, 1992, FEMS MICROBIOL LETT, V96, P89, DOI 10.1111/j.1574-6968.1992.tb05398.x
   CHANG CS, 1986, MOL BIOCHEM PARASIT, V18, P197, DOI 10.1016/0166-6851(86)90038-1
   CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245
   ETGES R, 1986, J BIOL CHEM, V261, P9098
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   FROMMEL TO, 1990, MOL BIOCHEM PARASIT, V38, P25, DOI 10.1016/0166-6851(90)90201-V
   HANDMAN E, 1990, EXP PARASITOL, V70, P427, DOI 10.1016/0014-4894(90)90127-X
   HANEKAMP T, 1991, MOL BIOCHEM PARASIT, V48, P27, DOI 10.1016/0166-6851(91)90161-X
   INVERSO JA, 1993, MOL BIOCHEM PARASIT, V57, P47, DOI 10.1016/0166-6851(93)90242-P
   IP HS, 1990, MOL BIOCHEM PARASIT, V40, P163, DOI 10.1016/0166-6851(90)90038-N
   JAFFE CL, 1990, CLIN EXP IMMUNOL, V80, P77, DOI 10.1111/j.1365-2249.1990.tb06444.x
   JARDIM A, 1990, J EXP MED, V172, P645, DOI 10.1084/jem.172.2.645
   KAHL LP, 1989, J IMMUNOL, V142, P4441
   LAINSON R, 1984, LEISHMANIASES, P1
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   MENDONCA SCF, 1991, CLIN EXP IMMUNOL, V83, P472, DOI 10.1111/j.1365-2249.1991.tb05663.x
   MILLER RA, 1990, MOL BIOCHEM PARASIT, V39, P267, DOI 10.1016/0166-6851(90)90065-T
   MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837
   MURRAY PJ, 1990, EXP PARASITOL, V71, P294, DOI 10.1016/0014-4894(90)90034-A
   RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888
   RUSSELL DG, 1988, J IMMUNOL, V140, P1274
   RUSSELL DG, 1992, J CELL SCI, V103, P1193
   RUSSELL DG, 1991, MOL IMMUNOLOGICAL AS, P72
   RUSSO DM, 1991, J IMMUNOL, V147, P3575
   SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955
   SCHNEIDER P, 1992, EXP PARASITOL, V75, P196, DOI 10.1016/0014-4894(92)90179-E
   SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364
   STEINER DF, 1992, J BIOL CHEM, V267, P23435
   STEINKRAUS HB, 1992, MOL BIOCHEM PARASIT, V52, P141, DOI 10.1016/0166-6851(92)90045-L
   TURCO SJ, 1990, EXP PARASITOL, V70, P241, DOI 10.1016/0014-4894(90)90105-L
   TZINIA AK, 1991, MOL BIOCHEM PARASIT, V47, P83, DOI 10.1016/0166-6851(91)90150-5
   ULIANA SRB, 1993, UNPUB IDENTIFICATION
   ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720
   WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4
   WEBB JR, 1991, MOL BIOCHEM PARASIT, V48, P173, DOI 10.1016/0166-6851(91)90113-K
   YANG DM, 1990, J IMMUNOL, V145, P2281
NR 47
TC 50
Z9 50
U1 0
U2 3
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 1056-2044
J9 INFECT AGENT DIS
JI Infect. Agents Dis.-Rev. Issues Comment.
PD FEB
PY 1993
VL 2
IS 1
BP 25
EP 34
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA KV874
UT WOS:A1993KV87400003
PM 8162351
DA 2020-12-16
ER

PT J
AU MEDINAACOSTA, E
   KARESS, RE
   RUSSELL, DG
AF MEDINAACOSTA, E
   KARESS, RE
   RUSSELL, DG
TI STRUCTURALLY DISTINCT GENES FOR THE SURFACE PROTEASE OF
   LEISHMANIA-MEXICANA ARE DEVELOPMENTALLY REGULATED
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
DE GP63; HETEROGENEITY; LEISHMANIA-MEXICANA; METALLOPROTEASE; STAGE
   REGULATION
ID TRANSPORTING ATPASE GENES; GLYCOPROTEIN GP63; MEMBRANE GLYCOPROTEIN;
   MOLECULAR KARYOTYPE; TRYPANOSOMA-BRUCEI; PROMASTIGOTES; ATTACHMENT;
   ACID; HETEROGENEITY; MACROPHAGES
AB gp63 is a highly abundant glycosylphosphatidylinositol (GPI)-anchored membrane protein expressed in both the promastigote and the amastigote forms of Leishmania species. In Leishmania mexicana, gp63 exists as a heterogeneous family of proteins that are differentially processed and localized during the 2 developmental stages. In this study we determined the molecular organization of the L. mexicana gp63 gene family, demonstrating that the gp63 genes fall into 3 linked families of tandemly repeated, but structurally distinct, entities designated as C1, C2 and C3. The C1 and C2 gene clusters contain 4-5 copies each, while the C3 gene may be single copy. Whilst promastigotes contain transcripts from all 3 gene classes, the intracellular amastigote only expresses detectable transcript from the C1 gene class. Moreover, the sequence of the C1 genes predicts a unique carboxy terminus substantially different from the GPI anchor addition signal sequence found in other Leishmania spp. and which has characteristics incompatible with substitution with a GPI anchor. These findings have significance for both the diversity of gp63 and for the regulation of tightly clustered, tandem gene arrays.
C1 NYU MED CTR,DEPT PATHOL,NEW YORK,NY 10016.
   NYU MED CTR,DEPT BIOCHEM,NEW YORK,NY 10016.
RI Russell, David G/N-5280-2019; Medina-Acosta, Enrique/G-3041-2010;
   Russell, David G/D-4533-2009
OI Russell, David G/0000-0002-9748-750X; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Russell, David G/0000-0002-9748-750X
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-26889] Funding Source: Medline; NIGMS
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM 37979] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI126889, R01AI026889, R01AI026889, R01AI026889, R01AI026889,
   R01AI026889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM037979, R01GM037979,
   R01GM037979] Funding Source: NIH RePORTER
CR ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6
   BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279
   BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988
   BOUVIER J, 1990, BIOCHEMISTRY-US, V29, P10113, DOI 10.1021/bi00495a015
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100
   CHANG CS, 1986, MOL BIOCHEM PARASIT, V18, P197, DOI 10.1016/0166-6851(86)90038-1
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   COLOMERGOULD V, 1985, J EXP MED, V162, P902, DOI 10.1084/jem.162.3.902
   CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245
   ETGES R, 1986, J BIOL CHEM, V261, P9098
   ETGES R, 1986, EMBO J, V5, P597, DOI 10.1002/j.1460-2075.1986.tb04252.x
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   FONG D, 1982, P NATL ACAD SCI-BIOL, V79, P7366, DOI 10.1073/pnas.79.23.7366
   FROMMEL TO, 1990, MOL BIOCHEM PARASIT, V38, P25, DOI 10.1016/0166-6851(90)90201-V
   GIANNINI SH, 1990, MOL BIOCHEM PARASIT, V39, P9, DOI 10.1016/0166-6851(90)90003-5
   HANEKAMP T, 1991, MOL BIOCHEM PARASIT, V48, P27, DOI 10.1016/0166-6851(91)90161-X
   IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131
   JARDIM A, 1990, J EXP MED, V172, P645, DOI 10.1084/jem.172.2.645
   JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5
   Kaiser K, 1985, DNA CLONING PRACTICA, P1
   KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0
   LANDFEAR SM, 1983, MOL CELL BIOL, V3, P1070, DOI 10.1128/MCB.3.6.1070
   LOWE ME, 1992, J CELL BIOL, V116, P799, DOI 10.1083/jcb.116.3.799
   MANIATIS T, 1982, LABORATORY MANUAL
   Maxam A M, 1980, Methods Enzymol, V65, P499
   MEADE JC, 1989, MOL BIOCHEM PARASIT, V33, P81, DOI 10.1016/0166-6851(89)90045-5
   MEADE JC, 1991, MOL BIOCHEM PARASIT, V45, P29, DOI 10.1016/0166-6851(91)90024-Z
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MICHELS PAM, 1986, EMBO J, V5, P1049, DOI 10.1002/j.1460-2075.1986.tb04321.x
   MILLER RA, 1990, MOL BIOCHEM PARASIT, V39, P267, DOI 10.1016/0166-6851(90)90065-T
   MURRAY PJ, 1990, EXP PARASITOL, V71, P294, DOI 10.1016/0014-4894(90)90034-A
   OLAFSON RW, 1990, J BIOL CHEM, V265, P12240
   OSINGA KA, 1985, EMBO J, V4, P3811, DOI 10.1002/j.1460-2075.1985.tb04152.x
   RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888
   RUSSELL DG, 1988, J IMMUNOL, V140, P1274
   RUSSELL DG, 1989, IMMUNOL TODAY, V10, P328, DOI 10.1016/0167-5699(89)90188-6
   RUSSELL DG, 1988, J EXP MED, V168, P279, DOI 10.1084/jem.168.1.279
   RUSSELL DG, 1986, J IMMUNOL, V136, P2613
   RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955
   SOTERIADOU KP, 1992, J BIOL CHEM, V267, P13980
   STEINKRAUS HB, 1992, MOL BIOCHEM PARASIT, V52, P141, DOI 10.1016/0166-6851(92)90045-L
   WEBB JR, 1991, MOL BIOCHEM PARASIT, V48, P173, DOI 10.1016/0166-6851(91)90113-K
   YANG DM, 1990, J IMMUNOL, V145, P2281
NR 49
TC 75
Z9 76
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD JAN
PY 1993
VL 57
IS 1
BP 31
EP 46
DI 10.1016/0166-6851(93)90241-O
PG 16
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA KG418
UT WOS:A1993KG41800003
PM 8426614
DA 2020-12-16
ER

PT J
AU INVERSO, JA
   MEDINAACOSTA, E
   OCONNOR, J
   RUSSELL, DG
   CROSS, GAM
AF INVERSO, JA
   MEDINAACOSTA, E
   OCONNOR, J
   RUSSELL, DG
   CROSS, GAM
TI CRITHIDIA-FASCICULATA CONTAINS A TRANSCRIBED LEISHMANIAL SURFACE
   PROTEINASE (GP63) GENE HOMOLOG
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
DE CRITHIDIA-FASCICULATA; GLYCOPROTEIN; LEISHMANIA; METALLOENDOPROTEINASE;
   PROTEINASE; GP63
ID GLYCOPROTEIN GP63; MEXICANA PROMASTIGOTES; MEMBRANE GLYCOPROTEIN;
   MOLECULAR KARYOTYPE; PROTEASE; MACROPHAGES; ATTACHMENT; ACID;
   IDENTIFICATION; PURIFICATION
AB We have cloned and analysed a gene from the insect parasite, Crithidia fasciculala, with homology to the gp63 metalloendoproteinase gene of Leishmania. The Crithidia gene homologue is arranged as a multicopy family comprised of approximately 7 genes. The mature transcript is 4.0 kb. The predicted amino acid sequence has significant homology with Leishmania gp63s, contains a zinc-binding motif and a potential site for addition of a glycosylphosphatidylinositol anchor. Demonstration of a gp63 homologue in C. fasciculata, a monogenetic parasite, suggests that the molecule may play a role in parasite survival within the insect gut.
C1 ROCKEFELLER UNIV, MOLEC PARASITOL LAB, 1230 YORK AVE, NEW YORK, NY 10021 USA.
   WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA.
RI Cross, George/B-7444-2011; Russell, David G/N-5280-2019; Medina-Acosta,
   Enrique/G-3041-2010; Russell, David G/D-4533-2009
OI Russell, David G/0000-0002-9748-750X; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Russell, David G/0000-0002-9748-750X;
   Cross, George/0000-0003-1374-6955
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI026197, R01AI026889, R01AI026197, R01AI026197, R01AI026197,
   R01AI026889, R01AI026197, R01AI026197, R01AI026889, R01AI026889,
   R01AI026889, R21AI126889, R01AI026197, R01AI026197] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI26889, AI26197] Funding
   Source: Medline
CR BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BOUVIER J, 1990, BIOCHEMISTRY-US, V29, P10113, DOI 10.1021/bi00495a015
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   BOUVIER J, 1985, J BIOL CHEM, V260, P5504
   BOUVIER J, 1987, MOL BIOCHEM PARASIT, V24, P73, DOI 10.1016/0166-6851(87)90117-4
   BRUN R, 1979, ACTA TROP, V36, P289
   BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100
   CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COLOMERGOULD V, 1985, J EXP MED, V162, P902, DOI 10.1084/jem.162.3.902
   CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245
   ETGES R, 1986, J BIOL CHEM, V261, P9098
   ETGES R, 1992, ACTA TROP, V50, P205, DOI 10.1016/0001-706X(92)90077-B
   ETGES RJ, 1985, MOL BIOCHEM PARASIT, V14, P141, DOI 10.1016/0166-6851(85)90033-7
   FROMMEL TO, 1990, MOL BIOCHEM PARASIT, V38, P25, DOI 10.1016/0166-6851(90)90201-V
   GIANNINI SH, 1990, MOL BIOCHEM PARASIT, V39, P9, DOI 10.1016/0166-6851(90)90003-5
   GREIG S, 1990, MOL BIOCHEM PARASIT, V39, P31, DOI 10.1016/0166-6851(90)90005-7
   HANEKAMP T, 1991, MOL BIOCHEM PARASIT, V48, P27, DOI 10.1016/0166-6851(91)90161-X
   HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7
   Hoare C.A., 1972, TRYPANOSOMES MAMMALS
   JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5
   LAKE JA, 1988, P NATL ACAD SCI USA, V85, P4779, DOI 10.1073/pnas.85.13.4779
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V57, P31, DOI 10.1016/0166-6851(93)90241-O
   MICHELS PAM, 1991, PARASITOL TODAY, V7, P105, DOI 10.1016/0169-4758(91)90167-M
   MILLER RA, 1990, MOL BIOCHEM PARASIT, V39, P267, DOI 10.1016/0166-6851(90)90065-T
   MOSSER DM, 1992, J CELL BIOL, V116, P511, DOI 10.1083/jcb.116.2.511
   RAMAMOORTHY R, 1992, J BIOL CHEM, V267, P1888
   Russell D.G., 1991, P73
   RUSSELL DG, 1986, J IMMUNOL, V136, P2613
   RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955
   STEINKRAUS HB, 1992, MOL BIOCHEM PARASIT, V52, P141, DOI 10.1016/0166-6851(92)90045-L
   WEBB JR, 1991, MOL BIOCHEM PARASIT, V48, P173, DOI 10.1016/0166-6851(91)90113-K
   WILSON ME, 1988, J IMMUNOL, V141, P265
NR 40
TC 48
Z9 49
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
EI 1872-9428
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD JAN
PY 1993
VL 57
IS 1
BP 47
EP 54
DI 10.1016/0166-6851(93)90242-P
PG 8
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA KG418
UT WOS:A1993KG41800004
PM 8426615
DA 2020-12-16
ER

PT J
AU FIELD, MC
   MEDINAACOSTA, E
   CROSS, GAM
AF FIELD, MC
   MEDINAACOSTA, E
   CROSS, GAM
TI CHARACTERIZATION OF A GLYCOSYLPHOSPHATIDYLINOSITOL MEMBRANE-PROTEIN
   ANCHOR PRECURSOR IN LEISHMANIA-MEXICANA
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Note
ID VARIANT SURFACE GLYCOPROTEINS; GLYCOLIPID PRECURSORS; RESISTANT
   GLYCOLIPIDS; LIPOPHOSPHOGLYCAN; BIOSYNTHESIS
RP FIELD, MC (corresponding author), ROCKEFELLER UNIV,MOLEC PARASITOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.
RI Cross, George/B-7444-2011; Medina-Acosta, Enrique/G-3041-2010
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Field,
   Mark/0000-0002-4866-2885; Cross, George/0000-0003-1374-6955
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI021531, R01AI021531, R01AI021531, R01AI021531, R01AI021531,
   R01AI021531, R01AI021531, R01AI021531, R01AI021531, R01AI021531,
   R01AI021531, R01AI021531] Funding Source: NIH RePORTER; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI21531] Funding Source: Medline
CR DOERING TL, 1989, J BIOL CHEM, V264, P11168
   FIELD MC, 1991, J BIOL CHEM, V266, P8392
   KRAKOW JL, 1986, J BIOL CHEM, V261, P2147
   LISANTI MP, 1991, IN PRESS EMBO J
   MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3
   MAYOR S, 1990, J BIOL CHEM, V265, P6164
   MAYOR S, 1990, J BIOL CHEM, V265, P6174
   MCCONVILLE MJ, 1987, P NATL ACAD SCI USA, V84, P8941, DOI 10.1073/pnas.84.24.8941
   MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385
   MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611
   MEDINAACOSTA E, 1989, MOL BIOCHEM PARASIT, V37, P263, DOI 10.1016/0166-6851(89)90158-8
   MENON AK, 1988, J BIOL CHEM, V263, P1970
   MENON AK, 1990, J BIOL CHEM, V265, P9033
   MURRAY PJ, 1989, J IMMUNOL, V143, P4221
   ROSEN G, 1989, J BIOL CHEM, V264, P10457
   SCHNEIDER P, 1990, J BIOL CHEM, V265, P16955
NR 16
TC 9
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD OCT
PY 1991
VL 48
IS 2
BP 227
EP 229
DI 10.1016/0166-6851(91)90118-P
PG 3
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA GE357
UT WOS:A1991GE35700011
PM 1837068
DA 2020-12-16
ER

PT B
AU RUSSELL, DG
   MEDINAACOSTA, E
   GOLUBEV, A
AF RUSSELL, DG
   MEDINAACOSTA, E
   GOLUBEV, A
BE SEILER, FR
   SCHWICK, HG
TI THE INTERFACE BETWEEN THE LEISHMANIA-INFECTED MACROPHAGE AND THE HOSTS
   IMMUNE-SYSTEM
SO BEHRING INSTITUTE MITTEILUNGEN, NO 88: MOLECULAR ASPECTS OF
   IMMUNOLOGICAL HOST-PARASITE-INTERACTIONS
SE BEHRING INSTITUTE MITTEILUNGEN
LA English
DT Proceedings Paper
CT 4TH INTERNATIONAL ERLANGEN WORKSHOP ON MOLECULAR ASPECTS OF
   IMMUNOLOGICAL HOST-PARASITE-INTERACTIONS
CY SEP 27-29, 1990
CL ERLANGEN, FED REP GER
SP ABBOTT, API BIOMERIEUX, BAYER, BECTON DICKINSON, BEECHAM, BEHRINGWERKE, BIOCHROM, BIOTEST PHARMA, CHARLES RIVER, ESSEX PHARMA
DE LEISHMANIA; MACROPHAGE; PHAGOCYTE; LYSOSOME; GP63
RI Medina-Acosta, Enrique/G-3041-2010; Russell, David G/N-5280-2019;
   Russell, David G/D-4533-2009
OI Medina-Acosta, Enrique/0000-0002-2529-0548; Russell, David
   G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 26889] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI026889, R01AI026889, R01AI026889, R21AI126889, R01AI026889,
   R01AI026889] Funding Source: NIH RePORTER
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MEDIZINISCHE VERLAGSGESELL MBH
PI MARBURG
PA MARBURG
J9 BEHR INST MITT
PY 1991
VL 88
BP 68
EP 79
PG 12
WC Biochemistry & Molecular Biology; Immunology; Microbiology; Parasitology
SC Biochemistry & Molecular Biology; Immunology; Microbiology; Parasitology
GA BU18W
UT WOS:A1991BU18W00009
PM 2049048
DA 2020-12-16
ER

PT J
AU MEDINAACOSTA, E
   KARESS, RE
   SCHWARTZ, H
   RUSSELL, DG
AF MEDINAACOSTA, E
   KARESS, RE
   SCHWARTZ, H
   RUSSELL, DG
TI THE PROMASTIGOTE SURFACE PROTEASE (GP63) OF LEISHMANIA IS EXPRESSED BUT
   DIFFERENTIALLY PROCESSED AND LOCALIZED IN THE AMASTIGOTE STAGE
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 NYU MED CTR, DEPT PATHOL, 550 1ST AVE, NEW YORK, NY 10016 USA.
   NYU MED CTR, DEPT BIOCHEM, NEW YORK, NY 10016 USA.
   MAX PLANCK INST BIOL, D-7400 TUBINGEN, GERMANY.
RI Russell, David G/N-5280-2019; Russell, David G/D-4533-2009;
   Medina-Acosta, Enrique/G-3041-2010
OI Russell, David G/0000-0002-9748-750X; Russell, David
   G/0000-0002-9748-750X; Medina-Acosta, Enrique/0000-0002-2529-0548
CR ALEXANDER J, 1975, J PROTOZOOL, V22, P502, DOI 10.1111/j.1550-7408.1975.tb05219.x
   BORDIER C, 1986, P NATL ACAD SCI USA, V83, P5988, DOI 10.1073/pnas.83.16.5988
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BOUVIER J, 1985, J BIOL CHEM, V260, P5504
   BOUVIER J, 1987, MOL BIOCHEM PARASIT, V24, P73, DOI 10.1016/0166-6851(87)90117-4
   BRUN R, 1979, ACTA TROP, V36, P289
   BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724
   BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5
   CARLEMALM E, 1982, J MICROSC-OXFORD, V126, P123, DOI 10.1111/j.1365-2818.1982.tb00362.x
   CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100
   CHANG CS, 1986, MOL BIOCHEM PARASIT, V18, P197, DOI 10.1016/0166-6851(86)90038-1
   CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742
   CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   COLOMERGOULD V, 1985, J EXP MED, V162, P902, DOI 10.1084/jem.162.3.902
   CONVIT J, 1982, INT J LEPROSY, V50, P415
   CONVIT J, 1987, LANCET, V1, P401
   COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753
   COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x
   DWYER DM, 1984, MOL BIOCHEM PARASIT, V10, P139, DOI 10.1016/0166-6851(84)90002-1
   ETGES R, 1986, J BIOL CHEM, V261, P9098
   ETGES RJ, 1985, MOL BIOCHEM PARASIT, V14, P141, DOI 10.1016/0166-6851(85)90033-7
   FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011
   FONG D, 1982, P NATL ACAD SCI-BIOL, V79, P7366, DOI 10.1073/pnas.79.23.7366
   GOTTLIEB M, 1981, EXP PARASITOL, V52, P117, DOI 10.1016/0014-4894(81)90067-9
   HANDMAN E, 1982, EXP PARASITOL, V54, P243, DOI 10.1016/0014-4894(82)90133-3
   HART DT, 1981, PARASITOLOGY, V82, P345, DOI 10.1017/S0031182000066889
   HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59
   HOWARD JG, 1986, INT REV EXP PATHOL, V28, P79
   HOWARD RJ, 1982, J PROTOZOOL, V29, P114, DOI 10.1111/j.1550-7408.1982.tb02891.x
   HUBBARD AL, 1975, J CELL BIOL, V64, P438, DOI 10.1083/jcb.64.2.438
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAINSON R, 1977, PROC R SOC SER B-BIO, V199, P309, DOI 10.1098/rspb.1977.0141
   LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x
   LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2
   MEDINAACOSTA E, 1989, J CELL BIOCH SE, V13, P111
   OUAISSI MA, 1988, PARASITOL TODAY, V4, P169, DOI 10.1016/0169-4758(88)90153-6
   RIZVI FS, 1988, EUR J IMMUNOL, V18, P473, DOI 10.1002/eji.1830180323
   RUSSELL DG, 1988, J IMMUNOL, V140, P1274
   RUSSELL DG, 1989, IMMUNOL TODAY, V10, P328, DOI 10.1016/0167-5699(89)90188-6
   RUSSELL DG, 1989, INFECT IMMUN, V57, P630, DOI 10.1128/IAI.57.2.630-632.1989
   RUSSELL DG, 1988, J EXP MED, V168, P279, DOI 10.1084/jem.168.1.279
   RUSSELL DG, 1987, ANN INST PASTEUR IMM, V138, P774, DOI 10.1016/S0769-2625(87)80037-5
   RUSSELL DG, 1986, J IMMUNOL, V136, P2613
   RUSSELL DG, 1984, MOL CELL BIOL, V4, P779, DOI 10.1128/MCB.4.4.779
   SADICK MD, 1985, INFECT IMMUN, V47, P395, DOI 10.1128/IAI.47.2.395-400.1985
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WEBSTER P, 1988, J CELL BIOL, V106, P279, DOI 10.1083/jcb.106.2.279
   WYLER DJ, 1985, INFECT IMMUN, V49, P305, DOI 10.1128/IAI.49.2.305-311.1985
   WYLER DJ, 1983, INFECT IMMUN, V42, P356, DOI 10.1128/IAI.42.1.356-361.1983
NR 50
TC 137
Z9 140
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
EI 1872-9428
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD DEC
PY 1989
VL 37
IS 2
BP 263
EP 273
DI 10.1016/0166-6851(89)90158-8
PG 11
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA CB549
UT WOS:A1989CB54900012
PM 2691889
DA 2020-12-16
ER

PT J
AU BUTTON, LL
   RUSSELL, DG
   KLEIN, HL
   MEDINAACOSTA, E
   KARESS, RE
   MCMASTER, WR
AF BUTTON, LL
   RUSSELL, DG
   KLEIN, HL
   MEDINAACOSTA, E
   KARESS, RE
   MCMASTER, WR
TI GENES ENCODING THE MAJOR SURFACE GLYCOPROTEIN IN LEISHMANIA ARE TANDEMLY
   LINKED AT A SINGLE CHROMOSOMAL LOCUS AND ARE CONSTITUTIVELY TRANSCRIBED
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 NYU MED CTR,DEPT PATHOL,NEW YORK,NY 10016.
   NYU MED CTR,DEPT BIOCHEM,NEW YORK,NY 10016.
RP BUTTON, LL (corresponding author), UNIV BRITISH COLUMBIA,DEPT MED GENET,226-6174 UNIV BLVD,VANCOUVER V6T 1W5,BC,CANADA.
RI Russell, David G/D-4533-2009; Russell, David G/N-5280-2019;
   Medina-Acosta, Enrique/G-3041-2010
OI Russell, David G/0000-0002-9748-750X; Russell, David
   G/0000-0002-9748-750X; Medina-Acosta, Enrique/0000-0002-2529-0548
FU NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399, S07RR005399, S07RR005399,
   S07RR005399, S07RR005399, S07RR005399] Funding Source: NIH RePORTER;
   NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [S07-RR5399-26] Funding Source: Medline
CR BELLOFATTO V, 1988, NUCLEIC ACIDS RES, V16, P3455, DOI 10.1093/nar/16.8.3455
   BENAMAR MF, 1988, MOL CELL BIOL, V8, P2166, DOI 10.1128/MCB.8.5.2166
   BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2
   BUTTON LL, 1988, J EXP MED, V167, P724, DOI 10.1084/jem.167.2.724
   CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756
   CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329
   CHANG CS, 1986, MOL BIOCHEM PARASIT, V18, P197, DOI 10.1016/0166-6851(86)90038-1
   COLOMERGOULD V, 1985, J EXP MED, V162, P902, DOI 10.1084/jem.162.3.902
   COMEAU AM, 1986, MOL BIOCHEM PARASIT, V21, P161, DOI 10.1016/0166-6851(86)90019-8
   DELANGE T, 1983, CELL, V34, P891, DOI 10.1016/0092-8674(83)90546-9
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   FONG D, 1982, P NATL ACAD SCI-BIOL, V79, P7366, DOI 10.1073/pnas.79.23.7366
   FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9
   GIANNINI SH, 1986, SCIENCE, V232, P762, DOI 10.1126/science.3961502
   GLASS DJ, 1986, MOL CELL BIOL, V6, P1457
   GONZALEZ A, 1985, NUCLEIC ACIDS RES, V13, P5789, DOI 10.1093/nar/13.16.5789
   JOHNSON PJ, 1987, CELL, V51, P273, DOI 10.1016/0092-8674(87)90154-1
   KRIEG PA, 1987, METHOD ENZYMOL, V155, P397
   LANDFEAR SM, 1986, MOL BIOCHEM PARASIT, V21, P235, DOI 10.1016/0166-6851(86)90129-5
   LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x
   LEBLANCQ SM, 1988, J MOL BIOL, V200, P439, DOI 10.1016/0022-2836(88)90534-7
   MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191
   MANIATIS T, 1982, MOL CLONING
   MEADE JC, 1987, MOL CELL BIOL, V7, P3937, DOI 10.1128/MCB.7.11.3937
   MICHELS PAM, 1986, EMBO J, V5, P1049, DOI 10.1002/j.1460-2075.1986.tb04321.x
   MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1
   NELSON RG, 1983, CELL, V34, P901, DOI 10.1016/0092-8674(83)90547-0
   REQUENA JM, 1988, NUCLEIC ACIDS RES, V16, P1393, DOI 10.1093/nar/16.4.1393
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUSSELL DG, 1988, J IMMUNOL, V140, P1274
   RUSSELL DG, 1988, J EXP MED, V168, P279, DOI 10.1084/jem.168.1.279
   RUSSELL DG, 1986, J IMMUNOL, V136, P2613
   SCHOLLER JK, 1986, MOL BIOCHEM PARASIT, V20, P279, DOI 10.1016/0166-6851(86)90108-8
   SEEBECK T, 1983, P NATL ACAD SCI-BIOL, V80, P4634, DOI 10.1073/pnas.80.15.4634
   SPITHILL TW, 1985, NUCLEIC ACIDS RES, V13, P4155, DOI 10.1093/nar/13.11.4155
   SPITHILL TW, 1987, MOL BIOCHEM PARASIT, V25, P279
   SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3
   THOMASHOW LS, 1983, CELL, V32, P35, DOI 10.1016/0092-8674(83)90494-4
   TSCHUDI C, 1985, P NATL ACAD SCI USA, V82, P3998, DOI 10.1073/pnas.82.12.3998
   TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x
   VANDERPLEG LHT, 1986, CELL, V47, P478
   WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814
NR 42
TC 120
Z9 120
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD JAN 15
PY 1989
VL 32
IS 2-3
BP 271
EP 283
DI 10.1016/0166-6851(89)90076-5
PG 13
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA R7215
UT WOS:A1989R721500016
PM 2927448
DA 2020-12-16
ER

EF